
<html lang="en"     class="pb-page"  data-request-id="20934d19-5d8f-41f6-82f7-ff94898df592"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-8;article:article:10.1021/acs.jmedchem.0c00396;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo" /></meta><meta name="dc.Creator" content="Zhiqiang  Li" /></meta><meta name="dc.Creator" content="Xinzhi  Li" /></meta><meta name="dc.Creator" content="Ming-Bo  Su" /></meta><meta name="dc.Creator" content="Li-Xin  Gao" /></meta><meta name="dc.Creator" content="Yu-Bo  Zhou" /></meta><meta name="dc.Creator" content="Bingchuan  Yuan" /></meta><meta name="dc.Creator" content="Xilin  Lyu" /></meta><meta name="dc.Creator" content="Ziqin  Yan" /></meta><meta name="dc.Creator" content="Chujiao  Hu" /></meta><meta name="dc.Creator" content="Hao  Zhang" /></meta><meta name="dc.Creator" content="Cheng  Luo" /></meta><meta name="dc.Creator" content="Zheng  Chen" /></meta><meta name="dc.Creator" content="Jia  Li" /></meta><meta name="dc.Creator" content="Yujun  Zhao" /></meta><meta name="dc.Description" content="The overexpression of NIK plays a critical role in liver inflammatory diseases. Treatment of such diseases with small-molecule NIK inhibitors is a reasonable but underexplored approach. In this pap..." /></meta><meta name="Description" content="The overexpression of NIK plays a critical role in liver inflammatory diseases. Treatment of such diseases with small-molecule NIK inhibitors is a reasonable but underexplored approach. In this pap..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 27, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00396" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00396" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00396" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00396" /></link>
        
    
    

<title>Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00396" /></meta><meta property="og:title" content="Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0021.jpeg" /></meta><meta property="og:description" content="The overexpression of NIK plays a critical role in liver inflammatory diseases. Treatment of such diseases with small-molecule NIK inhibitors is a reasonable but underexplored approach. In this paper, we reported the discovery of a potent and selective NIK inhibitor 46 (XT2). 46 inhibited the NIK kinase with an IC50 value of 9.1 nM in vitro, and it also potently suppressed NIK activities in intact cells. In isogenic primary hepatocytes, treatment of 46 efficiently suppressed the expressions of NIK-induced genes. 46 was orally bioavailable in mice with moderate systemic exposure. In a NIK-associated mouse liver inflammation model, 46 suppressed CCl4-induced upregulation of ALT, a key biomarker of acute liver injury. 46 also decreased immune cell infiltration into the injured liver tissue. Overall, these studies provide examples that an NIK inhibitor is able to suppress toxin-induced liver inflammations, which indicates its therapeutic potentials for the treatment of liver inflammatory diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00396"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00396">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00396&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00396&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00396&amp;href=/doi/10.1021/acs.jmedchem.0c00396" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 4388-4407</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00371" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jmv063i008_1372987" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zhiqiang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiqiang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiqiang++Li">Zhiqiang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xinzhi Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xinzhi Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xinzhi++Li">Xinzhi Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ming-Bo Su</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ming-Bo Su</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Bo++Su">Ming-Bo Su</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Li-Xin Gao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Li-Xin Gao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Li-Xin++Gao">Li-Xin Gao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yu-Bo Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu-Bo Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu-Bo++Zhou">Yu-Bo Zhou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bingchuan Yuan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bingchuan Yuan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bingchuan++Yuan">Bingchuan Yuan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xilin Lyu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xilin Lyu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xilin++Lyu">Xilin Lyu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ziqin Yan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ziqin Yan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ziqin++Yan">Ziqin Yan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chujiao Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chujiao Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chujiao++Hu">Chujiao Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hao Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hao Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hao++Zhang">Hao Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cheng Luo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cheng Luo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Luo">Cheng Luo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3864-8382" title="Orcid link">http://orcid.org/0000-0003-3864-8382</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zheng Chen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zheng Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China</div></div><span class="conrtib-corresp"><strong>*</strong>Z.C.: email, <a href="/cdn-cgi/l/email-protection#9dfef5f8f3e7f5f8f3faddf5f4e9b3f8f9e8b3fef3"><span class="__cf_email__" data-cfemail="503338353e2a38353e37103839247e3534257e333e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Chen">Zheng Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jia Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div><div class="loa-info-affiliations-info">Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China</div><div class="loa-info-affiliations-info">Open Studio for Druggability Research of Marine Natural Products, Pilot National Laboratory for Marine Science and Technology (Qingdao), 1 Wenhai Road, Aoshanwei, Jimo, Qingdao 266237, China</div></div><span class="conrtib-corresp"><strong>*</strong>J.L.: email, <a href="/cdn-cgi/l/email-protection#bdd7d1d4fdced4d0d093dcde93ded3"><span class="__cf_email__" data-cfemail="0a6066634a79636767246b69246964">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia++Li">Jia Li</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yujun Zhao</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yujun Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><span class="conrtib-corresp"><strong>*</strong>Y.Z.: phone, +86-21-50800608; email, <a href="/cdn-cgi/l/email-protection#5a233020323b351a29333737743b39743934"><span class="__cf_email__" data-cfemail="374e5d4d5f565877445e5a5a195654195459">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yujun++Zhao">Yujun Zhao</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1035-2272" title="Orcid link">http://orcid.org/0000-0003-1035-2272</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00396&amp;href=/doi/10.1021%2Facs.jmedchem.0c00396" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 4388–4407</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 27, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 March 2020</li><li><span class="item_label"><b>Published</b> online</span>27 March 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 April 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00396" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00396</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4388%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhiqiang%2BLi%252C%2BXinzhi%2BLi%252C%2BMing-Bo%2BSu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D8%26contentID%3Dacs.jmedchem.0c00396%26title%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BSelective%2BNF-%25CE%25BAB-Inducing%2BKinase%2B%2528NIK%2529%2BInhibitor%2BThat%2BHas%2BAnti-inflammatory%2BEffects%2Bin%2BVitro%2Band%2Bin%2BVivo%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4407%26publicationDate%3DApril%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00396"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2360</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00396" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhiqiang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Xinzhi&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Ming-Bo&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Li-Xin&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Yu-Bo&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Bingchuan&quot;,&quot;last_name&quot;:&quot;Yuan&quot;},{&quot;first_name&quot;:&quot;Xilin&quot;,&quot;last_name&quot;:&quot;Lyu&quot;},{&quot;first_name&quot;:&quot;Ziqin&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Chujiao&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Hao&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yujun&quot;,&quot;last_name&quot;:&quot;Zhao&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;4388-4407&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00396&quot;},&quot;abstract&quot;:&quot;The overexpression of NIK plays a critical role in liver inflammatory diseases. Treatment of such diseases with small-molecule NIK inhibitors is a reasonable but underexplored approach. In this paper, we reported the discovery of a potent and selective NIK inhibitor 46 (XT2). 46 inhibited the NIK kinase with an IC50 value of 9.1 nM in vitro, and it also potently suppressed NIK activities in intact cells. In isogenic primary hepatocytes, treatment of 46 efficiently suppressed the expressions of NIK-induced genes. 46 was orally bioavailable in mice with moderate systemic exposure. In a NIK-associated mouse liver inflammation model, 46 suppressed CCl4-induced upregulation of ALT, a key biomarker of acute liver injury. 46 also decreased immune cell infiltration into the injured liver tissue. Overall, these studies provide examples that an NIK inhibitor is able to suppress toxin-induced liver inflammations, which indicates its therapeutic potentials for the treatment of liver inflammatory diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00396&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00396" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00396&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00396" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00396&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00396" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00396&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00396&amp;href=/doi/10.1021/acs.jmedchem.0c00396" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00396" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00396" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00396%26sid%3Dliteratum%253Aachs%26pmid%3D32216342%26genre%3Darticle%26aulast%3DLi%26date%3D2020%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BSelective%2BNF-%25CE%25BAB-Inducing%2BKinase%2B%2528NIK%2529%2BInhibitor%2BThat%2BHas%2BAnti-inflammatory%2BEffects%2Bin%2BVitro%2Band%2Bin%2BVivo%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D8%26spage%3D4388%26epage%3D4407%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/jmcmar.2020.63.issue-8/20200423/jmcmar.2020.63.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The overexpression of NIK plays a critical role in liver inflammatory diseases. Treatment of such diseases with small-molecule NIK inhibitors is a reasonable but underexplored approach. In this paper, we reported the discovery of a potent and selective NIK inhibitor <b>46</b> (XT2). <b>46</b> inhibited the NIK kinase with an IC<sub>50</sub> value of 9.1 nM in vitro, and it also potently suppressed NIK activities in intact cells. In isogenic primary hepatocytes, treatment of <b>46</b> efficiently suppressed the expressions of NIK-induced genes. <b>46</b> was orally bioavailable in mice with moderate systemic exposure. In a NIK-associated mouse liver inflammation model, <b>46</b> suppressed CCl<sub>4</sub>-induced upregulation of ALT, a key biomarker of acute liver injury. <b>46</b> also decreased immune cell infiltration into the injured liver tissue. Overall, these studies provide examples that an NIK inhibitor is able to suppress toxin-induced liver inflammations, which indicates its therapeutic potentials for the treatment of liver inflammatory diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NF-κB-inducing kinase, also known as NIK or MAP3K14, is a key regulator of noncanonical NF-κB signaling pathway.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1−6)</a> Upon ligand binding of the TNF family receptors such as BAFFR, CD40, RANKL, and TWEAK, the receptor-associated TRAF3 degrades and consequently releases NIK from the TRAF3-TRAF2-cIAP1/2 complex.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> The released NIK is stabilized and activated, which in turn phorsphorates the Ser176 residue of IKKα.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Activation of NIK and IKKα results in phosphorylation of the Ser866 and Ser870 residues of p100, subsequent proteolytic cleavage of p100, and production of p52.<a onclick="showRef(event, 'ref3 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref3 ref10 ref11">(3,10,11)</a> Eventually, p52 and RELB form a heterodimer and translocate into the nucleus, where they initiate target gene expression.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The aberrant stabilization and activation of NIK correlate with augmented activities of NF-κB2, which are often associated with autoimmune diseases,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> inflammatory diseases,<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> and cancers.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> Therefore, inhibition of NIK has been pursued as an attractive strategy for the treatment of systemic lupus erythematosus,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> inflammatory disease,<a onclick="showRef(event, 'ref13 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref19 ref20 ref21">(13,19−21)</a> multiple myeloma,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and pancreatic cancer,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> among others.</div><div class="NLM_p">Previously, a few NIK inhibitors have been reported and several selected examples are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. Compound <b>1</b> inhibited NIK with an IC<sub>50</sub> value of 4.2 nM, and the cocrystal structure of NIK/<b>1</b> complex has been reported, showing the details of ligand-protein interacting features.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In addition, <b>2</b> and <b>3</b> have also been shown to exhibit inhibitory activities for NIK in enzymatic and cellular assays.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Furthermore, it has been demonstrated that <b>4</b> suppressed NIK activities with an IC<sub>50</sub> value in the pM range and was efficacious in animal models of systemic lupus erythematosus.<a onclick="showRef(event, 'ref18 ref26'); return false;" href="javascript:void(0);" class="ref ref18 ref26">(18,26)</a> In addition, <b>5</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <b>6</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> have also been reported as good NIK inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected examples of reported inhibitors of the NIK kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Overexpression of NIK plays a critical role in liver inflammatory diseases<a onclick="showRef(event, 'ref13 ref20'); return false;" href="javascript:void(0);" class="ref ref13 ref20">(13,20)</a> and B/T cell malfunction related diseases.<a onclick="showRef(event, 'ref18 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref18 ref29 ref30 ref31">(18,29−31)</a> Treatment of such diseases with small-molecule NIK inhibitors is a reasonable but underexplored approach.<a onclick="showRef(event, 'ref3 ref32'); return false;" href="javascript:void(0);" class="ref ref3 ref32">(3,32)</a> In this paper, we report our efforts to design and synthesize a very potent and highly selective small-molecule NIK inhibitor <b>46</b> (XT2), which has anti-inflammatory effects in vitro and in vivo.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Disscussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">On the basis of information showcased in the cocrystal structure of NIK/<b>1</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> we envisioned that a 7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine moiety could possibly mimic the structural function of the pyrimidine moiety of <b>1</b>; therefore the 7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-containing compounds could be a new class of NIK inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Upon extensive optimizations, we eventually found a hit compound <b>7</b>, which features a benzene ring as a replacement of the 2,3-dihydroindole core of <b>1</b>. In a kinase ATP consumption assay, <b>7</b> inhibited NIK kinase activity with an IC<sub>50</sub> value of 303 nM.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of the NIK Kinase Activity by 7-Phenyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine-Containing Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0014.gif" alt="" id="gr2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0015.gif" alt="" id="gr3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The values were from single experiments unless stated otherwise.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The values were calculated based on two or more independent experiments.</p></div></div><div></div></div><div class="NLM_p">Further optimization of <b>7</b> with various substitutions on the benzene ring yielded compounds <b>8</b>–<b>23</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The fluorine substitutions (<b>8</b>–<b>10</b>) were tolerated in terms of NIK inhibition, but no significant improvement was observed compared with that of <b>7</b>. <b>11</b> had an OMe group as R<sub>1</sub>, which was detrimental for its potency. <b>12</b> had an OMe group as R<sub>3</sub> and had a similar IC<sub>50</sub> value as that <b>7</b>, suggesting that the R<sub>3</sub> position tolerates substitution groups. A similar trend was observed for methyl-group-substituted <b>13</b> and <b>14</b> with the latter had comparable potency as that of <b>7</b>. Regarding two CN-containing analogues, <b>15</b> was 10-fold more potent than <b>16</b>, which suggests that the R<sub>1</sub> position might tolerate a basic group. However, large basic groups or soluble groups were incompatible at the R<sub>1</sub> position (<b>17</b>–<b>20</b>). Different substitutions on the 2-amine-5<i>H</i>-pyrrolo[3,2-<i>d</i>]-pyrimidin moiety (<b>21</b>, <b>22</b>) were also examined, but neither yielded more potent compounds. <b>23</b> had an IC<sub>50</sub> value of 3837 nM, 12-fold less potent than that of <b>7</b>, highlighting that 1,3-disubstitution pattern of the benzene ring was critical for optimal inhibition of NIK activity. Overall, <b>8</b>, <b>9</b>, and <b>15</b> had slightly improved enzymatic activity, and the beneficial effect of the CN group of <b>15</b> suggests that a small basic group might be beneficial for the inhibition of NIK enzymatic activities.</div><div class="NLM_p">In order to know the NIK binding mode of <b>7</b>, molecular docking studies have been carried out. The cocrystal structure of <b>1</b>/NIK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G3E">4G3E</a>) was selected as a docking template, and a putative binding mode was generated by Glide program. The docking results show that <b>7</b> bound to the active site of NIK and was partially superimposed on <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a></a>A). In addition, one hydrogen bond (H-bond) was observed between the <b>7</b> and the hinge region Glu472, and three additional H-bonds were observed between <b>7</b> and the DFG region Glu442, Asp536, and Phe537 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a></a>B). Interestingly, the carboxylic moiety of Asp536 was close to the benzene ring of <b>7</b> (3.5 Å, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a></a>C), which partially explained why the CN group of <b>15</b> was beneficial for good potency.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Putative binding mode of <b>7</b> and NIK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G3E">4G3E</a>). (A) <b>7</b> (yellow) and <b>1</b> (cyan) were superimposed in the docking models. (B) LIGPLOT<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> of the putative <b>7</b> and NIK interactions. <b>7</b> carbon atoms are shown as black, nitrogen atoms as blue, oxygen atoms as red, and sulfur atoms as yellow spheres. (C) The distance between the oxygen of Asp536 and the benzene moiety of <b>7</b> is 3.5 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given the insights provided by the molecular docking studies, we incorporated a pyridine ring into the molecules to make compounds <b>24</b>–<b>40</b>, which were summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Interestingly, <b>24</b> had an IC<sub>50</sub> value of 22.4 ± 0.3 nM, which was comparable to that of the control <b>1</b>. Replacement of the thiazole on <b>24</b> with an oxazole or a pyrazine group (<b>25</b> and <b>26</b>) did not improve the activity. When the thiazole group was replaced by a five-membered or six-membered lactam group, <b>27</b> and <b>28</b> exhibited potent inhibition of NIK activity as that of <b>1</b>. Meanwhile, other cyclic aliphatic rings were less tolerated (<b>29</b>–<b>34</b>), highlighting the importance of the lactam structures.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of the NIK Kinase Activity by 7-(Pyridin-4-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine-Containing Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0016.gif" alt="" id="gr5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0017.gif" alt="" id="gr6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The values were from single experiments unless stated otherwise.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The values were calculated based on two or more independent experiments.</p></div></div><div></div></div><div class="NLM_p">The incorporation of fluorine on the pyridine ring did not enhance the activity of <b>36</b>, and an ethyl group was not tolerated at the propargylic position of <b>35</b> with 100-fold decrease compared to <b>24</b>. Importantly, the N position in pyridine was critical for the high potency of <b>24</b> because a close analogue <b>37</b> was about 83-fold less potent than <b>24</b>. Removal of one N from the 2-aminopyrimidine ring yielded compound <b>38</b>, which is 95-fold less potent than <b>27</b>. Addition of a methyl or ethyl substitution on the 2-aminopyrimidine ring was detrimental for the kinase inhibitory activity as both <b>39</b> and <b>40</b> had weaker IC<sub>50</sub> values compared with that of <b>27</b>. These data suggest that the 2-aminopyrimidine is critical for good NIK inhibitory activities. Overall, compounds <b>24</b>, <b>27</b>, and <b>28</b> showed good inhibitory activities of the NIK kinase because of the incorporation of a nitrogen atom.</div><div class="NLM_p">We next studied the pharmacokinetic properties of <b>27</b> in mice. Unfortunately, it had oral bioavailability less than 1%, probably because of instability of the triple bond caused by the pyridine moiety.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In line with these, compound <b>24</b> was unstable in pH = 1 aqueous solution and also had very poor pharmacokinetic properties in mice. We then introduced a similar pyrrole-fused-pyrimidine core structure <b>41</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), hoping that improved pharmacokinetic profiles could be obtained with a different core structure. Subsequently, molecular docking studies have been performed on <b>41</b> to evaluate how it could possibly bind NIK (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a>). The docking results show that the thiazole, alcohol, and pyrimidine moieties of <b>41</b> and <b>1</b> all had the same poses, whereas the benzene of <b>41</b> and the indoline of <b>1</b> overlapped. The 2-aminopyrimidine moiety of <b>41</b> had two H-bonds with the hinge region Glu472 and Leu474. Additional three H-bonds were observed between the tertiary alcohol moiety of <b>41</b> and the DFG region Asp536, Phe537, and Glu442. Overall, the molecular docking results show that <b>41</b> could be well accommodated by the active site of NIK.</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Putative binding mode of <b>41</b> and NIK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G3E">4G3E</a>). (A) <b>41</b> (yellow) and <b>1</b> (cyan) were superimposed in the docking models. (B) LIGPLOT<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> of the putative <b>41</b> and NIK interactions. <b>41</b> carbon atoms are shown as black, nitrogen atoms as blue, oxygen atoms as red, and sulfur atoms as yellow spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of the NIK Kinase Activity by 7-Phenyl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine-Contaning Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0018.gif" alt="" id="gr8" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">comps</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">NIK IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">218</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">10910</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">319</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">85.5 ± 26.1<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b> (<i>S</i>-<b>44</b>)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2230 ± 220<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b> (<i>R</i>-<b>44</b>)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9.1 ± 2.0<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">290</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2204</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The values were from single experiments unless stated otherwise.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The values were calculated based on two or more independent experiments.</p></div></div></div><div class="NLM_p">Therefore, <b>41</b> was synthesize and it inhibited NIK with an IC<sub>50</sub> value of 218 nM. Further optimization of the benzene ring with a fluorine or OMe substitution provided compounds <b>42</b>–<b>44</b> and <b>47</b>–<b>49</b>. Among these compounds, <b>44</b> was the most potent molecule (IC<sub>50</sub> = 85.5 ± 26.1 nM). A methyl group at the R<sub>4</sub> position (<b>50</b>) was found to be detrimental compared with <b>44</b>. We have also determined that compound <b>46</b> with <i>R</i> absolute stereochemistry was the active enantiomer of <b>44</b>, which inhibited NIK with an IC<sub>50</sub> value of 9.1 ± 2.0 nM. In contrast, the <i>S</i> enantiomer <b>45</b> has an IC<sub>50</sub> value of 2230 ± 220 nM, >240-fold less potent than its enantiomer <b>46</b>.</div><div class="NLM_p">In addition to the modifications discussed above, it has been shown that proper substitutions of the propargyl alcohol moiety are critical for better NIK inhibitory activities.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> We therefore set out to optimize the thiazole group of <b>41</b>, and the results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Replacement of the thiazole with an oxazole (<b>51</b>), a pyrazine (<b>52</b>), or an α-OMe-pyridine group (<b>53</b>) did not improve the NIK inhibitory activity. In addition, the tertiary alcohol conformation was found to be essential as a secondary alcohol-containing compound <b>54</b> was much less potent. Replacement of the thiazole with a cyclohexyl group (<b>55</b>) or a methyl group (<b>56</b>) was not tolerated. Compounds <b>57</b> and <b>58</b> tethering cyclic five-membered rings did not show improved activities, while compounds <b>59</b> and <b>60</b> tethering amides were inactive within assay range.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Optimization of the 7-Phenyl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine-Contaning Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0019.gif" alt="" id="gr9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0020.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The values were from single experiments unless stated otherwise.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">The values were calculated based on two or more independent experiments.</p></div></div><div></div></div><div class="NLM_p">Interestingly, fluorine-containing compound <b>61</b> inhibited NIK with an IC<sub>50</sub> value of 5.9 ± 0.8 nM, which is more potent than that of <b>1</b>. Overall, through the examination of compounds <b>41</b>–<b>61</b>, we obtained compound <b>44</b>, its <i>R</i> enantiomer <b>46</b>, and <b>61</b>, which were stable in acidic aqueous media and show potent inhibition of the NIK activity.</div><div class="NLM_p">We next verified the NIK inhibitory activity of <b>46</b> with the aid of a commercial kinase assay (KINOMEscan). <b>46</b> had an IC<sub>50</sub> value of <i>K</i><sub>d</sub> = 4.9 ± 1.0 nM (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">4</a></a>), which was consistent with our in-house kinase assay data.</div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition curves (<i>K</i><sub>d</sub>) of the NIK kinase by <b>46</b> in the KINOMEscan assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to profile the kinase selectivities of <b>46</b>, we screened it in a panel of 98 kinases in a KINOMEscan assay, and the results are summarized in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">5</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_003.pdf" class="ext-link">Table S1 in the Supporting Information</a>. The data showed that <b>46</b> was a very selective kinase inhibitor and it had no apparent affinity against other 97 kinases at 500 nM concentration.</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinome map of <b>46</b> against 98 kinases at 500 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previous biological studies<a onclick="showRef(event, 'ref3 ref10 ref11 ref32'); return false;" href="javascript:void(0);" class="ref ref3 ref10 ref11 ref32">(3,10,11,32)</a> have proven that activation of NIK led to the phosphorylation of the Ser866 and Ser870 residues of p100, subsequent proteolytic cleavage of p100, and thus production of p52. In order to examine whether inhibition of NIK will halt the production of p52, the primary hepatocytes were infected with p100 and NIK adenovirus in the presence of <b>46</b> or a positive control compound <b>1</b> (B022).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">6</a></a>, the concentrations of two proteins, NIK and p100, were high in the double adenovirus-infected cells, whereas the level of p52 was also high as the consequence of the NIK mediated proteolysis of p100. In the presence of <b>46</b>, the level of p52 dose-dependently decreased, indicating the blockade of p100 proteolysis caused by inhibition of the cellular NIK activity. The control compound B022 (5 μM) showed the same cellular effects as that of <b>46</b> at 10 μM. In addition, the protein levels of cellular NIK were not affected by treatment of either <b>46</b> or B022, suggesting the down-regulation of p52 was not caused by decreasing of NIK protein levels. Overall, these data suggest that <b>46</b> effectively inhibited cellular NIK kinase activities.</div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>46</b> (XT2) suppressed NIK mediated proteolysis of p100 to p52 in primary hepatocytes infected with the p100 and Flag-tagged NIK adenovirus. The primary hepatocytes were infected with p100 and Flag-tagged NIK adenovirus in the presence of <b>46</b> (0, 1, or 10 μM) or B022 (5 μM) for 16 h. The cell lysate extracts were immunblotted with antibodies for Flag, NF-κB2, or tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we examined whether <b>46</b> inhibits NIK-induced expression of inflammatory genes in primary hepatocytes (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">7</a></a>). The primary hepatocytes were infected with NIK adenovirus in the presence of different concentrations of <b>46</b> (0, 1, or 10 μM). As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">7</a></a>, the expression levels of NIK-induced genes,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> TNFα, CCL2, CCL5, CXCL5, and NOS2, decreased dose-dependently in the presence of <b>46</b> in the primary hepatocytes infected with the NIK adenovirus. These data indicate that <b>46</b> inhibited the kinase activities of cellular NIK and therefore suppressed the expression of NIK-induced genes.</div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0007.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>46</b> (XT2) suppressed NIK-induced gene expression in primary hepatocytes infected with NIK adenovirus. The primary hepatocytes were infected with the NIK adenovirus in the presence of <b>46</b> (0, 1, or 10 μM) or B022 (5 μM) for 16 h. The relative mRNA levels of TNFα, CCL2, CCL5, CXCL5, and NOS2 were measured by qPCR (<i>N</i> = 6). **<i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We further evaluated the pharmacokinetic properties of <b>46</b> in order to know the systemic exposure of <b>46</b> in mice (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Upon intravenous injection of a single dose of <b>46</b> at 5 mg/kg in mice, the values of <i>C</i><sub>max</sub> and AUC achieved in plasma were 3040 ng/mL and 891 h·ng/mL, respectively, which indicate moderate systemic exposure but fast clearance rate of <b>46</b>. Upon oral administration of a single dose of <b>46</b> at 15 mg/kg in mice, the values of <i>C</i><sub>max</sub> and AUC achieved in plasma were 510 ng/mL and 348 h·ng/mL, respectively, and the oral bioavailability was relatively low at 13%. We have also examined the pharmacokinetic properties of <b>61</b>; unfortunately, it had even lower oral systemic exposure with 7% oral bioavailability (data not shown).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Studies of <b>46</b> in Mice<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" rowspan="2" align="center" valign="middle">dose</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center">AUC<sub>(0–<i>t</i>)</sub></th><th class="colsep0 rowsep0" align="center">VZ</th><th class="colsep0 rowsep0" align="center">CL</th><th class="colsep0 rowsep0" align="center"><i>F</i>*</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">h</th><th class="colsep0 rowsep0" align="center">h</th><th class="colsep0 rowsep0" align="center">ng/mL</th><th class="colsep0 rowsep0" align="center">h·ng/mL</th><th class="colsep0 rowsep0" align="center">mL/kg</th><th class="colsep0 rowsep0" align="center">mL h<sup>–1</sup> kg<sup>–1</sup></th><th class="colsep0 rowsep0" align="center">%</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b>, iv 5 mg/kg</td><td class="colsep0 rowsep0" align="left">3.28 ± 0.84</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">3040 ± 99</td><td class="colsep0 rowsep0" align="left">891 ± 58</td><td class="colsep0 rowsep0" align="left">26031 ± 4884</td><td class="colsep0 rowsep0" align="left">5545 ± 379</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b>, po 15 mg/kg</td><td class="colsep0 rowsep0" align="left">12.0 ± 16.7</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">510 ± 187</td><td class="colsep0 rowsep0" align="left">348 ± 84</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">13 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The values were calculated based on three data at each time point.</p></div></div></div><div class="NLM_p">In view of the anti-inflammatory activities of <b>46</b> in the primary hepatocytes and its moderate systemic exposure, we proceeded to evaluate its <i>in vivo</i> anti-inflammatory effects in a CCl<sub>4</sub>-induced mouse liver injury model (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">8</a></a>). Previous studies have demonstrated that the NIK mRNA level and p52 protein level were upregulated in mouse liver exposed to CCl<sub>4</sub>,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> which indicates strong association between activation of NIK/p52/NF-kB2 and CCl<sub>4</sub>-induced liver injury. The same mouse model had been adopted in the present study and in C57BL/6 mice; <b>46</b> was intravenously administrated at 40 mg/kg dose every 3 h following the intraperitoneal injection of CCl<sub>4</sub>. The blood samples and liver tissues were harvested at 12 h for analysis, and the data are summarized in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">8</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_003.pdf" class="ext-link">Supporting Information Figure S2</a>. The serum activity of alanine aminotransferase (ALT, a biomarker for acute liver injury) was measured, and the <b>46</b>-treated group had lower ALT levels compared with that of the untreated vehicle group (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">8</a></a>, panel A). In addition, the <b>46</b>-treated group had lower expression levels of NIK-induced genes,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> TNFα, NOS2, CCL5, CXCL5, and CCL2, in liver tissues compared with that of the untreated vehicle group (panel B). These data indicate that <b>46</b> inhibited the kinase activities of cellular NIK and therefore suppressed the expression of NIK-induced genes in vivo.</div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0008.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Anti-inflammatory effects of <b>46</b> (XT2) in a CCl<sub>4</sub>-induced mouse liver injury model. (A) Serum ALT activity. (B) The relative mRNA levels of TNFα, NOS2, CCL5, CXCL5, and CCL2 in liver tissues were measured by qPCR (<i>N</i> = 8–10). Wild-type (WT) C57BL/6 mice were intravenously injected with XT2 (40 mg/kg), B022 (25 mg/kg), or an equal volume of vehicle via the tail veins. Half an hour later, mice were intraperitoneally injected with CCl<sub>4</sub> (2.5 mL/kg, 10% in olive oil) followed by XT2 (40 mg/kg), B022 (25 mg/kg), or an equal volume of vehicle via the tail veins at 3, 6, and 9 h. The mice were euthanized at 12 h after the CCl<sub>4</sub> injection, and the blood samples and liver tissue were harvested for analysis. <i>N</i> = 8–10 per group. *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, immunofluorescent detection of the macrophage-specific antigen F4/80<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> in the mouse liver tissues showed that the <b>46</b>-treated group had less immune cell infiltration compared with that of the untreated vehicle group (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">9</a></a>). The B022-treated group had the same and slightly stronger effects compared with that of <b>46</b>. Overall, these results indicate that small-molecule NIK inhibitor <b>46</b> has suppressive effects on the CCl<sub>4</sub>-induced liver inflammation.</div><figure id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0009.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Immunofluorescent detection of the macrophage-specific antigen F4/80 and DAPI staining of liver tissues upon treatment of <b>46</b> (XT2) or B022 in a CCl<sub>4</sub>-induced mouse liver injury model. Macrophages are stained green and the nucleus blue. <i>N</i> = 5 per group, *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77508" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77508" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of final compounds <b>7</b>–<b>23</b> have been summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Starting from a known compound <b>S1</b><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and substituted iodobenzenes <b>S2a</b>–<b>S2n</b> and <b>S5</b>, the intermediates <b>7c</b>–<b>20c</b> and <b>23c</b> were obtained from CuI-promoted C–N cross-coupling reactions.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Upon treatment of NCS, <b>7c</b> was converted into <b>21c</b> in 74% yield. Intermediate <b>22c</b> was synthesized from <b>S4</b>, which was obtained from <b>S3</b> in quantitative yield. Finally, the Sonogashira coupling reactions of <b>7c</b>–<b>23c</b> and <b>S6</b> provided the corresponding compounds <b>7</b>–<b>23</b>, respectively.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0010.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Intermediates <b>7c</b>–<b>23c</b> and Final Compounds <b>7</b>–<b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CuI, K<sub>2</sub>CO<sub>3</sub>, <span class="smallcaps smallerCapital">l</span>-proline, DMSO, 90 °C, 16 h; (b) NCS, DMF, rt, 12 h; (c) MeONa (30% in MeOH), MeOH, 70 °C, 12 h; (d) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, PPh<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NH, DMSO, 80 °C, overnight.</p></p></figure><div class="NLM_p">The syntheses of final compounds <b>24</b>–<b>40</b> have been summarized in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The intermediates <b>24c</b> and <b>36c</b>–<b>40c</b> were obtained from CuI-promoted C–N cross-coupling reactions of the corresponding <b>S1</b>/<b>S7a</b>–<b>S7c</b> and <b>S2o</b>–<b>S2q</b>. The Sonogashira coupling reactions of <b>24c</b> with the corresponding substituted alkyne <b>S6</b>, <b>S8</b>, <b>25d</b>–<b>26d</b>, or <b>28d</b>–<b>35d</b> afforded the final compounds <b>24</b>–<b>35</b>, respectively. Final compounds <b>36</b>–<b>40</b> were obtained from the Sonogashira coupling reactions of <b>36c</b>–<b>40c</b> with the corresponding substituted alkyne <b>S6</b> or <b>S8</b>, respectively.</div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0011.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Intermediates <b>24c</b>, <b>36c</b>–<b>40c</b>, and Final Compounds <b>24</b>–<b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CuI, K<sub>2</sub>CO<sub>3</sub>, <span class="smallcaps smallerCapital">l</span>-proline, DMSO, 90 °C, 16 h; (b) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, PPh<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NH, DMSO, 80 °C, overnight.</p></p></figure><div class="NLM_p">The syntheses of final compounds <b>41</b>–<b>50</b> have been summarized in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The intermediates <b>41c</b>–<b>44c</b> and <b>47c</b>–<b>50c</b> were obtained in moderate yields following a known method.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The Sonogashira coupling reactions of <b>41c</b>–<b>44c</b> and <b>47c</b>–<b>50c</b> with the corresponding alkyne intermediates <b>S6</b>, (<i>S</i>)<b>-S6</b>, and (<i>R</i>)<b>-S6</b> afforded the final compounds <b>41</b>–<b>50</b>.</div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0012.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Intermediates <b>41c</b>–<b>50c</b> and Final Compounds <b>41</b>–<b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) (4-aminophenyl)boronic acid, di-<i>tert</i>-butyl azodicarboxylate, Cu(OAc)<sub>2</sub>, MeOH, 65 °C, 1 h; (b) <b>S9a–S9h</b>, 4 N HCl/1,4-dioxane, 80 °C, 16 h; (c) Boc<sub>2</sub>O, DMAP, THF, rt, overnight; (d) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, PPh<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NH, DMSO, 80 °C, overnight; (e) TFA, DCM, rt, 1 h.</p></p></figure><div class="NLM_p">The syntheses of final compounds <b>51</b>–<b>61</b> have been summarized in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The intermediate <b>S11</b> was obtained in moderate yield following a known method.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The final compounds <b>51</b>–<b>60</b> were obtained from the Sonogashira coupling reactions of <b>S11</b> with the corresponding alkyne intermediates <b>S8</b>, <b>25d</b>, <b>26d</b>, <b>31d</b>, <b>34d, 53d</b>–<b>56d</b>, and <b>59d</b>, respectively. The final compounds <b>61</b> were obtained from the Sonogashira coupling reactions of <b>44c</b> and <b>S8</b>.</div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0013.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Intermediate <b>S11</b> and Final Compounds <b>51</b>–<b>61</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) (4-aminophenyl)boronic acid, di-<i>tert</i>-butyl azodicarboxylate, Cu(OAc)<sub>2</sub>, MeOH, 65 °C, 1 h; (b) <b>S10</b>, 4 N HCl/1,4-dioxane, 80 °C, 16 h; (c) Boc<sub>2</sub>O, DMAP, THF, rt, overnight; (d) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, PPh<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NH, DMSO, 80 °C, overnight; (e) TFA, DCM, rt, 1 h.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have discovered and optimized a series of 5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-containing compounds, which yielded a very potent and highly selective small-molecule NIK inhibitor <b>46</b>. <b>46</b> inhibited NIK kinase with an IC<sub>50</sub> value of 9.1 nM in vitro and also potently suppressed NIK activities in intact cells. In isogenic primary hepatocytes, treatment of <b>46</b> efficiently suppressed the expressions of NIK-induced genes, such as TNFα, CCL2, CCL5, CXCL5, and NOS2, which are all liver inflammation related. <b>46</b> was orally bioavailable in mice with moderate systemic exposure. In a NIK-associated mouse liver injury model, <b>46</b> suppressed CCl<sub>4</sub>-induced upregulation of ALT, a key biomarker of acute liver injury. <b>46</b> also decreased immune cell infiltration into the injured liver tissue. Overall, these studies provide examples that a NIK inhibitor is able to suppress toxin-induced liver inflammations, which indicates its therapeutic potentials for the treatment of liver inflammatory diseases.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">1.  General Methods</h3><div class="NLM_p last">Unless otherwise indicated, all commercial reagents and anhydrous solvents were used without further purifications. <sup>1</sup>H NMR spectra were recorded with a Bruker Advance NMR 400 spectrometer and calibrated with tetramethylsilane (δ = 0 ppm), DMSO-<i>d</i><sub>6</sub> (δ = 2.5 ppm), MeOH-<i>d</i><sub>4</sub> (δ = 3.31 ppm), or CDCl<sub>3</sub> (δ = 7.26 ppm). <sup>13</sup>C NMR spectra were obtained by a Bruker Advance NMR 500 spectrometer and calibrated with DMSO-<i>d</i><sub>6</sub> (δ = 39.5 ppm), MeOH-<i>d</i><sub>4</sub> (δ = 49.0 ppm), or CDCl<sub>3</sub> (δ = 77.2 ppm). Multiplicities are given as follows: s (singlet), d (doublet), t (triplet), q (quartet), dd (doublet of doublets), dt (doublet of triplets), and m (multiplets). High-resolution mass spectral (HRMS) analysis was performed on UHPLC-QTOF (Agilent Corporation) and Thermo DFS (Thermo Fisher Scientific). Reverse phase HPLC purification used SunFire Prep C18 OBR 5 μm, 19 mm × 150 mm column with a 10 mL/min flow rate. Solvent A was H<sub>2</sub>O with 0.1% TFA, and solvent B was CH<sub>3</sub>CN with 0.1% TFA. The purity of the final compounds was analyzed on the SHIMADZU LC20-AR with a SunFire C18 column (5 μm, 4.6 mm × 150 mm) or the Waters UPLC H class with an ACQUITY UPLC BEH C18 column (1.7 μm, 2.1 mm × 50 mm). The purity of all final compounds was greater than 95%.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">2.  Synthesis of Intermediates and Final Compounds</h3><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure A for C–N Coupling</h4><div class="NLM_p last">7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>S1</b>) or its analogues (1 equiv), aryl iodide (2 equiv), proline (0.2 equiv), K<sub>2</sub>CO<sub>3</sub> (3 equiv) were added into DMSO (10 mL) at room temperature. The solution was degassed before addition of copper(I) iodide (0.1 equiv). The reaction was degassed and heated up at 90 °C under N<sub>2</sub> for 16 h. The reaction was then quenched by addition of water. The aqueous layer was extracted with ethyl acetate, and combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The volatile components were removed, and the residues were purified by flash column chromatography to afford the target molecules.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure B for Sonagashira Coupling</h4><div class="NLM_p last">Aryl halide (1 equiv), bis(triphenylphosphine)palladium(II) chloride (1 equiv), triphenylphosphine (2 equiv), and copper(I) iodide (1 equiv) were added into DMSO (10 mL) at room temperature. The solution was degassed before addition of alkyne (3 equiv) in one portion. The solution was degassed followed by addition of diisopropylamine (0.2 mL). The solution was degassed and heated up at 80 °C under N<sub>2</sub> for overnight. The reaction was then quenched by addition of water. The aqueous layer was extracted with ethyl acetate, and combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The volatile components were removed, and the residues were purified by flash column chromatography and subsequent reverse phase HPLC purification. The desired products were obtained as salts of trifluoroacetic acid (TFA).</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure C for Fischer Indole Synthesis</h4><div class="NLM_p last">(2-Aminopyrimidin-5-yl)boronic acid (1.5 equiv), di-<i>tert</i>-butyl azodicarboxylate (1 equiv), and Cu(OAc)<sub>2</sub> (0.05 equiv) were dissolved in MeOH. The solution was degassed and then heated up at 65 °C under N<sub>2</sub> for 1 h. The reaction was cooled followed by addition of the corresponding 2-arylacetaldehyde (1.5 equiv in 1,4-dioxane). Subsequently, 4 N HCl/1,4-dioxane (16 equiv) was added. The solution was heated up at 80 °C for 18 h. The volatile components were removed and the residue was dissolved in saturated NaHCO<sub>3</sub> aqueous solution/CH<sub>2</sub>Cl<sub>2</sub> (1:4). The solution was stirred at room temperature for 1 h. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The volatile components were removed and the residues were purified by flash column chromatography to afford the desired products.</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure D for Sonagashira Coupling Reaction</h4><div class="NLM_p last">Boc protected aryl halide (1 equiv), bis(triphenylphosphine)palladium(II) dichloride (1 equiv), triphenylphosphine (2 equiv), copper(I) iodide (1 equiv) were added into toluene (10 mL) at room temperature. The solution was degassed before addition of alkyne (3 equiv) in one portion. The solution was degassed followed by addition of diisopropylamine (0.2 mL). The solution was degassed again and heated up at 80 °C under N<sub>2</sub> for overnight. The reaction was then quenched by addition of water. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The volatile components were removed, and the residue was purified by flash column chromatography. The crude products were dissolved in CH<sub>2</sub>Cl<sub>2</sub> and TFA (4:1) and stirred at room temperature for 1 h. The final products were purified by reverse phase HPLC purification.</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-Bromo-4-iodobenzamide</h4><div class="NLM_p last">To a solution of 2-bromo-4-iodobenzoic acid (1 g, 3.06 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and DMF (0.05 mL) at 0 °C, oxalyl chloride (772 mg, 6.12 mmol) was added. The resulting mixture was allowed to warm up to room temperature in 30 min. The mixture was stirred at room temperature for an additional 3 h, after which the volatile components were removed. The residue was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> and cooled to 0 °C. An excessive amount of ammonia was added at 0 °C, and the mixture was stirred at room temperature for 12 h, and the reaction was then quenched by addition of water. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The dried solution was filtered, and the filtrate was concentrated. The final product was used directly for the next step without further purification.</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-Bromo-4-iodobenzonitrile (<b>S2i</b>)</h4><div class="NLM_p last">2-Bromo-4-iodobenzamide (400 mg, 1.23 mmol) was added into a round-bottom flask followed by addition of POCl<sub>3</sub> (30 mL, excess). The mixture was stirred at 110 °C for 12 h, and then the volatile components were removed. NaHCO<sub>3</sub> (sat.) was added, and the aqueous layer was extracted with ethyl acetate, and combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The dried solution was filtered, and the filtrate was concentrated. The resulting crude material was purified by flash column chromatography on silica gel to afford 381 mg (40%, solid) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.08 (d, <i>J</i> = 1.56 Hz, 1H), 7.78 (dd, <i>J</i> = 8.16, 1.59 Hz, 1H), 7.35 (d, <i>J</i> = 8.17 Hz, 1H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 141.71, 137.16, 134.86, 125.85, 116.83, 115.40, 100.52. HRMS (EI) calculated for C<sub>7</sub>H<sub>3</sub><sup>79</sup>Br<sup>127</sup>IN [M]<sup>+</sup> = 306.8488, found 306.8487.</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-Bromo-4-iodo-<i>N</i>,<i>N</i>-dimethylaniline (<b>S2k</b>)</h4><div class="NLM_p last">To a solution of 2-bromo-4-iodoaniline (298 mg, 1 mmol) in anhydrous DMF (5 mL) at 0 °C, NaH (60%, 120 mg, 3 mmol) was added followed by addition of the MeI (568 mg, 4 mmol)). The resulting mixture was heated up at 100 °C for 12 h, the reaction was then quenched by addition of water. The aqueous layer was extracted with ethyl acetate, and combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The resulting crude material was purified by flash column chromatography on silica gel to afford 242 mg (74%, solid) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.85 (d, <i>J</i> = 2.09 Hz, 1H), 7.53 (dd, <i>J</i> = 8.51, 2.10 Hz, 1H), 6.80 (d, <i>J</i> = 8.46 Hz, 1H), 2.78 (s, 6H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 151.94, 141.72, 137.08, 122.30, 119.98, 85.51, 44.10. HRMS (ESI) calculated for C<sub>8</sub>H<sub>10</sub><sup>79</sup>BrIN [M + H]<sup>+</sup> = 325.9036, found 325.9038.</div></div><div id="sec5_1_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-Bromo-4-iodo-1-(2-methoxyethoxy)benzene (<b>S2l</b>)</h4><div class="NLM_p last">To a solution of 2-bromo-4-iodophenol (500 mg, 1.68 mmol) in anhydrous DMF (5 mL) at 0 °C, NaH (60%, 110 mg, 2.52 mmol) was added followed by addition of 1-bromo-2-methoxyethane (350 mg, 2.52 mmol). The resulting mixture was heated at 100 °C for 12 h, and the reaction was then quenched by addition of water. The aqueous layer was extracted with ethyl acetate, and combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The resulting crude material was purified by flash column chromatography on silica gel to afford 530 mg (88%, solid) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.77 (d, <i>J</i> = 2.22 Hz, 1H), 7.46 (dd, <i>J</i> = 8.64, 2.18 Hz, 1H), 6.61 (d, <i>J</i> = 8.65 Hz, 1H), 4.07 (t, <i>J</i> = 4.76 Hz, 2H), 3.73 (t, <i>J</i> = 4.74 Hz, 2H), 3.42 (s, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 155.23, 140.81, 137.10, 115.26, 113.45, 82.88, 70.59, 68.94, 59.39. HRMS (EI) calculated for C<sub>9</sub>H<sub>10</sub><sup>79</sup>BrIO<sub>2</sub> [M]<sup>+</sup> = 355.8903, found 355.8904.</div></div><div id="sec5_1_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(2-Bromo-4-iodophenoxy)-<i>N</i>,<i>N</i>-dimethylethan-1-amine (<b>S2m</b>)</h4><div class="NLM_p last">2-Bromo-4-iodophenol (600 mg, 2 mmol), <i>N</i>,<i>N</i>-dimethyl-2-chloroethanamine hydrochloride (278 mg, 2.6 mmol), Cs<sub>2</sub>CO<sub>3</sub> (1630 mg, 5 mmol), and KI (83 mg, 0.5 mmol) were added into anhydrous CH<sub>3</sub>CN (10 mL). The mixture was heated up at 100 °C for 12 h, and the reaction was then quenched by addition of water. The aqueous layer was extracted with ethyl acetate, and combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The resulting crude material was purified by flash column chromatography on silica gel to afford 682 mg (92%, solid) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80 (d, <i>J</i> = 2.16 Hz, 1H), 7.51 (dd, <i>J</i> = 8.62, 2.14 Hz, 1H), 6.64 (d, <i>J</i> = 8.66 Hz, 1H), 4.08 (t, <i>J</i> = 5.80 Hz, 2H), 2.78 (t, <i>J</i> = 5.81 Hz, 2H), 2.36 (s, 6H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 155.26, 140.92, 137.16, 114.97, 113.42, 82.70, 68.03, 57.76, 46.18. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub><sup>79</sup>BrINO [M + H]<sup>+</sup> = 369.9298, found 369.9296.</div></div><div id="sec5_1_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Bromo-4-iodo-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>S2n</b>)</h4><div class="NLM_p last">To a solution of 2-bromo-4-iodobenzoic acid (500 mg, 1.53 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and DMF (0.05 mL) at 0 °C, oxalyl chloride (389 mg, 3.06 mmol) was added, and the resulting mixture was warmed up to room temperature in 30 min. The mixture was stirred at room temperature for an additional 3 h, after which the volatile components were removed. The residue was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> and cooled to 0 °C. Me<sub>2</sub>NH (2 M in THF, 2 mL, 4 mmol) and EtN(<i>i</i>-Pr)<sub>2</sub> (583 mg, 4.59 mmol) were added at 0 °C, and the mixture was stirred at room temperature for 12 h. The reaction was then quenched by addition of water. The aqueous layer was extracted with ethyl acetate, and combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The dried solution was filtered, and the filtrate was concentrated. The resulting crude material was purified by flash column chromatography on silica gel to afford 275 mg (51%, solid) of the title compound. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.85 (d, <i>J</i> = 1.60 Hz, 1H), 7.61 (dd, <i>J</i> = 8.04, 1.62 Hz, 1H), 6.92 (d, <i>J</i> = 7.98 Hz, 1H), 3.02 (s, 3H), 2.76 (s, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 168.10, 140.46, 137.86, 136.67, 128.85, 119.72, 94.44, 38.01, 34.52. HRMS (EI) calculated for C<sub>9</sub>H<sub>9</sub><sup>79</sup>BrINO [M]<sup>+</sup> = 352.8907, found 352.8908.</div></div><div id="sec5_1_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 7-(3-Bromophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>7c</b>)</h4><div class="NLM_p last">7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>S1</b>, 270 mg, 2.01 mmol) was reacted with 1-bromo-3-iodobenzene (1128 mg, 4 mmol) following the general procedure A to afford 50 mg (8%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.61 (s, 1H), 7.93 (t, <i>J</i> = 1.98 Hz, 1H), 7.67 (ddd, <i>J</i> = 8.01, 2.09, 1.00 Hz, 1H), 7.45 (ddd, <i>J</i> = 8.05, 1.87, 1.02 Hz, 1H), 7.36 (t, <i>J</i> = 8.04 Hz, 1H), 7.15 (d, <i>J</i> = 3.77 Hz, 1H), 6.53 (d, <i>J</i> = 3.77 Hz, 1H), 4.97 (s, 2H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.81, 152.80, 151.57, 139.00, 130.68, 129.56, 126.62, 125.06, 122.92, 122.09, 113.30, 102.39. HRMS (ESI) calculated for C<sub>12</sub>H<sub>10</sub><sup>79</sup>BrN<sub>4</sub> [M + H]<sup>+</sup> = 289.0083, found 289.0087.</div></div><div id="sec5_1_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 7-(3-Bromo-4-fluorophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>8c</b>)</h4><div class="NLM_p last"><b>S1</b> (134 mg, 1 mmol) was reacted with 2-bromo-1-fluoro-4-iodobenzene (600 mg, 2 mmol) following the general procedure A to afford 103 mg (32%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (s, 1H), 8.23 (dd, <i>J</i> = 6.13, 2.69 Hz, 1H), 7.91 (ddd, <i>J</i> = 9.01, 4.33, 2.72 Hz, 1H), 7.56–7.48 (m, 2H), 6.55 (d, <i>J</i> = 3.78 Hz, 1H), 6.42 (s, 2H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.84, 157.56 (d, <i>J</i> = 247.77 Hz), 152.81, 151.61, 134.63 (d, <i>J</i> = 3.58 Hz), 128.73, 125.09, 124.17 (d, <i>J</i> = 7.33 Hz), 116.95 (d, <i>J</i> = 23.60 Hz), 113.09, 109.61 (d, <i>J</i> = 22.18 Hz), 102.37. HRMS (ESI) calculated for C<sub>12</sub>H<sub>9</sub><sup>79</sup>BrFN<sub>4</sub> [M + H]<sup>+</sup> = 306.9989, found 306.9989.</div></div><div id="sec5_1_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 7-(5-Bromo-2-fluorophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>9c</b>)</h4><div class="NLM_p last"><b>S1</b> (270 mg, 2 mmol) was reacted with 4-bromo-1-fluoro-2-iodobenzene (1200 mg, 4 mmol) following the general procedure A to afford 240 mg (39%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (s, 1H), 7.89 (dd, <i>J</i> = 6.77, 2.52 Hz, 1H), 7.69 (ddd, <i>J</i> = 8.83, 4.30, 2.50 Hz, 1H), 7.47 (dd, <i>J</i> = 10.14, 8.85 Hz, 1H), 7.26 (dd, <i>J</i> = 3.77, 1.71 Hz, 1H), 6.55 (d, <i>J</i> = 3.71 Hz, 1H), 6.41 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.64, 155.86 (d, <i>J</i> = 249.98 Hz), 153.35, 151.37, 132.27 (d, <i>J</i> = 8.10 Hz), 131.55, 126.49 (d, <i>J</i> = 13.71 Hz), 125.99, 118.75 (d, <i>J</i> = 21.89 Hz), 116.00 (d, <i>J</i> = 3.61 Hz), 110.58, 101.71. HRMS (ESI) calculated for C<sub>12</sub>H<sub>9</sub><sup>79</sup>BrFN<sub>4</sub> [M + H]<sup>+</sup> = 306.9989, found 306.9990.</div></div><div id="sec5_1_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 7-(5-Bromo-2,4-difluorophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>10c</b>)</h4><div class="NLM_p last"><b>S1</b> (134 mg, 1 mmol) was reacted with 1-bromo-2,4-difluoro-5-iodobenzene (636 mg, 2 mmol) following the general procedure A to afford 110 mg (34%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (s, 1H), 8.08 (t, <i>J</i> = 7.63 Hz, 1H), 7.80 (dd, <i>J</i> = 10.21, 8.84 Hz, 1H), 7.24 (dd, <i>J</i> = 3.77, 1.42 Hz, 1H), 6.55 (d, <i>J</i> = 3.69 Hz, 1H), 6.39 (s, 2H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.95, 158.14 (dd, <i>J</i> = 249.75, 11.09 Hz), 155.92 (dd, <i>J</i> = 253.10, 10.48 Hz), 153.51, 151.58, 132.31, 126.31 (d, <i>J</i> = 2.96 Hz), 122.48 (dd, <i>J</i> = 12.66, 4.51 Hz), 112.39, 106.17 (dd, <i>J</i> = 26.74, 25.03 Hz), 104.12 (dd, <i>J</i> = 22.03, 4.11 Hz), 102.21. HRMS (ESI) calculated for C<sub>12</sub>H<sub>8</sub><sup>79</sup>BrF<sub>2</sub>N<sub>4</sub> [M + H]<sup>+</sup> = 324.9895, found 324.9902.</div></div><div id="sec5_1_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 7-(3-Bromo-4-methoxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>11c</b>)</h4><div class="NLM_p last"><b>S1</b> (134 mg, 1 mmol) was reacted with 2-bromo-4-iodo-1-methoxybenzene (500 mg, 1.6 mmol) following the general procedure A to afford 101 mg (31%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.59 (s, 1H), 7.86 (d, <i>J</i> = 2.60 Hz, 1H), 7.58 (dd, <i>J</i> = 8.80, 2.63 Hz, 1H), 7.07 (d, <i>J</i> = 3.70 Hz, 1H), 7.00 (d, <i>J</i> = 8.83 Hz, 1H), 6.49 (d, <i>J</i> = 3.73 Hz, 1H), 4.99 (s, 2H), 3.94 (s, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.79, 154.74, 152.75, 151.42, 131.45, 129.06, 125.62, 124.17, 112.98, 112.10, 112.01, 101.70, 56.68. HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub><sup>79</sup>BrN<sub>4</sub>O [M + H]<sup>+</sup> = 319.0189, found 319.0184.</div></div><div id="sec5_1_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 7-(5-Bromo-2-methoxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>12c</b>)</h4><div class="NLM_p last"><b>S1</b> (388 mg, 2.9 mmol) was reacted with 4-bromo-2-iodo-1-methoxybenzene (2560 mg, 8.6 mmol) following the general procedure A to afford 60 mg (6%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.58 (s, 1H), 7.65 (d, <i>J</i> = 2.50 Hz, 1H), 7.48 (dd, <i>J</i> = 8.84, 2.48 Hz, 1H), 7.03 (d, <i>J</i> = 3.69 Hz, 1H), 6.95 (d, <i>J</i> = 8.84 Hz, 1H), 6.48 (d, <i>J</i> = 3.67 Hz, 1H), 4.90 (s, 2H), 3.79 (s, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.76, 153.61, 153.53, 151.07, 131.91, 131.41, 127.60, 127.14, 114.02, 112.56, 112.47, 100.79, 56.26. HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub><sup>79</sup>BrN<sub>4</sub>O [M + H]<sup>+</sup> = 319.0189, found 319.0188.</div></div><div id="sec5_1_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 7-(3-Bromo-4-methylphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>13c</b>)</h4><div class="NLM_p last"><b>S1</b> (134 mg, 1 mmol) was reacted with 2-bromo-4-iodo-1-methylbenzene (600 mg, 2 mmol) following the general procedure A to afford 200 mg (66%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.60 (s, 1H), 7.91 (d, <i>J</i> = 2.23 Hz, 1H), 7.55 (dd, <i>J</i> = 8.19, 2.27 Hz, 1H), 7.34 (d, <i>J</i> = 8.17 Hz, 1H), 7.12 (d, <i>J</i> = 3.78 Hz, 1H), 6.51 (d, <i>J</i> = 3.72 Hz, 1H), 4.95 (s, 2H), 2.44 (s, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.79, 152.77, 151.48, 136.50, 136.36, 131.21, 127.43, 125.30, 125.13, 122.56, 113.20, 101.99, 22.63. HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub><sup>79</sup>BrN<sub>4</sub> [M + H]<sup>+</sup> = 303.0240, found 303.0245.</div></div><div id="sec5_1_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 7-(5-Bromo-2-methylphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>14c</b>)</h4><div class="NLM_p last"><b>S1</b> (134 mg, 1 mmol) was reacted with 4-bromo-2-iodo-1-methylbenzene (600 mg, 2 mmol) following the general procedure A to afford 42 mg (14%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.61 (s, 1H), 7.49 (dd, <i>J</i> = 8.16, 2.10 Hz, 1H), 7.45 (d, <i>J</i> = 2.08 Hz, 1H), 7.24 (d, <i>J</i> = 8.19 Hz, 1H), 6.87 (d, <i>J</i> = 3.67 Hz, 1H), 6.51 (d, <i>J</i> = 3.61 Hz, 1H), 4.95 (s, 2H), 2.07 (s, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.90, 153.32, 151.41, 137.69, 135.11, 132.58, 131.86, 131.01, 126.62, 119.50, 112.23, 101.45, 17.95. HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub><sup>79</sup>BrN<sub>4</sub> [M + H]<sup>+</sup> = 303.0240, found 303.0240.</div></div><div id="sec5_1_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-bromobenzonitrile (<b>15c</b>)</h4><div class="NLM_p last"><b>S1</b> (134 mg, 1 mmol) was reacted with 2-bromo-4-iodobenzonitrile (381 mg, 1.3 mmol) following the general procedure A to afford 110 mg (35%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.62 (d, <i>J</i> = 2.15 Hz, 1H), 8.59 (s, 1H), 8.31 (dd, <i>J</i> = 8.68, 2.20 Hz, 1H), 8.06 (d, <i>J</i> = 8.59 Hz, 1H), 7.72 (d, <i>J</i> = 3.92 Hz, 1H), 6.64 (d, <i>J</i> = 3.91 Hz, 1H), 6.61 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.56, 153.24, 151.88, 142.50, 135.50, 125.34, 125.02, 123.56, 120.75, 117.34, 112.00, 110.26, 103.89. HRMS (ESI) calculated for C<sub>13</sub>H<sub>9</sub><sup>79</sup>BrN<sub>5</sub> [M + H]<sup>+</sup> = 314.0036, found 314.0041.</div></div><div id="sec5_1_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-4-bromobenzonitrile (<b>16c</b>)</h4><div class="NLM_p last"><b>S1</b> (134 mg, 1 mmol) was reacted with 3-bromo-5-iodobenzonitrile (618 mg, 2 mmol) following the general procedure A to afford 224 mg (71%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61 (t, <i>J</i> = 1.94 Hz, 1H), 8.59 (s, 1H), 8.53 (t, <i>J</i> = 1.67 Hz, 1H), 8.06 (t, <i>J</i> = 1.54 Hz, 1H), 7.68 (d, <i>J</i> = 3.84 Hz, 1H), 6.61 (d, <i>J</i> = 3.88 Hz, 1H), 6.59 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.55, 152.90, 151.81, 139.61, 131.18, 129.15, 124.34, 123.85, 122.68, 117.21, 113.81, 111.74, 103.19. HRMS (ESI) calculated for C<sub>13</sub>H<sub>9</sub><sup>79</sup>BrN<sub>5</sub> [M + H]<sup>+</sup> = 314.0036, found 314.0040.</div></div><div id="sec5_1_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 7-(3-Bromo-4-(dimethylamino)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>17c</b>)</h4><div class="NLM_p last"><b>S1</b> (200 mg, 1.5 mmol) was reacted with <b>S2k</b> (652 mg, 2 mmol) following the general procedure A to afford 80 mg (16%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56 (s, 1H), 8.02 (d, <i>J</i> = 2.53 Hz, 1H), 7.74 (dd, <i>J</i> = 8.62, 2.55 Hz, 1H), 7.43 (d, <i>J</i> = 3.73 Hz, 1H), 7.29 (d, <i>J</i> = 8.68 Hz, 1H), 6.52 (d, <i>J</i> = 3.72 Hz, 1H), 6.37 (s, 2H), 2.74 (s, 6H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.19, 152.82, 150.66, 150.13, 132.85, 129.25, 126.11, 123.54, 120.75, 119.24, 113.00, 101.94, 44.33. HRMS (ESI) calculated for C<sub>14</sub>H<sub>15</sub><sup>79</sup>BrN<sub>5</sub> [M + H]<sup>+</sup> = 332.0505, found 332.0512.</div></div><div id="sec5_1_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 7-(3-Bromo-4-(2-methoxyethoxy)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>18c</b>)</h4><div class="NLM_p last"><b>S1</b> (200 mg, 1.5 mmol) was reacted with <b>S2l</b> (530 mg, 1.5 mmol) following the general procedure A to afford 130 mg (24%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.59 (s, 1H), 7.87 (d, <i>J</i> = 2.58 Hz, 1H), 7.57 (dd, <i>J</i> = 8.77, 2.60 Hz, 1H), 7.08 (d, <i>J</i> = 3.71 Hz, 1H), 7.03 (d, <i>J</i> = 8.82 Hz, 1H), 6.49 (d, <i>J</i> = 3.69 Hz, 1H), 4.96 (s, 2H), 4.25–4.19 (m, 2H), 3.85–3.80 (m, 2H), 3.50 (s, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.77, 154.19, 152.74, 151.43, 131.79, 128.99, 125.61, 124.03, 113.98, 113.04, 112.84, 101.74, 70.96, 69.55, 59.67. HRMS (ESI) calculated for C<sub>15</sub>H<sub>16</sub><sup>79</sup>BrN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 363.0451, found 363.0450.</div></div><div id="sec5_1_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 7-(3-Bromo-4-(2-(dimethylamino)ethoxy)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>19c</b>)</h4><div class="NLM_p last"><b>S1</b> (200 mg, 1.5 mmol) was reacted with <b>S2m</b> (738 mg, 2 mmol) following the general procedure A to afford 120 mg (21%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.55 (s, 1H), 7.83 (d, <i>J</i> = 2.61 Hz, 1H), 7.51 (dd, <i>J</i> = 8.78, 2.61 Hz, 1H), 7.03 (d, <i>J</i> = 3.76 Hz, 1H), 6.95 (d, <i>J</i> = 8.82 Hz, 1H), 6.45 (d, <i>J</i> = 3.71 Hz, 1H), 5.16 (s, 2H), 4.15 (t, <i>J</i> = 5.68 Hz, 2H), 2.83 (t, <i>J</i> = 5.68 Hz, 2H), 2.39 (s, 6H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.79, 153.88, 152.62, 151.26, 131.50, 128.88, 125.45, 123.96, 113.27, 112.79, 112.39, 101.64, 68.09, 57.83, 46.10. HRMS (ESI) calculated for C<sub>16</sub>H<sub>19</sub><sup>79</sup>BrN<sub>5</sub>O [M + H]<sup>+</sup> = 376.0767, found 376.0773.</div></div><div id="sec5_1_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-bromo-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>20c</b>)</h4><div class="NLM_p last"><b>S1</b> (200 mg, 1.5 mmol) was reacted with <b>S2n</b> (550 mg, 1.6 mmol) following the procedure A to afford 350 mg (66%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 8.61 (s, 1H), 8.06 (d, <i>J</i> = 2.08 Hz, 1H), 7.78 (dd, <i>J</i> = 8.31, 2.08 Hz, 1H), 7.39 (d, <i>J</i> = 8.31 Hz, 1H), 7.16 (d, <i>J</i> = 3.79 Hz, 1H), 6.55 (d, <i>J</i> = 3.79 Hz, 1H), 4.98 (s, 2H), 3.16 (s, 3H), 2.94 (s, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>): δ 168.83, 159.84, 152.88, 151.70, 139.04, 136.25, 128.52, 127.09, 124.62, 122.30, 119.75, 113.38, 102.87, 38.47, 34.90. HRMS (ESI) calculated for C<sub>15</sub>H<sub>15</sub><sup>79</sup>BrN<sub>5</sub>O [M + H]<sup>+</sup> = 360.0454, found 360.0459.</div></div><div id="sec5_1_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 7-(3-Bromophenyl)-5-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>21c</b>)</h4><div class="NLM_p last"><b>7c</b> (156 mg, 0.54 mmol) was reacted with NCS (87 mg, 0.65 mmol) in DMF at room temperature for 12 h. The reaction was quenched by water. The aqueous layer was extracted with ethyl acetate, and combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The volatile components were removed to afford 130 mg (74%, solid) of the desired compound. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.51 (s, 1H), 7.72 (dt, <i>J</i> = 6.54, 1.64 Hz, 2H), 7.54 (t, <i>J</i> = 8.28 Hz, 1H), 7.47 (dt, <i>J</i> = 7.91, 1.48 Hz, 1H), 6.66 (s, 1H), 6.47 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.59, 153.28, 150.43, 135.53, 131.71, 131.53, 131.07, 128.08, 121.65, 121.57, 109.73, 99.67. HRMS (ESI) calculated for C<sub>12</sub>H<sub>9</sub><sup>79</sup>Br<sup>35</sup>ClN<sub>4</sub> [M + H]<sup>+</sup> = 322.9694, found 322.9696.</div></div><div id="sec5_1_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 7-(3-Bromophenyl)-4-methoxy-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>22c</b>)</h4><div class="NLM_p last">4-Methoxy-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>S4</b>, 164 mg, 1 mmol) was reacted with 1-bromo-3-iodobenzene (560 mg, 2 mmol) following the general procedure A to afford 131 mg (41%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (t, <i>J</i> = 1.97 Hz, 1H), 7.87 (ddd, <i>J</i> = 7.82, 2.14, 1.23 Hz, 1H), 7.50 (dt, <i>J</i> = 8.08, 1.45 Hz, 1H), 7.45 (t, <i>J</i> = 7.96 Hz, 1H), 7.36 (d, <i>J</i> = 3.71 Hz, 1H), 6.47 (d, <i>J</i> = 3.70 Hz, 1H), 6.40 (s, 2H), 3.95 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.28, 160.10, 153.91, 139.58, 130.99, 128.50, 125.28, 121.81, 121.69, 121.69, 100.64, 98.06, 52.99. HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub><sup>79</sup>BrN<sub>4</sub>O [M + H]<sup>+</sup> = 319.0189, found 319.0191.</div></div><div id="sec5_1_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 7-(4-Bromophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>23c</b>)</h4><div class="NLM_p last"><b>S1</b> (70 mg, 0.5 mmol) was reacted with 1-bromo-4-iodobenzene (450 mg, 1.6 mmol) following the general procedure A to afford 65 mg (45%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (s, 1H), 7.90–7.81 (m, 2H), 7.73–7.65 (m, 2H), 7.51 (d, <i>J</i> = 3.79 Hz, 1H), 6.56 (d, <i>J</i> = 3.79 Hz, 1H), 6.41 (s, 2H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 159.54, 152.78, 150.93, 136.74, 132.51, 125.35, 125.16, 120.04, 113.23, 102.30. HRMS (ESI) calculated for C<sub>12</sub>H<sub>10</sub><sup>79</sup>BrN<sub>4</sub> [M + H]<sup>+</sup> = 289.0083, found 289.0091.</div></div><div id="sec5_1_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 7-(2-Bromopyridin-4-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>24c</b>)</h4><div class="NLM_p last"><b>S1</b> (160 mg, 1.2 mmol) was reacted with 2-bromo-4-iodopyridine (676 mg, 2.4 mmol) following the general procedure A to afford 250 mg (73%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (s, 1H), 8.50 (d, <i>J</i> = 1.98 Hz, 1H), 8.43 (d, <i>J</i> = 5.64 Hz, 1H), 8.31 (dd, <i>J</i> = 5.67, 2.05 Hz, 1H), 7.81 (d, <i>J</i> = 3.95 Hz, 1H), 6.76–6.60 (m, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.50, 153.72, 151.80, 151.10, 146.51, 142.33, 122.90, 118.14, 114.55, 112.20, 104.31. HRMS (ESI) calculated for C<sub>11</sub>H<sub>9</sub><sup>79</sup>BrN<sub>5</sub> [M + H]<sup>+</sup> = 290.0036, found 290.0040.</div></div><div id="sec5_1_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 7-(2-Bromo-5-fluoropyridin-4-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>36c</b>)</h4><div class="NLM_p last"><b>S1</b> (134 mg, 1 mmol) was reacted with 2-bromo-5-fluoro-4-iodopyridine (604 mg, 2 mmol) following the general procedure A to afford 40 mg (13%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.68 (d, <i>J</i> = 2.57 Hz, 1H), 8.61 (s, 1H), 8.26 (d, <i>J</i> = 5.62 Hz, 1H), 7.43–7.34 (m, 1H), 6.64 (d, <i>J</i> = 3.81 Hz, 1H), 6.59 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.76, 153.38, 152.16 (d, <i>J</i> = 256.79 Hz), 151.86, 139.96 (d, <i>J</i> = 25.16 Hz), 135.75 (d, <i>J</i> = 3.03 Hz), 134.26 (d, <i>J</i> = 10.10 Hz), 124.98, 124.90 (d, <i>J</i> = 5.64 Hz), 110.77, 103.39. HRMS (ESI) calculated for C<sub>11</sub>H<sub>8</sub><sup>79</sup>BrFN<sub>5</sub> [M + H]<sup>+</sup> = 307.9942, found 307.9941.</div></div><div id="sec5_1_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 7-(5-Bromopyridin-3-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>37c</b>)</h4><div class="NLM_p last"><b>S1</b> (160 mg, 1.2 mmol) was reacted with 3-bromo-5-iodopyridine (676 mg, 2.4 mmol) following the general procedure A to afford 24 mg (7%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (s, 1H), 8.72–8.54 (m, 3H), 7.67 (d, <i>J</i> = 3.87 Hz, 1H), 6.62 (d, <i>J</i> = 3.80 Hz, 1H), 6.56 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.53, 152.92, 151.68, 146.87, 141.90, 135.39, 131.63, 123.84, 119.87, 111.57, 103.09. HRMS (ESI) calculated for C<sub>11</sub>H<sub>9</sub><sup>79</sup>BrN<sub>5</sub> [M + H]<sup>+</sup> = 290.0036, found 290.0035.</div></div><div id="sec5_1_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(2-Bromopyridin-4-yl)-1H-pyrrolo[2,3-<i>b</i>]pyridin-6-amine (<b>38c</b>)</h4><div class="NLM_p last">1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-6-amine (57 mg, 0.42 mmol) was reacted with 2-bromo-4-iodopyridine (100 mg, 0.35 mmol) following the general procedure A to afford 33 mg (32%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57 (d, <i>J</i> = 1.91 Hz, 1H), 8.44–8.30 (m, 2H), 7.73 (d, <i>J</i> = 3.89 Hz, 1H), 7.67 (d, <i>J</i> = 8.44 Hz, 1H), 6.55 (d, <i>J</i> = 3.85 Hz, 1H), 6.44 (d, <i>J</i> = 8.44 Hz, 1H), 6.14 (s, 2H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 155.27, 150.74, 147.40, 147.11, 143.01, 131.78, 121.19, 119.37, 114.90, 114.79, 105.44, 104.90. HRMS (ESI) calculated for C<sub>12</sub>H<sub>10</sub><sup>79</sup>BrN<sub>4</sub> [M + H]<sup>+</sup> = 289.0083, found 289.0085.</div></div><div id="sec5_1_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 7-(2-Bromopyridin-4-yl)-4-methyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>39c</b>)</h4><div class="NLM_p last">4-Methyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (20 mg, 0.14 mmol) was reacted with 2-bromo-4-iodopyridine (76 mg, 0.27 mmol) following the general procedure A to afford 10 mg (23%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.51 (d, <i>J</i> = 1.99 Hz, 1H), 8.42 (d, <i>J</i> = 5.69 Hz, 1H), 8.31 (dd, <i>J</i> = 5.71, 2.04 Hz, 1H), 7.76 (d, <i>J</i> = 3.99 Hz, 1H), 6.75 (d, <i>J</i> = 3.93 Hz, 1H), 6.57 (s, 2H), 2.47 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.08, 160.41, 153.59, 151.08, 146.72, 142.33, 121.63, 118.02, 114.44, 111.12, 104.16, 21.03. HRMS (ESI) calculated for C<sub>12</sub>H<sub>11</sub><sup>79</sup>BrN<sub>5</sub> [M + H]<sup>+</sup> = 304.0192, found 304.0201.</div></div><div id="sec5_1_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 7-(2-Bromopyridin-4-yl)-4-ethyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>40c</b>)</h4><div class="NLM_p last">4-Ethyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (30 mg, 0.19 mmol) was reacted with 2-bromo-4-iodopyridine (105 mg, 0.37 mmol) following the general procedure A to afford 20 mg (33%, solid) of the title compound after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.40 (d, <i>J</i> = 5.59 Hz, 1H), 8.16 (d, <i>J</i> = 1.95 Hz, 1H), 7.88 (dd, <i>J</i> = 5.63, 2.02 Hz, 1H), 7.20 (d, <i>J</i> = 3.91 Hz, 1H), 6.62 (d, <i>J</i> = 3.91 Hz, 1H), 5.05 (s, 2H), 2.88 (q, <i>J</i> = 7.64 Hz, 2H), 1.35 (t, <i>J</i> = 7.64 Hz, 3H). <sup>13</sup>C NMR (125 MHz, chloroform-<i>d</i>) δ 166.92, 160.05, 153.64, 150.95, 146.67, 143.13, 121.51, 119.63, 114.96, 111.90, 104.05, 28.76, 13.03. HRMS (ESI) calculated for C<sub>13</sub>H<sub>13</sub><sup>79</sup>BrN<sub>5</sub> [M + H]<sup>+</sup> = 318.0349, found 318.0357.</div></div><div id="sec5_1_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 7-(3-Bromophenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>41c</b>)</h4><div class="NLM_p last">Following the general procedure C using 2-(3-bromophenyl)acetaldehyde (618 mg, 2.9 mmol), the title compound was obtained in 180 mg yield (31%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (s, 1H), 8.41 (s, 1H), 8.22–8.15 (m, 2H), 7.34–7.28 (m, 2H), 6.05 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.10, 148.40, 141.89, 137.05, 130.50, 130.34, 127.56, 127.51, 124.07, 123.30, 121.97, 110.13. HRMS (ESI) calculated for C<sub>12</sub>H<sub>10</sub><sup>79</sup>BrN<sub>4</sub> [M + H]<sup>+</sup> = 289.0083, found 289.0087.</div></div><div id="sec5_1_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 7-(3-Bromo-2-fluorophenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>42c</b>)</h4><div class="NLM_p last">Following the general procedure C using 2-(3-bromo-2-fluorophenyl)acetaldehyde (1970 mg, 9 mmol), the title compound was obtained in 480 mg yield (15%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (td, <i>J</i> = 7.59, 1.68 Hz, 1H), 8.58 (s, 1H), 8.05 (d, <i>J</i> = 3.05 Hz, 1H), 7.50 (ddd, <i>J</i> = 8.09, 6.50, 1.68 Hz, 1H), 7.20 (t, <i>J</i> = 7.92 Hz, 1H), 6.23 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.77, 154.45 (d, <i>J</i> = 246.55 Hz), 148.95, 141.64, 132.99 (d, <i>J</i> = 13.27 Hz), 129.54, 128.68 (d, <i>J</i> = 3.79 Hz), 125.50 (d, <i>J</i> = 4.40 Hz), 123.60 (d, <i>J</i> = 13.69 Hz), 122.49, 108.56 (d, <i>J</i> = 21.24 Hz), 104.57. HRMS (ESI) calculated for C<sub>12</sub>H<sub>9</sub><sup>79</sup>BrFN<sub>4</sub> [M + H]<sup>+</sup> = 306.9989, found 306.9998.</div></div><div id="sec5_1_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 7-(3-Bromo-5-fluorophenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>43c</b>)</h4><div class="NLM_p last">Following the general procedure C using 2-(3-bromo-5-fluorophenyl)acetaldehyde (2106 mg, 9.7 mmol), the title compound was obtained in 750 mg yield (37%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (s, 1H), 8.33–8.22 (m, 2H), 8.17 (dt, <i>J</i> = 10.86, 1.93 Hz, 1H), 7.25 (dt, <i>J</i> = 8.33, 2.07 Hz, 1H), 6.11 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.47 (d, <i>J</i> = 245.46 Hz), 159.35, 148.43, 142.26, 138.78 (d, <i>J</i> = 10.00 Hz), 131.03, 123.53 (d, <i>J</i> = 2.39 Hz), 123.26, 122.07 (d, <i>J</i> = 11.04 Hz), 114.60 (d, <i>J</i> = 24.91 Hz), 110.69 (d, <i>J</i> = 22.24 Hz), 109.09 (d, <i>J</i> = 2.39 Hz). HRMS (ESI) calculated for C<sub>12</sub>H<sub>9</sub><sup>79</sup>BrFN<sub>4</sub> [M + H]<sup>+</sup> = 306.9989, found 306.9984.</div></div><div id="sec5_1_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 7-(2-Fluoro-5-iodophenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>44c</b>)</h4><div class="NLM_p last">Following the general procedure C using 2-(2-fluoro-5-iodophenyl)acetaldehyde (880 mg, 3.3 mmol), the title compound was obtained in 310 mg yield (39%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.05 (dd, <i>J</i> = 7.35, 2.33 Hz, 1H), 8.53 (s, 1H), 7.97 (d, <i>J</i> = 3.15 Hz, 1H), 7.52 (ddd, <i>J</i> = 8.61, 4.67, 2.36 Hz, 1H), 7.09 (dd, <i>J</i> = 11.73, 8.55 Hz, 1H), 6.07 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.28, 158.44 (d, <i>J</i> = 244.86 Hz), 148.71, 142.34, 136.94 (d, <i>J</i> = 4.43 Hz), 134.74 (d, <i>J</i> = 8.35 Hz), 132.38 (d, <i>J</i> = 14.82 Hz), 124.68 (d, <i>J</i> = 13.09 Hz), 122.46, 118.06 (d, <i>J</i> = 23.67 Hz), 103.73, 88.64. HRMS (ESI) calculated for C<sub>12</sub>H<sub>9</sub>FIN<sub>4</sub> [M + H]<sup>+</sup> = 354.9850, found 354.9856.</div></div><div id="sec5_1_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 7-(3-Bromo-5-methoxyphenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>47c</b>)</h4><div class="NLM_p last">Following the general procedure C using 2-(3-bromo-5-methoxyphenyl)acetaldehyde (200 mg, 0.88 mmol), the title compound was obtained in 68 mg yield (24%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.47 (s, 1H), 8.21 (s, 1H), 7.97 (t, <i>J</i> = 1.51 Hz, 1H), 7.85 (t, <i>J</i> = 1.77 Hz, 1H), 6.91 (t, <i>J</i> = 2.05 Hz, 1H), 6.03 (s, 2H), 3.82 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.31, 159.20, 148.44, 142.04, 137.70, 130.63, 123.32, 122.24, 120.09, 112.97, 110.36, 110.04, 55.48. HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub><sup>79</sup>BrN<sub>4</sub>O [M + H]<sup>+</sup> = 319.0189, found 319.0188.</div></div><div id="sec5_1_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 7-(5-Bromo-2-methoxyphenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>48c</b>)</h4><div class="NLM_p last">Following the general procedure C using 2-(5-bromo-2-methoxyphenyl)acetaldehyde (1830 mg, 8 mmol), the title compound was obtained in 740 mg yield (43%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98 (d, <i>J</i> = 2.64 Hz, 1H), 8.50 (s, 1H), 8.18 (d, <i>J</i> = 3.14 Hz, 1H), 7.30 (dd, <i>J</i> = 8.72, 2.65 Hz, 1H), 7.02 (d, <i>J</i> = 8.80 Hz, 1H), 6.00 (s, 2H), 3.89 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.98, 154.65, 149.02, 141.85, 133.25, 130.43, 127.96, 125.23, 122.29, 113.16, 112.16, 106.08, 55.70. HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub><sup>79</sup>BrN<sub>4</sub>O [M + H]<sup>+</sup> = 319.0189, found 319.0198.</div></div><div id="sec5_1_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 7-(3-Bromo-5-chlorophenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>49c</b>)</h4><div class="NLM_p last">Following the general procedure C using 2-(3-bromo-5-chlorophenyl)acetaldehyde (1253 mg, 5.4 mmol), the title compound was obtained in 231 mg yield (19%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (s, 1H), 8.39 (t, <i>J</i> = 1.61 Hz, 1H), 8.35–8.28 (m, 2H), 7.42 (t, <i>J</i> = 1.87 Hz, 1H), 6.12 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.32, 148.41, 142.24, 138.59, 134.24, 131.18, 126.61, 126.00, 123.59, 123.24, 122.46, 108.78. HRMS (ESI) calculated for C<sub>12</sub>H<sub>9</sub><sup>79</sup>Br<sup>35</sup>ClN<sub>4</sub> [M + H]<sup>+</sup> = 322.9694, found 322.9693.</div></div><div id="sec5_1_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 7-(3-Bromophenyl)-6-methyl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>50c</b>)</h4><div class="NLM_p last">Following the general procedure C using 1-(3-bromophenyl)propan-2-one (1700 mg, 8 mmol), the title compound was obtained in 270 mg yield (11%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.34 (s, 1H), 7.92 (d, <i>J</i> = 1.86 Hz, 1H), 7.68 (dt, <i>J</i> = 7.27, 1.64 Hz, 1H), 7.45–7.31 (m, 2H), 5.87 (s, 2H), 2.51 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.22, 149.86, 140.91, 139.99, 136.76, 130.74, 130.19, 127.77, 127.22, 121.65, 121.57, 108.37, 13.77. HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub><sup>79</sup>BrN<sub>4</sub> [M + H]<sup>+</sup> = 303.0240, found 303.0240.</div></div><div id="sec5_1_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 7-(3-Iodophenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>S11</b>)</h4><div class="NLM_p last">Following the general procedure C using 2-(3-iodophenyl)acetaldehyde (1100 mg, 4.4 mmol), the title compound was obtained in 226 mg yield (22%, solid) after flash column chromatography purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (t, <i>J</i> = 1.74 Hz, 1H), 8.47 (s, 1H), 8.21 (dt, <i>J</i> = 7.89, 1.31 Hz, 1H), 8.16 (s, 1H), 7.49 (dt, <i>J</i> = 7.74, 1.34 Hz, 1H), 7.15 (t, <i>J</i> = 7.82 Hz, 1H), 6.00 (s, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.17, 148.39, 142.08, 137.10, 133.45, 133.33, 130.41, 124.56, 123.46, 123.41, 110.01, 95.26. HRMS (ESI) calculated for C<sub>12</sub>H<sub>10</sub>IN<sub>4</sub> [M + H]<sup>+</sup> = 336.9945, found 336.9953.</div></div><div id="sec5_1_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(3-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>7</b>)</h4><div class="NLM_p last"><b>7c</b> (110 mg, 0.38 mmol) was reacted with 2-(thiazol-2-yl)but-3-yn-2-ol (<b>S6</b>) following the general procedure B in toluene to afford 18.6 mg (9%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (s, 1H), 7.91–7.85 (m, 1H), 7.80–7.70 (m, 3H), 7.60–7.50 (m, 3H), 6.81 (d, <i>J</i> = 3.97 Hz, 1H), 1.96 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>16</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> = 362.1070, found 362.1071.</div></div><div id="sec5_1_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-(5-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-fluorophenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>8</b>)</h4><div class="NLM_p last"><b>8c</b> (40 mg, 0.13 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 50.8 mg (79%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (s, 1H), 7.91 (dd, <i>J</i> = 6.03, 2.77 Hz, 1H), 7.80–7.74 (m, 2H), 7.69 (d, <i>J</i> = 3.99 Hz, 1H), 7.58 (d, <i>J</i> = 3.29 Hz, 1H), 7.35 (t, <i>J</i> = 8.90 Hz, 1H), 6.80 (d, <i>J</i> = 4.03 Hz, 1H), 1.98 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>15</sub>FN<sub>5</sub>OS [M + H]<sup>+</sup> = 380.0976, found 380.0982.</div></div><div id="sec5_1_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(3-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-4-fluorophenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>9</b>)</h4><div class="NLM_p last"><b>9c</b> (50 mg, 0.16 mmol) was reacted with <b>S6</b> following the general procedure B in toluene to afford 8.8 mg (11%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.68 (s, 1H), 7.82–7.75 (m, 2H), 7.64 (ddd, <i>J</i> = 8.65, 4.68, 2.12 Hz, 1H), 7.58–7.54 (m, 2H), 7.40 (dd, <i>J</i> = 10.14, 8.69 Hz, 1H), 6.82 (d, <i>J</i> = 3.96 Hz, 1H), 1.94 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>15</sub>FN<sub>5</sub>OS [M + H]<sup>+</sup> = 380.0976, found 380.0969.</div></div><div id="sec5_1_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-(5-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2,4-difluorophenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>10</b>)</h4><div class="NLM_p last"><b>10c</b> (50 mg, 0.15 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 55 mg (71%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.68 (s, 1H), 7.86 (t, <i>J</i> = 7.65 Hz, 1H), 7.77 (d, <i>J</i> = 3.29 Hz, 1H), 7.57 (d, <i>J</i> = 3.30 Hz, 1H), 7.54 (dd, <i>J</i> = 3.99, 1.70 Hz, 1H), 7.39 (dd, <i>J</i> = 10.14, 9.07 Hz, 1H), 6.81 (d, <i>J</i> = 3.99 Hz, 1H), 1.96 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>14</sub>F<sub>2</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> = 398.0882, found 398.0887.</div></div><div id="sec5_1_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(5-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-methoxyphenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>11</b>)</h4><div class="NLM_p last"><b>11c</b> (50 mg, 0.16 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 26.7 mg (32%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.62 (s, 1H), 7.80–7.73 (m, 2H), 7.66–7.60 (m, 2H), 7.58 (s, 1H), 7.15 (d, <i>J</i> = 8.99 Hz, 1H), 6.76 (d, <i>J</i> = 3.99 Hz, 1H), 3.91 (s, 3H), 1.96 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> = 392.1176, found 392.1181.</div></div><div id="sec5_1_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-(3-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-4-methoxyphenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>12</b>)</h4><div class="NLM_p last"><b>12c</b> (60 mg, 0.19 mmol) was reacted with <b>S6</b> following the general procedure B in toluene to afford 9 mg (9%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.61 (s, 1H), 7.77 (d, <i>J</i> = 3.39 Hz, 1H), 7.61–7.54 (m, 3H), 7.46 (d, <i>J</i> = 3.95 Hz, 1H), 7.22 (d, <i>J</i> = 9.19 Hz, 1H), 6.74 (d, <i>J</i> = 3.92 Hz, 1H), 3.84 (s, 3H), 1.93 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> = 392.1176, found 392.1179.</div></div><div id="sec5_1_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-(5-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-methylphenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>13</b>)</h4><div class="NLM_p last"><b>13c</b> (40 mg, 0.13 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 26.9 mg (42%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.62 (s, 1H), 7.79 (d, <i>J</i> = 3.30 Hz, 1H), 7.77 (d, <i>J</i> = 2.35 Hz, 1H), 7.65 (d, <i>J</i> = 3.97 Hz, 1H), 7.62–7.54 (m, 2H), 7.38 (d, <i>J</i> = 8.29 Hz, 1H), 6.76 (d, <i>J</i> = 3.99 Hz, 1H), 2.46 (s, 3H), 1.99 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> = 376.1227, found 376.1234.</div></div><div id="sec5_1_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 4-(3-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-4-methylphenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>14</b>)</h4><div class="NLM_p last"><b>14c</b> (42 mg, 0.13 mmol) was reacted with <b>S6</b> following the general procedure B in toluene to afford 6.5 mg (10%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.67 (s, 1H), 7.77 (s, 1H), 7.59–7.49 (m, 2H), 7.48–7.38 (m, 3H), 6.81 (d, <i>J</i> = 3.88 Hz, 1H), 2.14 (s, 3H), 1.93 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> = 376.1227, found 376.1222.</div></div><div id="sec5_1_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-(3-hydroxy-3-(thiazol-2-yl)but-1-yn-1-yl)benzonitrile (<b>15</b>)</h4><div class="NLM_p last"><b>15c</b> (50 mg, 0.16 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 4.5 mg (5%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.69 (s, 1H), 8.22 (d, <i>J</i> = 2.21 Hz, 1H), 8.06 (dd, <i>J</i> = 8.54, 2.28 Hz, 1H), 7.96 (d, <i>J</i> = 8.56 Hz, 1H), 7.85 (d, <i>J</i> = 4.03 Hz, 1H), 7.80 (d, <i>J</i> = 3.27 Hz, 1H), 7.60 (d, <i>J</i> = 3.17 Hz, 1H), 6.86 (d, <i>J</i> = 4.03 Hz, 1H), 2.03 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>15</sub>N<sub>6</sub>OS [M + H]<sup>+</sup> = 387.1023, found 387.1032.</div></div><div id="sec5_1_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-5-(3-hydroxy-3-(thiazol-2-yl)but-1-yn-1-yl)benzonitrile (<b>16</b>)</h4><div class="NLM_p last"><b>16c</b> (50 mg, 0.16 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 17.8 mg (22%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.68 (s, 1H), 8.31–8.25 (m, 1H), 8.23–8.17 (m, 1H), 7.87 (t, <i>J</i> = 1.46 Hz, 1H), 7.80 (dd, <i>J</i> = 6.17, 3.68 Hz, 2H), 7.59 (d, <i>J</i> = 3.30 Hz, 1H), 6.84 (d, <i>J</i> = 4.06 Hz, 1H), 1.96 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>15</sub>N<sub>6</sub>OS [M + H]<sup>+</sup> = 387.1023, found 387.1021.</div></div><div id="sec5_1_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 4-(5-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-(methylamino)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>17</b>)</h4><div class="NLM_p last"><b>17c</b> (40 mg, 0.12 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 6.2 mg (10%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.62 (s, 1H), 7.85 (d, <i>J</i> = 1.90 Hz, 1H), 7.72–7.68 (m, 2H), 7.61 (d, <i>J</i> = 3.32 Hz, 2H), 7.46 (d, <i>J</i> = 8.82 Hz, 1H), 7.42 (dd, <i>J</i> = 8.77, 2.00 Hz, 1H), 6.78 (d, <i>J</i> = 3.91 Hz, 1H), 6.72 (s, 1H), 3.65 (s, 3H), 2.11 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>19</sub>N<sub>6</sub>OS [M + H]<sup>+</sup> = 391.1336, found 391.1345.</div></div><div id="sec5_1_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 4-(5-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-(2-methoxyethoxy)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>18</b>)</h4><div class="NLM_p last"><b>18c</b> (40 mg, 0.11 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 20.3 mg (33%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.62 (s, 1H), 7.84–7.72 (m, 2H), 7.67–7.55 (m, 3H), 7.14 (d, <i>J</i> = 8.98 Hz, 1H), 6.76 (d, <i>J</i> = 3.98 Hz, 1H), 4.25–4.17 (m, 2H), 3.82–3.74 (m, 2H), 3.43 (s, 3H), 1.97 (s, 3H). HRMS (ESI) calculated for C<sub>22</sub>H<sub>22</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> = 436.1438, found 436.1441.</div></div><div id="sec5_1_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 4-(5-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-(2-(dimethylamino)ethoxy)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>19</b>)</h4><div class="NLM_p last"><b>19c</b> (40 mg, 0.10 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 12.7 mg (22%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.66 (s, 1H), 7.88 (d, <i>J</i> = 2.73 Hz, 1H), 7.81 (d, <i>J</i> = 3.28 Hz, 1H), 7.73 (dd, <i>J</i> = 8.92, 2.77 Hz, 1H), 7.67 (d, <i>J</i> = 3.99 Hz, 1H), 7.60 (d, <i>J</i> = 3.31 Hz, 1H), 7.25 (d, <i>J</i> = 8.96 Hz, 1H), 6.80 (d, <i>J</i> = 4.01 Hz, 1H), 4.53–4.47 (m, 2H), 3.70–3.64 (m, 2H), 3.05 (s, 6H), 1.97 (s, 3H). HRMS (ESI) calculated for C<sub>23</sub>H<sub>25</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> = 449.1754, found 449.1760.</div></div><div id="sec5_1_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-2-(3-hydroxy-3-(thiazol-2-yl)but-1-yn-1-yl)-<i>N</i>,<i>N</i>-dimethylbenzamide (<b>20</b>)</h4><div class="NLM_p last"><b>20c</b> (45 mg, 0.13 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 21.3 mg (30%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.67 (s, 1H), 8.00 (d, <i>J</i> = 2.18 Hz, 1H), 7.89 (dd, <i>J</i> = 8.33, 2.21 Hz, 1H), 7.82–7.75 (m, 2H), 7.59 (d, <i>J</i> = 3.20 Hz, 1H), 7.51 (d, <i>J</i> = 8.33 Hz, 1H), 6.83 (d, <i>J</i> = 4.01 Hz, 1H), 3.05 (s, 3H), 2.90 (s, 3H), 1.95 (s, 3H). HRMS (ESI) calculated for C<sub>22</sub>H<sub>21</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> = 433.1441, found 433.1448.</div></div><div id="sec5_1_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 4-(3-(2-Amino-5-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>21</b>)</h4><div class="NLM_p last"><b>21c</b> (130 mg, 0.40 mmol) was reacted with <b>S6</b> following the general procedure B in toluene to afford 16.4 mg (8%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.60 (s, 1H), 7.77 (d, <i>J</i> = 3.29 Hz, 1H), 7.66 (dt, <i>J</i> = 7.58, 1.37 Hz, 1H), 7.61–7.55 (m, 3H), 7.49–7.45 (m, 1H), 6.85 (s, 1H), 1.95 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>15</sub><sup>35</sup>ClN<sub>5</sub>OS [M + H]<sup>+</sup> = 396.0680, found 396.0680.</div></div><div id="sec5_1_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-(3-(2-Amino-4-methoxy-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>22</b>)</h4><div class="NLM_p last"><b>22c</b> (131 mg, 0.41 mmol) was reacted with <b>S6</b> following the general procedure B in toluene to afford 28.4 mg (13%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.78 (d, <i>J</i> = 3.29 Hz, 1H), 7.74–7.69 (m, 1H), 7.61–7.55 (m, 4H), 7.17 (d, <i>J</i> = 3.60 Hz, 1H), 6.67 (d, <i>J</i> = 3.62 Hz, 1H), 4.17 (s, 3H), 1.95 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> = 392.1176, found 392.1180.</div></div><div id="sec5_1_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 4-(4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>23</b>)</h4><div class="NLM_p last"><b>23c</b> (65 mg, 0.23 mmol) was reacted with <b>S6</b> following the procedure B in toluene to afford 15.1 mg (13%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (s, 1H), 7.82–7.77 (m, 3H), 7.75 (d, <i>J</i> = 4.02 Hz, 1H), 7.64 (d, <i>J</i> = 8.28 Hz, 2H), 7.58 (d, <i>J</i> = 3.30 Hz, 1H), 6.82 (d, <i>J</i> = 4.00 Hz, 1H), 1.97 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>16</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> = 362.1070, found 362.1063.</div></div><div id="sec5_1_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-(4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>24</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 37.2 mg (55%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.70 (s, 1H), 8.66 (d, <i>J</i> = 5.81 Hz, 1H), 8.34 (d, <i>J</i> = 2.20 Hz, 1H), 8.13 (dd, <i>J</i> = 5.77, 2.31 Hz, 1H), 7.97 (d, <i>J</i> = 4.15 Hz, 1H), 7.80 (d, <i>J</i> = 3.28 Hz, 1H), 7.60 (d, <i>J</i> = 3.30 Hz, 1H), 6.89 (d, <i>J</i> = 4.10 Hz, 1H), 2.00 (s, 3H). HRMS (ESI) calculated for C<sub>18</sub>H<sub>15</sub>N<sub>6</sub>OS [M + H]<sup>+</sup> = 363.1023, found 363.1026.</div></div><div id="sec5_1_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 4-(4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol (<b>25</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 2-(5-methylisoxazol-3-yl)but-3-yn-2-ol following the general procedure B in DMSO to afford 54.3 mg (81%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.70 (s, 1H), 8.66 (d, <i>J</i> = 5.78 Hz, 1H), 8.30 (d, <i>J</i> = 2.29 Hz, 1H), 8.11 (dd, <i>J</i> = 5.75, 2.28 Hz, 1H), 7.97 (d, <i>J</i> = 4.10 Hz, 1H), 6.89 (d, <i>J</i> = 4.16 Hz, 1H), 6.35 (s, 1H), 2.45 (s, 3H), 1.92 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>17</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 361.1408, found 361.1418.</div></div><div id="sec5_1_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 4-(4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)-2-(pyrazin-2-yl)but-3-yn-2-ol (<b>26</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 2-(pyrazin-2-yl)but-3-yn-2-ol following the general procedure B in DMSO to afford 6.7 mg (10%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 9.10 (s, 1H), 8.75–8.53 (m, 4H), 8.29 (s, 1H), 8.16–8.08 (m, 1H), 7.97 (d, <i>J</i> = 4.15 Hz, 1H), 6.89 (d, <i>J</i> = 4.09 Hz, 1H), 1.97 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>16</sub>N<sub>7</sub>O [M + H]<sup>+</sup> = 358.1411, found 358.1416.</div></div><div id="sec5_1_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 3-((4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)-3-hydroxy-1-methylpyrrolidin-2-one (<b>27</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one (<b>S8</b>) following the general procedure B in DMSO to afford 6.2 mg (9%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.70 (s, 1H), 8.65 (d, <i>J</i> = 5.78 Hz, 1H), 8.34 (d, <i>J</i> = 2.20 Hz, 1H), 8.10 (dd, <i>J</i> = 5.80, 2.29 Hz, 1H), 7.96 (d, <i>J</i> = 4.16 Hz, 1H), 6.89 (d, <i>J</i> = 4.12 Hz, 1H), 3.55–3.48 (m, 2H), 2.95 (s, 3H), 2.65 (ddd, <i>J</i> = 13.03, 6.66, 4.56 Hz, 1H), 2.36 (dt, <i>J</i> = 13.02, 7.23 Hz, 1H). HRMS (ESI) calculated for C<sub>18</sub>H<sub>17</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 349.1408, found 349.1401.</div></div><div id="sec5_1_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 3-((4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)-3-hydroxy-1-methylpiperidin-2-one (<b>28</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 3-ethynyl-3-hydroxy-1-methylpiperidin-2-one following the general procedure B in DMSO to afford 3.2 mg (4%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.70 (s, 1H), 8.66 (d, <i>J</i> = 5.69 Hz, 1H), 8.32 (d, <i>J</i> = 2.19 Hz, 1H), 8.09 (dd, <i>J</i> = 5.82, 2.31 Hz, 1H), 7.97 (d, <i>J</i> = 4.14 Hz, 1H), 6.89 (d, <i>J</i> = 4.09 Hz, 1H), 3.48–3.42 (m, 2H), 2.99 (s, 3H), 2.41–2.34 (m, 1H), 2.29–2.19 (m, 1H), 2.18–2.10 (m, 1H), 2.09–2.01 (m, 1H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>19</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 363.1564, found 363.1559.</div></div><div id="sec5_1_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-((4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)piperidin-4-ol (<b>29</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with <i>tert</i>-butyl 4-ethynyl-4-hydroxypiperidine-1-carboxylate following the general procedure B in DMSO to afford 22.8 mg (36%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.71 (s, 1H), 8.69 (d, <i>J</i> = 5.82 Hz, 1H), 8.29 (d, <i>J</i> = 2.19 Hz, 1H), 8.17 (dd, <i>J</i> = 5.79, 2.30 Hz, 1H), 7.98 (d, <i>J</i> = 4.14 Hz, 1H), 6.90 (d, <i>J</i> = 4.16 Hz, 1H), 3.46–3.33 (m, 4H), 2.33–2.20 (m, 2H), 2.20–2.09 (m, 2H). HRMS (ESI) calculated for C<sub>18</sub>H<sub>19</sub>N<sub>6</sub>O [M + H]<sup>+</sup> = 335.1615, found 335.1613.</div></div><div id="sec5_1_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 1-((4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)cyclobutan-1-ol (<b>30</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 1-ethynylcyclobutan-1-ol following the general procedure B in DMSO to afford 25 mg (42%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.75–8.64 (m, 2H), 8.39 (d, <i>J</i> = 2.22 Hz, 1H), 8.23 (dd, <i>J</i> = 5.98, 2.28 Hz, 1H), 8.00 (d, <i>J</i> = 4.14 Hz, 1H), 6.91 (d, <i>J</i> = 4.12 Hz, 1H), 2.61–2.52 (m, 2H), 2.40–2.32 (m, 2H), 1.98–1.89 (m, 2H). HRMS (ESI) calculated for C<sub>17</sub>H<sub>16</sub>N<sub>5</sub>O [M + H]<sup>+</sup> = 306.1349, found 306.1340.</div></div><div id="sec5_1_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 1-((4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)cyclopentan-1-ol (<b>31</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 1-ethynylcyclopentan-1-ol following the general procedure B in DMSO to afford 34.6 mg (57%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.81–8.61 (m, 2H), 8.36 (s, 1H), 8.22 (dd, <i>J</i> = 5.93, 2.30 Hz, 1H), 7.99 (d, <i>J</i> = 4.16 Hz, 1H), 6.91 (d, <i>J</i> = 4.16 Hz, 1H), 2.12–2.02 (m, 4H), 1.93–1.79 (m, 4H). HRMS (ESI) calculated for C<sub>18</sub>H<sub>18</sub>N<sub>5</sub>O [M + H]<sup>+</sup> = 320.1506, found 320.1504.</div></div><div id="sec5_1_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 1-((4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)cyclohexan-1-ol (<b>32</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 1-ethynylcyclohexan-1-ol following the general procedure B in DMSO to afford 56.8 mg (90%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.70 (s, 1H), 8.67 (d, <i>J</i> = 5.85 Hz, 1H), 8.25 (d, <i>J</i> = 2.19 Hz, 1H), 8.16 (dd, <i>J</i> = 5.86, 2.31 Hz, 1H), 7.98 (d, <i>J</i> = 4.14 Hz, 1H), 6.90 (d, <i>J</i> = 4.16 Hz, 1H), 2.07–1.99 (m, 2H), 1.79–1.58 (m, 7H), 1.42–1.31 (m, 1H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O [M + H]<sup>+</sup> = 334.1662, found 334.1651.</div></div><div id="sec5_1_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 1-((4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)cycloheptan-1-ol (<b>33</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 1-ethynylcycloheptan-1-ol following the general procedure B in DMSO to afford 35.1 mg (54%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.78–8.61 (m, 2H), 8.32 (d, <i>J</i> = 2.24 Hz, 1H), 8.25 (dd, <i>J</i> = 5.94, 2.30 Hz, 1H), 8.00 (d, <i>J</i> = 4.17 Hz, 1H), 6.91 (d, <i>J</i> = 4.15 Hz, 1H), 2.21–2.11 (m, 2H), 2.02–1.91 (m, 2H), 1.78–1.61 (m, 8H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>22</sub>N<sub>5</sub>O [M + H]<sup>+</sup> = 348.1819, found 348.1809.</div></div><div id="sec5_1_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 4-(4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)-2-hydroxy-2-methyl-1-(pyrrolidin-1-yl)but-3-yn-1-one (<b>34</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 2-hydroxy-2-methyl-1-(pyrrolidin-1-yl)but-3-yn-1-one following the general procedure B in DMSO to afford 3.3 mg (5%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.70 (s, 1H), 8.67 (d, <i>J</i> = 5.81 Hz, 1H), 8.29 (d, <i>J</i> = 2.23 Hz, 1H), 8.12 (dd, <i>J</i> = 5.77, 2.28 Hz, 1H), 7.97 (d, <i>J</i> = 4.10 Hz, 1H), 6.90 (d, <i>J</i> = 4.09 Hz, 1H), 4.07–4.00 (m, 1H), 3.96–3.89 (m, 1H), 3.52 (t, <i>J</i> = 7.00 Hz, 2H), 1.98 (p, <i>J</i> = 6.62 Hz, 2H), 1.89 (p, <i>J</i> = 6.49 Hz, 2H), 1.79 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>21</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 377.1721, found 377.1720.</div></div><div id="sec5_1_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 1-(4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)-3-(thiazol-2-yl)pent-1-yn-3-ol (<b>35</b>)</h4><div class="NLM_p last"><b>24c</b> (40 mg, 0.14 mmol) was reacted with 3-(thiazol-2-yl)pent-1-yn-3-ol following the procedure B in DMSO to afford 25.2 mg (36%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.69 (s, 1H), 8.65 (d, <i>J</i> = 5.76 Hz, 1H), 8.30 (d, <i>J</i> = 2.18 Hz, 1H), 8.11 (dd, <i>J</i> = 5.77, 2.25 Hz, 1H), 7.95 (d, <i>J</i> = 4.13 Hz, 1H), 7.81 (d, <i>J</i> = 3.28 Hz, 1H), 7.60 (d, <i>J</i> = 3.25 Hz, 1H), 6.88 (d, <i>J</i> = 4.09 Hz, 1H), 2.34–2.18 (m, 2H), 1.08 (t, <i>J</i> = 7.35 Hz, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>17</sub>N<sub>6</sub>OS [M + H]<sup>+</sup> = 377.1179, found 377.1171.</div></div><div id="sec5_1_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 4-(4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)-5-fluoropyridin-2-yl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>36</b>)</h4><div class="NLM_p last"><b>36c</b> (40 mg, 0.13 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 54.8 mg (85%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.72 (s, 1H), 8.69 (d, <i>J</i> = 2.57 Hz, 1H), 8.12 (d, <i>J</i> = 5.92 Hz, 1H), 7.78 (s, 1H), 7.68 (t, <i>J</i> = 3.40 Hz, 1H), 7.58 (s, 1H), 6.87 (d, <i>J</i> = 4.06 Hz, 1H), 1.97 (s, 3H). HRMS (ESI) calculated for C<sub>18</sub>H<sub>14</sub>FN<sub>6</sub>OS [M + H]<sup>+</sup> = 381.0928, found 381.0932.</div></div><div id="sec5_1_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 4-(5-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-3-yl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>37</b>)</h4><div class="NLM_p last"><b>37c</b> (24 mg, 0.08 mmol) was reacted with <b>S6</b> following the general procedure B in DMSO to afford 4.2 mg (11%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 9.03 (d, <i>J</i> = 2.48 Hz, 1H), 8.72–8.64 (m, 2H), 8.39 (t, <i>J</i> = 2.14 Hz, 1H), 7.81 (dd, <i>J</i> = 12.86, 3.66 Hz, 2H), 7.59 (d, <i>J</i> = 3.30 Hz, 1H), 6.87 (d, <i>J</i> = 4.02 Hz, 1H), 1.98 (s, 3H). HRMS (ESI) calculated for C<sub>18</sub>H<sub>15</sub>N<sub>6</sub>OS [M + H]<sup>+</sup> = 363.1023, found 363.1026.</div></div><div id="sec5_1_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 3-((4-(6-Amino-1H-pyrrolo[2,3-<i>b</i>]pyridin-1-yl)pyridin-2-yl)ethynyl)-3-hydroxy-1-methylpyrrolidin-2-one (<b>38</b>)</h4><div class="NLM_p last"><b>38c</b> (33 mg, 0.11 mmol) was reacted with <b>S8</b> following the general procedure B in DMSO to afford 23 mg (45%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.53 (d, <i>J</i> = 5.20 Hz, 1H), 8.16 (d, <i>J</i> = 8.96 Hz, 1H), 7.88–7.80 (m, 2H), 7.38 (dd, <i>J</i> = 5.18, 1.22 Hz, 1H), 6.80–6.70 (m, 2H), 3.51 (dd, <i>J</i> = 7.33, 5.65 Hz, 2H), 2.95 (s, 3H), 2.62 (dt, <i>J</i> = 13.12, 5.74 Hz, 1H), 2.36 (dt, <i>J</i> = 13.04, 7.20 Hz, 1H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 348.1455, found 348.1456.</div></div><div id="sec5_1_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 3-((4-(2-Amino-4-methyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)-3-hydroxy-1-methylpyrrolidin-2-one (<b>39</b>)</h4><div class="NLM_p last"><b>39c</b> (10 mg, 0.03 mmol) was reacted with <b>S8</b> following the general procedure B in DMSO to afford 2.2 mg (15%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.64 (d, <i>J</i> = 5.72 Hz, 1H), 8.32 (d, <i>J</i> = 2.17 Hz, 1H), 8.05 (dd, <i>J</i> = 5.73, 2.29 Hz, 1H), 7.89 (d, <i>J</i> = 4.13 Hz, 1H), 6.97 (d, <i>J</i> = 4.10 Hz, 1H), 3.54–3.47 (m, 2H), 2.94 (s, 3H), 2.78 (s, 3H), 2.68–2.60 (m, 1H), 2.39–2.30 (m, 1H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>19</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 363.1564, found 363.1561.</div></div><div id="sec5_1_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 3-((4-(2-Amino-4-ethyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-7-yl)pyridin-2-yl)ethynyl)-3-hydroxy-1-methylpyrrolidin-2-one (<b>40</b>)</h4><div class="NLM_p last"><b>40c</b> (20 mg, 0.06 mmol) was reacted with <b>S8</b> following the general procedure B in DMSO to afford 2.4 mg (8%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (d, <i>J</i> = 5.72 Hz, 1H), 8.33 (d, <i>J</i> = 2.24 Hz, 1H), 8.05 (dd, <i>J</i> = 5.71, 2.28 Hz, 1H), 7.90 (d, <i>J</i> = 4.19 Hz, 1H), 7.00 (d, <i>J</i> = 4.16 Hz, 1H), 3.54–3.47 (m, 2H), 3.12 (q, <i>J</i> = 7.65 Hz, 2H), 2.94 (s, 3H), 2.65 (ddd, <i>J</i> = 13.02, 6.74, 4.39 Hz, 1H), 2.35 (dt, <i>J</i> = 13.02, 7.38 Hz, 1H), 1.46 (t, <i>J</i> = 7.65 Hz, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>21</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 377.1721, found 377.1720.</div></div><div id="sec5_1_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>41</b>)</h4><div class="NLM_p last"><b>41c</b> (18 mg, 0.06 mmol) was reacted with <b>S6</b> in toluene following the general procedure D to afford 4.5 mg (15%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (s, 1H), 8.49 (s, 1H), 8.09 (s, 1H), 8.00–7.91 (m, 1H), 7.79 (d, <i>J</i> = 3.30 Hz, 1H), 7.57 (d, <i>J</i> = 3.26 Hz, 1H), 7.49–7.31 (m, 2H), 1.98 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>16</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> = 362.1070, found 362.1063.</div></div><div id="sec5_1_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)-2-fluorophenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>42</b>)</h4><div class="NLM_p last"><b>42c</b> (31 mg, 0.1 mmol) was reacted with <b>S6</b> following the general procedure D to afford 6.2 mg (12%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.73 (s, 1H), 8.39 (s, 1H), 8.25–8.13 (m, 1H), 7.79 (d, <i>J</i> = 3.32 Hz, 1H), 7.58 (d, <i>J</i> = 3.29 Hz, 1H), 7.49–7.42 (m, 1H), 7.25 (t, <i>J</i> = 7.78 Hz, 1H), 1.98 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>15</sub>FN<sub>5</sub>OS [M + H]<sup>+</sup> = 380.0976, found 380.0972.</div></div><div id="sec5_1_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)-5-fluorophenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>43</b>)</h4><div class="NLM_p last"><b>43c</b> (31 mg, 0.1 mmol) was reacted with <b>S6</b> following the general procedure D to afford 1.7 mg (3%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.63 (s, 1H), 8.60 (s, 1H), 7.99–7.87 (m, 2H), 7.80 (s, 1H), 7.59 (s, 1H), 7.11 (d, <i>J</i> = 9.14 Hz, 1H), 1.97 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>15</sub>FN<sub>5</sub>OS [M + H]<sup>+</sup> = 380.0976, found 380.0974.</div></div><div id="sec5_1_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)-4-fluorophenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>44</b>)</h4><div class="NLM_p last"><b>44c</b> (107 mg, 0.35 mmol) was reacted with <b>S6</b> following the general procedure D to afford 81.3 mg (45%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.51 (s, 1H), 8.25 (d, <i>J</i> = 1.99 Hz, 1H), 8.18 (dd, <i>J</i> = 7.33, 2.15 Hz, 1H), 7.82 (d, <i>J</i> = 3.35 Hz, 1H), 7.58 (d, <i>J</i> = 3.32 Hz, 1H), 7.26 (ddd, <i>J</i> = 8.66, 4.90, 2.18 Hz, 1H), 7.04 (dd, <i>J</i> = 11.23, 8.52 Hz, 1H), 1.98 (s, 3H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ 178.85, 160.31 (d, <i>J</i> = 250.44 Hz), 152.95, 151.29, 143.81 (d, <i>J</i> = 12.63 Hz), 143.12, 134.59, 133.28, 132.67 (d, <i>J</i> = 8.8 Hz), 122.60, 121.49, 120.85 (d, <i>J</i> = 13.68 Hz), 119.66 (d, <i>J</i> = 3.05 Hz), 117.01 (d, <i>J</i> = 23.91 Hz), 107.57, 91.56, 84.49, 69.77, 32.28. HRMS (ESI) calculated for [M + H]<sup>+</sup> = C<sub>19</sub>H<sub>15</sub>FN<sub>5</sub>OS 380.0976, found 380.0973. Final compounds <b>45</b> (<i>S</i>-44) and <b>46</b> (<i>R</i>-44) were obtained by the same method from (<i>S</i>)-<b>S6</b> (ee = 98.12%, [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +33.4°, <i>c</i> = 1.0, CH<sub>3</sub>OH) and (<i>R</i>)-<b>S6</b> (ee = 99.02%, [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −32.4°, <i>c</i> = 1.0, CH<sub>3</sub>OH), respectively. For <b>45</b> (<i>S</i>-44), [α]<sub class="stack">D</sub><sup class="stack">20</sup> = +35.9° (<i>c</i> = 1.0, CH<sub>3</sub>OH). For <b>46</b> (<i>R</i>-44), [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −40.7° (<i>c</i> = 1.0, CH<sub>3</sub>OH).</div></div><div id="sec5_1_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)-5-methoxyphenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>47</b>)</h4><div class="NLM_p last"><b>47c</b> (26 mg, 0.08 mmol) was reacted with <b>S6</b> following the general procedure D to afford 3.9 mg (9%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.64 (s, 1H), 8.51 (s, 1H), 7.80 (d, <i>J</i> = 3.37 Hz, 1H), 7.69–7.55 (m, 3H), 6.95 (d, <i>J</i> = 2.00 Hz, 1H), 3.85 (s, 3H), 1.97 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> = 392.1176, found 392.1177.</div></div><div id="sec5_1_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)-4-methoxyphenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>48</b>)</h4><div class="NLM_p last"><b>48c</b> (61 mg, 0.19 mmol) was reacted with <b>S6</b> following the general procedure D to afford 4.8 mg (5%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.75 (s, 1H), 8.62 (d, <i>J</i> = 3.76 Hz, 1H), 8.52 (s, 1H), 8.46–8.33 (m, 2H), 7.73 (dd, <i>J</i> = 8.54, 2.35 Hz, 1H), 7.37 (d, <i>J</i> = 8.66 Hz, 1H), 6.87–6.81 (m, 1H), 4.03 (s, 3H), 1.92 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> = 392.1176, found 392.1169.</div></div><div id="sec5_1_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)-5-chlorophenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>49</b>)</h4><div class="NLM_p last"><b>49c</b> (29 mg, 0.09 mmol) was reacted with <b>S6</b> following the general procedure D to afford 2 mg (4%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.70 (s, 1H), 8.68 (s, 1H), 8.61 (d, <i>J</i> = 3.69 Hz, 1H), 8.47 (s, 1H), 8.41 (d, <i>J</i> = 3.72 Hz, 1H), 8.33 (s, 1H), 7.68 (s, 1H), 7.00 (s, 1H), 1.93 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>15</sub><sup>35</sup>ClN<sub>5</sub>OS [M + H]<sup>+</sup> = 396.0680, found 396.0686.</div></div><div id="sec5_1_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-(3-(2-Amino-6-methyl-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(thiazol-2-yl)but-3-yn-2-ol (<b>50</b>)</h4><div class="NLM_p last"><b>50c</b> (43 mg, 0.14 mmol) was reacted with <b>S6</b> following the general procedure D to afford 8 mg (11%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.50 (s, 1H), 7.78 (d, <i>J</i> = 3.31 Hz, 1H), 7.69 (s, 1H), 7.60–7.53 (m, 2H), 7.47 (d, <i>J</i> = 4.66 Hz, 2H), 2.61 (s, 3H), 1.96 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> = 376.1227, found 376.1226.</div></div><div id="sec5_1_1_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol (<b>51</b>)</h4><div class="NLM_p last">7-(3-Iodophenyl)-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-2-amine (<b>S11</b>, 28 mg, 0.08 mmol) was reacted with 2-(5-methylisoxazol-3-yl)but-3-yn-2-ol following the general procedure D to afford 2.5 mg (6%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.66 (s, 1H), 8.51 (s, 1H), 8.10 (s, 1H), 7.97 (d, <i>J</i> = 7.17 Hz, 1H), 7.46–7.34 (m, 2H), 6.32 (s, 1H), 2.44 (s, 3H), 1.89 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 360.1455, found 360.1459.</div></div><div id="sec5_1_1_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(pyrazin-2-yl)but-3-yn-2-ol (<b>52</b>)</h4><div class="NLM_p last"><b>S11</b> (24 mg, 0.07 mmol) was reacted with 2-(pyrazin-2-yl)but-3-yn-2-ol following the general procedure D to afford 1.4 mg (4%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 9.10 (s, 1H), 8.68–8.57 (m, 3H), 8.51 (s, 1H), 8.11 (s, 1H), 7.96 (d, <i>J</i> = 7.38 Hz, 1H), 7.45–7.36 (m, 2H), 1.94 (s, 3H). HRMS (ESI) calculated for C<sub>20</sub>H<sub>17</sub>N<sub>6</sub>O [M + H]<sup>+</sup> = 357.1458, found 357.1462.</div></div><div id="sec5_1_1_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-(6-methoxypyridin-2-yl)but-3-yn-2-ol (<b>53</b>)</h4><div class="NLM_p last"><b>S11</b> (55 mg, 0.16 mmol) was reacted with 2-(6-methoxypyridin-2-yl)but-3-yn-2-ol following the general procedure B to afford 2 mg (3%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (s, 1H), 8.49 (s, 1H), 8.05 (s, 1H), 7.94 (dt, <i>J</i> = 7.47, 1.77 Hz, 1H), 7.72 (dd, <i>J</i> = 8.25, 7.42 Hz, 1H), 7.43–7.34 (m, 3H), 6.73 (dd, <i>J</i> = 8.29, 0.75 Hz, 1H), 3.96 (s, 3H), 1.90 (s, 3H). HRMS (ESI) calculated for C<sub>22</sub>H<sub>20</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 386.1612, found 386.1617.</div></div><div id="sec5_1_1_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 3-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-1-(thiazol-2-yl)prop-2-yn-1-ol (<b>54</b>)</h4><div class="NLM_p last"><b>S11</b> (27 mg, 0.08 mmol) was reacted with 1-(thiazol-2-yl)prop-2-yn-1-ol following the general procedure D to afford 2.2 mg (6%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.66 (s, 1H), 8.58 (s, 1H), 8.42 (s, 1H), 8.15 (d, <i>J</i> = 3.06 Hz, 1H), 8.09 (dt, <i>J</i> = 8.02, 1.33 Hz, 1H), 8.06 (s, 2H), 8.04 (d, <i>J</i> = 3.06 Hz, 1H), 7.72 (dt, <i>J</i> = 7.89, 1.33 Hz, 1H), 7.54 (t, <i>J</i> = 7.76 Hz, 1H). HRMS (ESI) calculated for C<sub>18</sub>H<sub>14</sub>N<sub>5</sub>OS [M + H]<sup>+</sup> = 348.0914, found 348.0915.</div></div><div id="sec5_1_1_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-cyclohexylbut-3-yn-2-ol (<b>55</b>)</h4><div class="NLM_p last"><b>S11</b> (28 mg, 0.08 mmol) was reacted with 2-cyclohexylbut-3-yn-2-ol following the general procedure D to afford 3.3 mg (8%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.66 (s, 1H), 8.45 (s, 1H), 7.91–7.78 (m, 2H), 7.40 (t, <i>J</i> = 7.66 Hz, 1H), 7.18 (d, <i>J</i> = 7.64 Hz, 1H), 2.21–2.14 (m, 2H), 2.13–2.05 (m, 2H), 1.85 (s, 3H), 1.56–1.47 (m, 4H), 1.40–1.34 (m, 2H), 1.31–1.28 (m, 1H). HRMS (ESI) calculated for C<sub>22</sub>H<sub>25</sub>N<sub>4</sub>O [M + H]<sup>+</sup> = 361.2023, found 361.2024.</div></div><div id="sec5_1_1_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-methylbut-3-yn-2-ol (<b>56</b>)</h4><div class="NLM_p last"><b>S11</b> (60 mg, 0.18 mmol) was reacted with 2-methylbut-3-yn-2-ol following the general procedure B in toluene to afford 1.7 mg (2%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.66 (s, 1H), 8.49 (s, 1H), 8.04 (s, 1H), 7.92 (d, <i>J</i> = 7.84 Hz, 1H), 7.41 (t, <i>J</i> = 7.68 Hz, 1H), 7.34 (dt, <i>J</i> = 7.70, 1.43 Hz, 1H), 1.59 (s, 6H). HRMS (ESI) calculated for C<sub>17</sub>H<sub>17</sub>N<sub>4</sub>O [M + H]<sup>+</sup> = 293.1397, found 293.1401.</div></div><div id="sec5_1_1_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 3-((3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)ethynyl)-3-hydroxy-1-methylpyrrolidin-2-one (<b>57</b>)</h4><div class="NLM_p last"><b>S11</b> (29 mg, 0.08 mmol) was reacted with <b>S8</b> following the general procedure D to afford 3.7 mg (10%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (s, 1H), 8.51 (s, 1H), 8.12 (s, 1H), 7.95 (d, <i>J</i> = 7.26 Hz, 1H), 7.44–7.36 (m, 2H), 3.52–3.46 (m, 2H), 2.95 (s, 3H), 2.63–2.57 (m, 1H), 2.37–2.29 (m, 1H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 348.1455, found 348.1445.</div></div><div id="sec5_1_1_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 1-((3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)ethynyl)cyclopentan-1-ol (<b>58</b>)</h4><div class="NLM_p last"><b>S11</b> (40 mg, 0.12 mmol) was reacted with 3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one following the general procedure B to afford 4.8 mg (12%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (s, 1H), 8.49 (s, 1H), 8.04 (s, 1H), 7.91 (d, <i>J</i> = 7.92 Hz, 1H), 7.80–7.69 (m, 1H), 7.61–7.53 (m, 1H), 7.40 (dd, <i>J</i> = 8.67, 6.73 Hz, 1H), 7.33 (dt, <i>J</i> = 7.68, 1.45 Hz, 1H), 2.08–1.97 (m, 4H), 1.95–1.71 (m, 4H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>19</sub>N<sub>4</sub>O [M + H]<sup>+</sup> = 319.1553, found 319.1545.</div></div><div id="sec5_1_1_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-hydroxy-<i>N</i>,<i>N</i>,2-trimethylbut-3-ynamide (<b>59</b>)</h4><div class="NLM_p last"><b>41c</b> (52 mg, 0.18 mmol) was reacted with 2-hydroxy-<i>N</i>,<i>N</i>,2-trimethylbut-3-ynamide following the general procedure D to afford 3.2 mg (4%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.66 (s, 1H), 8.51 (s, 1H), 8.07 (s, 1H), 7.98 (d, <i>J</i> = 7.67 Hz, 1H), 7.43 (t, <i>J</i> = 7.70 Hz, 1H), 7.37 (d, <i>J</i> = 7.75 Hz, 1H), 3.45 (s, 3H), 3.02 (s, 3H), 1.77 (s, 3H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 350.1612, found 350.1610.</div></div><div id="sec5_1_1_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 4-(3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)phenyl)-2-hydroxy-2-methyl-1-(pyrrolidin-1-yl)but-3-yn-1-one (<b>60</b>)</h4><div class="NLM_p last"><b>S11</b> (40 mg, 0.12 mmol) was reacted with 2-hydroxy-2-methyl-1-(pyrrolidin-1-yl)but-3-yn-1-one following the general procedure B to afford 4.3 mg (7%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.65 (s, 1H), 8.52 (s, 1H), 8.08 (s, 1H), 7.97 (d, <i>J</i> = 7.44 Hz, 1H), 7.42 (t, <i>J</i> = 7.72 Hz, 1H), 7.36 (dt, <i>J</i> = 7.66, 1.43 Hz, 1H), 4.07–4.00 (m, 1H), 3.99–3.91 (m, 1H), 3.52 (t, <i>J</i> = 7.00 Hz, 2H), 2.01–1.94 (m, 2H), 1.93–1.86 (m, 2H), 1.76 (s, 3H). HRMS (ESI) calculated for C<sub>21</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 376.1768, found 376.1766.</div></div><div id="sec5_1_1_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 3-((3-(2-Amino-5<i>H</i>-pyrrolo[3,2-<i>d</i>]pyrimidin-7-yl)-4-fluorophenyl)ethynyl)-3-hydroxy-1-methylpyrrolidin-2-one (<b>61</b>)</h4><div class="NLM_p last"><b>44c</b> (30 mg, 0.08 mmol) was reacted with 3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one following the general procedure B to afford 4.8 mg (12%, solid) of the title compound upon reverse phase HPLC purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.69 (s, 1H), 8.50–8.26 (m, 2H), 7.52–7.29 (m, 2H), 7.21 (dd, <i>J</i> = 11.05, 8.48 Hz, 1H), 3.49 (t, <i>J</i> = 6.46 Hz, 2H), 2.95 (s, 3H), 2.65–2.54 (m, 1H), 2.38–2.28 (m, 1H). HRMS (ESI) calculated for C<sub>19</sub>H<sub>17</sub>FN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> = 366.1361, found 366.1362.</div></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113">3.  Molecular Modeling Methods</h3><div class="NLM_p last">The cocrystal structure of NIK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G3E">4G3E</a>) was obtained from RCSB Protein Data Bank. The water molecules were removed, while an NIK structure in the asymmetric unit was extracted and optimized using the Protein Preparation Wizard module in Schrödinger software. A grid box of 20 Å × 20 Å × 20 Å centered on the active site was generated as the docking area using the Receptor Grid Generation module. Subsequently, proper conformations of <b>7</b> and <b>41</b> were prepared in the Ligprep module, while the ionized states of <b>7</b> and <b>41</b> (pH = 7.4 ± 1.0) were generated using the Epik method. The aforementioned NIK structure and conformations of <b>7</b> and <b>41</b> were allowed to dock in the Glide module. Finally, the best binding modes were chosen according to the glide docking scores and visualized in Pymol.</div></div><div id="secsec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114">4.  NIK ATP Consumption Assay</h3><div class="NLM_p last">The recombinant human NIK protein (318–947aa) was purchased from BPS Bioscience. The NIK ATP consumption assay was performed with an ADP-Glo kinase assay kit (Promega) according to the manufacturer’s protocol. Briefly, the assay components including 2 μL of enzyme solution (30 nM NIK), 2 μL of substrate solution (5 μM ultrapure ATP), and 1 μL inhibitor solution were added to the individual well of a 384-well microplate, diluted in HEPES buffer (50 mM HEPES, 10 mM MgCl<sub>2</sub>, 0.01% Triton X-100, 2 mM DTT, pH 7.2), and incubated at room temperature for 1 h. Subsequently, 5 μL of ADP-Glo reagent was added to terminate the kinase reaction and deplete the remaining ATP in each well. Finally, the detecting reagent was added to convert ADP into ATP and the newly synthesized ATP was measured using a luciferase/luciferin reaction in Envision (PerkinElmer). Each compound was tested in triplicates, and the IC<sub>50</sub> values were calculated by fitting the data to a sigmoidal dose–response (variable slope) equation.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115">5.  Cell Culture and Adenoviral Infection</h3><div class="NLM_p last">Primary hepatocytes were isolated from C57BL/6 male mice (8 weeks old) by liver perfusion with type II collagenase (Worthington Biochem, Lakewood, NJ) as reported previously.<a onclick="showRef(event, 'ref19 ref38'); return false;" href="javascript:void(0);" class="ref ref19 ref38">(19,38)</a> Cells were cultured at 37 °C in 5% CO<sub>2</sub> in DMEM supplemented with 100 U/mL penicillin, 100 U/mL streptomycin, and 5% fetal bovine serum. The cells were then infected with βGal, NIK, or p100 adenoviruses at 5000 virus particle/cell as described previously<a onclick="showRef(event, 'ref19 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref19 ref39 ref40">(19,39,40)</a> in the presence or absence of the indicated NIK inhibitors for 16 h.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116">6.  Western-Blot Assay</h3><div class="NLM_p last">Primary hepatocytes were harvested in an L-RIPA lysis buffer [50 mM Tris (pH 7.5), 1% Nonidet P-40, 150 mM NaCl, 2 mM EGTA, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 100 mM NaF, 10 mM Na<sub>4</sub>P<sub>2</sub>O<sub>7</sub>, and 1 mM PMSF]. Proteins were separated by SDS–PAGE and immunoblotted with the indicated antibodies. The antibodies used were listed as follows: Flag (F1804, Sigma-Aldrich), NF-κB2 (4882, Cell Signaling Technology), tubulin (sc5286, Santa Cruz Biotechnology).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117">7.  Real-Time qPCR Assay</h3><div class="NLM_p last">The total RNAs were extracted from primary hepatocytes using TriPure isolation reagent kit (Roche Diagnostics, Mannheim, Germany). Subsequently, the cDNAs were synthesized with random primers and the M-MLV reverse transcriptase (Promega). The abundance of RNA was measured using the qPCR SYBR Mix and a Light Cycler 480 real-time PCR system. The relative expression levels of individual genes were normalized based on the expression of the control housekeeping gene, 36B4. Primers used for real-time qPCR were listed as follows: TNFα, forward, CATCTTCTCAAAATTCGAGTGACAA, reverse, TGGGAGTAGACAAGGTACAA-CCC; CCL2, forward, ACTGAAGCCAGCTCTCTCTTCCTC, reverse, TTCCTTC-TTGGGGTCAGCACAGAC; CCL5, forward, CCACTTCTTCTCTGGGTTGG, reverse, GTGCCCACGTCAAGGAGTAT, CXCL5, forward, TGCATTCCGCTTAG-CTTTCT, reverse, CAGAAGGAGGTCTGTCTGGA, NOS2, forward, CAGGGC-CACCTCTA CATTTG, reverse, TGCCCCATAGGAAAAGACTG.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118">8.  Pharmacokinetic Studies in Mice</h3><div class="NLM_p last">The pharmacokinetic experiments of <b>46</b> in ICR mice were evacuated by Shanghai Medicilon Inc. The tested compound was dissolved in the vehicle containing 5% DMSO/10% Cremophor/85% PBS. The dose for intravenous administration (iv) was 5 mg/kg (12 male mice), or the dose for oral administration (po) was 15 mg/kg (12 male mice). Upon administration of <b>46</b>, the blood samples were collected from mice at different time points (5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 8 h, and 24 h for iv; 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h, and 24 h for po) and centrifuged at 8000 rpm for 6 min, while the supernatant plasma was saved at −80 °C until analysis. Plasma concentrations of the tested compounds were analyzed by the LC–MS/MS method. The Phoenix WinNonlin 7.0 software has been used to calculate all pharmacokinetic parameters.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119">9.  Efficacy Studies in the CCl<sub>4</sub>-Induced Liver Injury Model in Mice</h3><div class="NLM_p last">Mice were housed on a 12 h light/12 h dark cycle with free access to water. All animal procedures described in this study were performed in adherence with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, Bethesda, MD, USA) and approved by the Institutional Animal Care & Use Committee of Harbin Institute of Technology for Prof. Zheng Chen. The approval number is IACUC-2018004. For efficacy studies in the CCl<sub>4</sub>-induced liver injury mouse model, wild-type (WT) C57BL/6 mice (<i>N</i> = 8–10 per group) were intravenously injected with <b>46</b> (40 mg/kg), B022 (25 mg/kg), or an equal volume of vehicle via the tail veins. Half an hour later, mice were intraperitoneally injected with CCl<sub>4</sub> (2.5 mL/kg body weight, 10% in olive oil) followed by <b>46</b> (40 mg/kg body weight), B022 (25 mg/kg body weight), or an equal volume of vehicle through the tail veins at 3, 6, and 9 h. The mice were euthanized at 12 h after the CCl<sub>4</sub> injection. The blood samples were collected from the retro-orbital sinus. The serum alanine aminotransferase (ALT) activity was measured with an ALT detecting kit (C009-2-1, Nanjing Jiancheng Bioengineering Institute). The liver tissues were harvested directly, and small pieces of liver samples were fixed in 4% PFA for H&E and F4/80 staining (30325T, Cell Signaling Technology). The rest of liver samples were immediately frozen in liquid nitrogen and then stored at −80 °C.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120">10.  Statistical Analysis</h3><div class="NLM_p last">Data were presented as mean values ± SE. Differences between groups were analyzed by Student’s <i>t</i> tests. <i>p</i> < 0.05 was considered statistically significant: *, <i>p</i> < 0.05; **, <i>p</i> < 0.01.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i121"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00396" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00396?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00396</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Spectral data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_002.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Spectra of <sup>1</sup>H and <sup>13</sup>C NMR, crystallography data of (<i>S</i>)-<b>S6</b>, a list of 98 kinases in a KINOMEscan assay (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_003.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_001.pdf">jm0c00396_si_001.pdf (7.84 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_002.xlsx">jm0c00396_si_002.xlsx (12.25 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_003.pdf">jm0c00396_si_003.pdf (6.49 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00396" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47177" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47177" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Chen</span> - <span class="hlFld-Affiliation affiliation">HIT
Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#54373c313a2e3c313a33143c3d207a3130217a373a"><span class="__cf_email__" data-cfemail="a5c6cdc0cbdfcdc0cbc2e5cdccd18bc0c1d08bc6cb">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span>; 
    <span class="hlFld-Affiliation affiliation">Nanjing
University of Chinese Medicine, Nanjing, Jiangsu 210023, China</span>; 
    <span class="hlFld-Affiliation affiliation">Open
Studio for Druggability Research of Marine Natural Products, Pilot National Laboratory for Marine Science and Technology
(Qingdao), 1 Wenhai Road,
Aoshanwei, Jimo, Qingdao 266237, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bad0d6d3fac9d3d7d794dbd994d9d4"><span class="__cf_email__" data-cfemail="b9d3d5d0f9cad0d4d497d8da97dad7">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yujun Zhao</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1035-2272" title="Orcid link">http://orcid.org/0000-0003-1035-2272</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#21584b5b49404e6152484c4c0f40420f424f"><span class="__cf_email__" data-cfemail="0a736070626b654a79636767246b69246964">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiqiang Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinzhi Li</span> - <span class="hlFld-Affiliation affiliation">HIT
Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Bo Su</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">Nanjing
University of Chinese Medicine, Nanjing, Jiangsu 210023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li-Xin Gao</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu-Bo Zhou</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bingchuan Yuan</span> - <span class="hlFld-Affiliation affiliation">HIT
Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150001, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xilin Lyu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ziqin Yan</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chujiao Hu</span> - <span class="hlFld-Affiliation affiliation">State Key
Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hao Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Luo</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3864-8382" title="Orcid link">http://orcid.org/0000-0003-3864-8382</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Z.L., X.L., and M.-B.S. have equal contributions.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i123">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge financial support from the National Natural Science Foundation of China (Grants 81872724 and 81673295 to Y.Z., Grants 31671225 and 31971083 to Z.C., and Grant 81125023 to J.L.), National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program”, China (Grant 2018ZX09711002-004-010 to Y.Z.), Natural Science Foundation of Heilongjiang Province (Grant YQ2019C011 to Z.C.), Science and Technology Commission of Shanghai Municipality (Grant 18431907100 to Y.Z.), and K. C. Wong Education Foundation (to J. L. and Y.Z). X.L. is supported by the Chinese Postoctoral Science Foundation (Grant AUGA4130900619)</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κB</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">NOS</td><td class="NLM_def"><p class="first last">nitric oxide synthase</p></td></tr><tr><td class="NLM_term">ALT</td><td class="NLM_def"><p class="first last">alanine aminotransferase</p></td></tr><tr><td class="NLM_term">MAP3K14</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase kinase 14</p></td></tr><tr><td class="NLM_term">BAFFR</td><td class="NLM_def"><p class="first last">B-cell activating factor receptor</p></td></tr><tr><td class="NLM_term">CD40</td><td class="NLM_def"><p class="first last">cluster of differentiation 40</p></td></tr><tr><td class="NLM_term">RANKL</td><td class="NLM_def"><p class="first last">receptor activator of nuclear factor κΒ ligand</p></td></tr><tr><td class="NLM_term">TWEAK</td><td class="NLM_def"><p class="first last">TNF-related weak inducer of apoptosis</p></td></tr><tr><td class="NLM_term">TRAF</td><td class="NLM_def"><p class="first last">TNF receptor-associated factor</p></td></tr><tr><td class="NLM_term">cIAP1/2</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis protein 1/2</p></td></tr><tr><td class="NLM_term">IKK</td><td class="NLM_def"><p class="first last">inhibitor of κB kinase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, R.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-kappaB signaling initiated by BAFF influences B cell biology at multiple junctures</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">509</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2013.00509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.3389%2Ffimmu.2013.00509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=24432023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A280%3ADC%252BC2cflsFChtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=509&author=S.+Gardamauthor=R.+Brink&title=Non-canonical+NF-kappaB+signaling+initiated+by+BAFF+influences+B+cell+biology+at+multiple+junctures&doi=10.3389%2Ffimmu.2013.00509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures</span></div><div class="casAuthors">Gardam Sandra; Brink Robert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">509</span>
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    </div><div class="casAbstract">It has been more than a decade since it was recognized that the nuclear factor of kappa light polypeptide gene enhancer in B cells (NF-κB) transcription factor family was activated by two distinct pathways: the canonical pathway involving NF-κB1 and the non-canonical pathway involving NF-κB2.  During this time a great deal of evidence has been amassed on the ligands and receptors that activate these pathways, the cytoplasmic adapter molecules involved in transducing the signals from receptors to nucleus, and the resulting physiological outcomes within body tissues.  In contrast to NF-κB1 signaling, which can be activated by a wide variety of receptors, the NF-κB2 pathway is typically only activated by a subset of receptor and ligand pairs belonging to the tumor necrosis factor (TNF) family.  Amongst these is B cell activating factor of the TNF family (BAFF) and its receptor BAFFR.  Whilst BAFF is produced by many cell types throughout the body, BAFFR expression appears to be restricted to the hematopoietic lineage and B cells in particular.  For this reason, the main physiological outcomes of BAFF mediated NF-κB2 activation are confined to B cells.  Indeed BAFF mediated NF-κB2 signaling contributes to peripheral B cell survival and maturation as well as playing a role in antibody responses and long term maintenance plasma cells.  Thus the importance BAFF and NF-κB2 permeates the entire B cell lifespan and impacts on this important component of the immune system in a variety of ways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRZYu_AE1Nlz0O18WR3iAofW6udTcc2ea2CCm67UxBg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflsFChtg%253D%253D&md5=8533ec7c1fc24e6f66b35d491a8c98b1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2013.00509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2013.00509%26sid%3Dliteratum%253Aachs%26aulast%3DGardam%26aufirst%3DS.%26aulast%3DBrink%26aufirst%3DR.%26atitle%3DNon-canonical%2520NF-kappaB%2520signaling%2520initiated%2520by%2520BAFF%2520influences%2520B%2520cell%2520biology%2520at%2520multiple%2520junctures%26jtitle%3DFront.%2520Immunol.%26date%3D2014%26volume%3D4%26spage%3D509%26doi%3D10.3389%2Ffimmu.2013.00509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Storz, P.</span></span> <span> </span><span class="NLM_article-title">Targeting the alternative NF-kappaB pathway in pancreatic cancer: a new direction for therapy?</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1586/era.13.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1586%2Fera.13.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=23617340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFWlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=501-504&author=P.+Storz&title=Targeting+the+alternative+NF-kappaB+pathway+in+pancreatic+cancer%3A+a+new+direction+for+therapy%3F&doi=10.1586%2Fera.13.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?</span></div><div class="casAuthors">Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-504</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer, due to its late diagnosis,is difficult to treat.  In addn., current therapy options are insufficient and new approaches for combination treatment are required.  Recent demonstration of the importance of constitutive signaling of NF-κB-inducing kinase (NIK,also named MAP3K14) in maintaining the high basal activity of the alternative NF-κB pathway in pancreatic cancer suggests novel possibilities for therapeutic intervention.  Strategies to target the alternative NF-κB pathway include not only the use of small mol. inhibitors for NIK and IκB kinase a (IKKa), but also broad spectrum approaches such as using proteasome inhibitors or combinatorial approaches targeting both alternative and canonical pathways.  These may also act synergistically with currently used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkO5O_6UCQkrVg90H21EOLACvtfcHk0lj4ZoJl-k1riQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFWlsL4%253D&md5=a4945c62cf71cb211141608f6790b853</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1586%2Fera.13.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.13.28%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520alternative%2520NF-kappaB%2520pathway%2520in%2520pancreatic%2520cancer%253A%2520a%2520new%2520direction%2520for%2520therapy%253F%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2013%26volume%3D13%26spage%3D501%26epage%3D504%26doi%3D10.1586%2Fera.13.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltimore, D.</span></span> <span> </span><span class="NLM_article-title">30 Years of NF-kappaB: A blossoming of relevance to human pathobiology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.cell.2016.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=28086098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=37-57&author=Q.+Zhangauthor=M.+J.+Lenardoauthor=D.+Baltimore&title=30+Years+of+NF-kappaB%3A+A+blossoming+of+relevance+to+human+pathobiology&doi=10.1016%2Fj.cell.2016.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology</span></div><div class="casAuthors">Zhang, Qian; Lenardo, Michael J.; Baltimore, David</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">37-57</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  NF-κB was discovered 30 years ago as a rapidly inducible transcription factor.  Since that time, it has been found to have a broad role in gene induction in diverse cellular responses, particularly throughout the immune system.  Here, we summarize elaborate regulatory pathways involving this transcription factor and use recent discoveries in human genetic diseases to place specific proteins within their relevant medical and biol. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4iAPEV1Opt7Vg90H21EOLACvtfcHk0lgS8XmWUq6H-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOjurw%253D&md5=5d2314414a07418d6d5bdcdda2ab03a7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26aulast%3DBaltimore%26aufirst%3DD.%26atitle%3D30%2520Years%2520of%2520NF-kappaB%253A%2520A%2520blossoming%2520of%2520relevance%2520to%2520human%2520pathobiology%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D37%26epage%3D57%26doi%3D10.1016%2Fj.cell.2016.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-κB signaling pathway</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fcr.2010.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=21173796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=71-85&author=S.-C.+Sun&title=Non-canonical+NF-%CE%BAB+signaling+pathway&doi=10.1038%2Fcr.2010.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical NF-κB signaling pathway</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The non-canonical NF-κB pathway is an important arm of NF-κB signaling that predominantly targets activation of the p52/RelB NF-κB complex.  This pathway depends on the inducible processing of p100, a mol. functioning as both the precursor of p52 and a RelB-specific inhibitor.  A central signaling component of the non-canonical pathway is NF-κB-inducing kinase (NIK), which integrates signals from a subset of TNF receptor family members and activates a downstream kinase, IκB kinase-α (IKKα), for triggering p100 phosphorylation and processing.  A unique mechanism of NIK regulation is through its fate control: the basal level of NIK is kept low by a TRAF-cIAP destruction complex and signal-induced non-canonical NF-κB signaling involves NIK stabilization.  Tight control of the fate of NIK is important, since deregulated NIK accumulation is assocd. with lymphoid malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiQeRjZvae3LVg90H21EOLACvtfcHk0lgS8XmWUq6H-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D&md5=20244440c91b4a4355f60e4ffd23119a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.177%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.-C.%26atitle%3DNon-canonical%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D71%26epage%3D85%26doi%3D10.1038%2Fcr.2010.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span> <span> </span><span class="NLM_article-title">The non-canonical NF-κB pathway in immunity and inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1038/nri.2017.52</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fnri.2017.52" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=28580957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1OgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=545-558&author=S.-C.+Sun&title=The+non-canonical+NF-%CE%BAB+pathway+in+immunity+and+inflammation&doi=10.1038%2Fnri.2017.52"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The non-canonical NF-κB pathway in immunity and inflammation</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">545-558</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The nuclear factor-κB (NF-κB) family of transcription factors is activated by canonical and non-canonical signalling pathways, which differ in both signalling components and biol. functions.  Recent studies have revealed important roles for the non-canonical NF-κB pathway in regulating different aspects of immune functions.  Defects in non-canonical NF-κB signalling are assocd. with severe immune deficiencies, whereas dysregulated activation of this pathway contributes to the pathogenesis of various autoimmune and inflammatory diseases.  Here we review the signalling mechanisms and the biol. function of the non-canonical NF-κB pathway.  We also discuss recent progress in elucidating the mol. mechanisms regulating non-canonical NF-κB pathway activation, which may provide new opportunities for therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz7QEbrIECD7Vg90H21EOLACvtfcHk0lgS8XmWUq6H-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1OgsLw%253D&md5=b28dd6a87e76f3b61b5e108a24cf62f9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnri.2017.52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri.2017.52%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.-C.%26atitle%3DThe%2520non-canonical%2520NF-%25CE%25BAB%2520pathway%2520in%2520immunity%2520and%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2017%26volume%3D17%26spage%3D545%26epage%3D558%26doi%3D10.1038%2Fnri.2017.52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cildir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tergaonkar, V.</span></span> <span> </span><span class="NLM_article-title">Noncanonical NF-kappaB signaling in health and disease</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.molmed.2016.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=27068135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC28Xksl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=414-429&author=G.+Cildirauthor=K.+C.+Lowauthor=V.+Tergaonkar&title=Noncanonical+NF-kappaB+signaling+in+health+and+disease&doi=10.1016%2Fj.molmed.2016.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Noncanonical NF-κB Signaling in Health and Disease</span></div><div class="casAuthors">Cildir, Gokhan; Low, Kee Chung; Tergaonkar, Vinay</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">414-429</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Noncanonical NF-κB signaling differs from canonical NF-κB signaling by being activated through different cell surface receptors, cytoplasmic adaptors, and NF-κB dimers.  Under normal physiol. conditions, this noncanonical pathway has been implicated in diverse biol. processes, including lymphoid organogenesis, B cell maturation, osteoclast differentiation, and various functions of other immune cells.  Recently, dysfunction of this pathway has also been causally assocd. with numerous immune-mediated pathologies and human malignancies.  Here, we summarize the core elements as well as the recently identified novel regulators of the noncanonical NF-κB signaling pathway.  The involvement of this pathway in different pathologies and the potential therapeutic options that are currently envisaged are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQEKnTsSKRcLVg90H21EOLACvtfcHk0lha7QQeT96oCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xksl2gs7g%253D&md5=dd1360156a7b67455d8c04cca385c310</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DCildir%26aufirst%3DG.%26aulast%3DLow%26aufirst%3DK.%2BC.%26aulast%3DTergaonkar%26aufirst%3DV.%26atitle%3DNoncanonical%2520NF-kappaB%2520signaling%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D414%26epage%3D429%26doi%3D10.1016%2Fj.molmed.2016.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baud, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Is NF-κB a good target for cancer therapy? Hopes and pitfalls</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1038/nrd2781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fnrd2781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=19116625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCku7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=33-40&author=V.+Baudauthor=M.+Karin&title=Is+NF-%CE%BAB+a+good+target+for+cancer+therapy%3F+Hopes+and+pitfalls&doi=10.1038%2Fnrd2781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Is NF-κB a good target for cancer therapy? Hopes and pitfalls</span></div><div class="casAuthors">Baud, Veronique; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear factor κB (NF-κB) transcription factors have a key role in many physiol. processes such as innate and adaptive immune responses, cell proliferation, cell death, and inflammation.  It has become clear that aberrant regulation of NF-κB and the signaling pathways that control its activity are involved in cancer development and progression, as well as in resistance to chemotherapy and radiotherapy.  This article discusses recent evidence from cancer genetics and cancer genome studies that support the involvement of NF-κB in human cancer, particularly in multiple myeloma.  The therapeutic potential and benefit of targeting NF-κB in cancer, and the possible complications and pitfalls of such an approach, are explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWTMItNVBQzrVg90H21EOLACvtfcHk0lhdv34LNZbf1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCku7%252FM&md5=dfc230dd77b8fd4989907eee889b8a2a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd2781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2781%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DV.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DIs%2520NF-%25CE%25BAB%2520a%2520good%2520target%2520for%2520cancer%2520therapy%253F%2520Hopes%2520and%2520pitfalls%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D33%26epage%3D40%26doi%3D10.1038%2Fnrd2781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhapurapu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignali, D. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1370</span>, <span class="refDoi"> DOI: 10.1038/ni.1678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fni.1678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=18997792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1364-1370&author=S.+Vallabhapurapuauthor=A.+Matsuzawaauthor=W.+Zhangauthor=P.-H.+Tsengauthor=J.+J.+Keatsauthor=H.+Wangauthor=D.+A.+A.+Vignaliauthor=P.+L.+Bergsagelauthor=M.+Karin&title=Nonredundant+and+complementary+functions+of+TRAF2+and+TRAF3+in+a+ubiquitination+cascade+that+activates+NIK-dependent+alternative+NF-%CE%BAB+signaling&doi=10.1038%2Fni.1678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling</span></div><div class="casAuthors">Vallabhapurapu, Sivakumar; Matsuzawa, Atsushi; Zhang, WeiZhou; Tseng, Ping-Hui; Keats, Jonathan J.; Wang, Haopeng; Vignali, Dario A. A.; Bergsagel, P. Leif; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1364-1370</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-κB (NF-κB) signaling in resting cells by targeting NF-κB-inducing kinase (NIK) for ubiquitin-dependent degrdn., thus preventing processing of the NF-κB2 precursor protein p100 to release p52.  However, the resp. functions of TRAF2 and TRAF3 in NIK degrdn. and activation of alternative NF-κB signaling have remained elusive.  We now show that CD40 or BAFF receptor activation result in TRAF3 degrdn. in a cIAP1-cIAP2- and TRAF2-dependent way owing to enhanced cIAP1, cIAP2 TRAF3-directed ubiquitin ligase activity.  Receptor-induced activation of cIAP1 and cIAP2 correlated with their K63-linked ubiquitination by TRAF2.  Degrdn. of TRAF3 prevented assocn. of NIK with the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, which resulted in NIK stabilization and NF-κB2-p100 processing.  Constitutive activation of this pathway causes perinatal lethality and lymphoid defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohqDvmlMG8NrVg90H21EOLACvtfcHk0liOVV0ZqymLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsb3K&md5=37793636ab6dd59cfc73a923b5f22702</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fni.1678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1678%26sid%3Dliteratum%253Aachs%26aulast%3DVallabhapurapu%26aufirst%3DS.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTseng%26aufirst%3DP.-H.%26aulast%3DKeats%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DVignali%26aufirst%3DD.%2BA.%2BA.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DNonredundant%2520and%2520complementary%2520functions%2520of%2520TRAF2%2520and%2520TRAF3%2520in%2520a%2520ubiquitination%2520cascade%2520that%2520activates%2520NIK-dependent%2520alternative%2520NF-%25CE%25BAB%2520signaling%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1364%26epage%3D1370%26doi%3D10.1038%2Fni.1678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goeddel, D. V.</span></span> <span> </span><span class="NLM_article-title">NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">3792</span>– <span class="NLM_lpage">3797</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.7.3792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1073%2Fpnas.95.7.3792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=9520446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADyaK1cXitlKjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3792-3797&author=L.+Lingauthor=Z.+Caoauthor=D.+V.+Goeddel&title=NF-%CE%BAB-inducing+kinase+activates+IKK-%CE%B1+by+phosphorylation+of+Ser-176&doi=10.1073%2Fpnas.95.7.3792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176</span></div><div class="casAuthors">Ling, Lei; Cao, Zhaodan; Goeddel, David V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3792-3797</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activation of the transcription factor NF-κB by inflammatory cytokines involves the successive action of NF-κB-inducing kinase (NIK) and two IκB kinases, IKK-α and IKK-β.  Here we show that NIK preferentially phosphorylates IKK-α over IKK-β, leading to the activation of IKK-α kinase activity.  This phosphorylation of IKK-α occurs specifically on Ser-176 in the activation loop between kinase subdomains VII and VIII.  A mutant form of IKK-α contg. alanine at residue 176 cannot be phosphorylated or activated by NIK and acts as a dominant neg. inhibitor of interleukin 1-and tumor necrosis factor-induced NF-κB activation.  Conversely, a mutant form of IKK-α contg. glutamic acid at residue 176 is constitutively active.  Thus, the phosphorylation of IKK-α on Ser-176 by NIK may be required for cytokine-mediated NF-κB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhsT-T6KrzObVg90H21EOLACvtfcHk0lgBUbKDfYWLew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitlKjtLo%253D&md5=3d5f01f4187051b2df02d6bc5327fb61</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.7.3792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.7.3792%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DGoeddel%26aufirst%3DD.%2BV.%26atitle%3DNF-%25CE%25BAB-inducing%2520kinase%2520activates%2520IKK-%25CE%25B1%2520by%2520phosphorylation%2520of%2520Ser-176%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D3792%26epage%3D3797%26doi%3D10.1073%2Fpnas.95.7.3792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harhaj, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span> <span> </span><span class="NLM_article-title">NF-κB-inducing kinase regulates the processing of NF-κB2 p100</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(01)00187-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2FS1097-2765%2801%2900187-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=11239468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1KitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=401-409&author=G.+Xiaoauthor=E.+W.+Harhajauthor=S.-C.+Sun&title=NF-%CE%BAB-inducing+kinase+regulates+the+processing+of+NF-%CE%BAB2+p100&doi=10.1016%2FS1097-2765%2801%2900187-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB-inducing kinase regulates the processing of NF-κB2 p100</span></div><div class="casAuthors">Xiao, Gutian; Harhaj, Edward W.; Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">401-409</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Processing of the nfκb2 gene product p100 to generate p52 is an important step in NF-κB regulation.  We show that this step is neg. regulated by a processing-inhibitory domain (PID) within p100 and pos. regulated by the NF-κB-inducing kinase (NIK).  While the PID suppresses the constitutive processing of p100, NIK induces p100 processing by stimulating site-specific phosphorylation and ubiquitination of this precursor protein.  Further, a natural mutation of the gene encoding NIK in alymphoplasia (aly) mice cripples the function of NIK in p100 processing, causing a severe defect in p52 prodn.  These data suggest that NIK is a specific kinase regulating p100 processing and explain why the aly and nfκb2 knockout mice exhibit similar immune deficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMGXPp8bnACLVg90H21EOLACvtfcHk0lgBUbKDfYWLew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1KitL8%253D&md5=e2e56951018f599fa9df60f3ca72b262</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2801%2900187-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252801%252900187-3%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DHarhaj%26aufirst%3DE.%2BW.%26aulast%3DSun%26aufirst%3DS.-C.%26atitle%3DNF-%25CE%25BAB-inducing%2520kinase%2520regulates%2520the%2520processing%2520of%2520NF-%25CE%25BAB2%2520p100%26jtitle%3DMol.%2520Cell%26date%3D2001%26volume%3D7%26spage%3D401%26epage%3D409%26doi%3D10.1016%2FS1097-2765%2801%2900187-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Senftleben, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krähn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonizzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">1495</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1126/science.1062677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1126%2Fscience.1062677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=11520989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVeqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=1495-1499&author=U.+Senftlebenauthor=Y.+Caoauthor=G.+Xiaoauthor=F.+R.+Gretenauthor=G.+Kr%C3%A4hnauthor=G.+Bonizziauthor=Y.+Chenauthor=Y.+Huauthor=A.+Fongauthor=S.-C.+Sunauthor=M.+Karin&title=Activation+by+IKK%CE%B1+of+a+second%2C+evolutionary+conserved%2C+NF-%CE%BAB+signaling+pathway&doi=10.1126%2Fscience.1062677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway</span></div><div class="casAuthors">Senftleben, Uwe; Cao, Yixue; Xiao, Gutian; Greten, Florian R.; Kraehn, Gertraud; Bonizzi, Giuseppina; Chen, Yi; Hu, Yinling; Fong, Abraham; Sun, Shao-Cong; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5534</span>),
    <span class="NLM_cas:pages">1495-1499</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In mammals, the canonical nuclear factor κB (NF-κB) signaling pathway activated in response to infections is based on degrdn. of IκB inhibitors.  This pathway depends on the IκB kinase (IKK), which contains two catalytic subunits, IKKα and IKKβ.  IKKβ is essential for inducible IκB phosphorylation and degrdn., whereas IKKα is not.  Here the authors show that IKKα is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-κB target genes, and processing of the NF-κB2 (p100) precursor.  IKKα preferentially phosphorylates NF-κB2, and this activity requires its phosphorylation by upstream kinases, one of which may be NF-κB-inducing kinase (NIK).  IKKα is therefore a pivotal component of a second NF-κB activation pathway based on regulated NF-κB2 processing rather than IκB degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL1TLJXkDAYrVg90H21EOLACvtfcHk0lj3MqfN-bpoKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVeqs7s%253D&md5=fbd1395649a813a75e82a154543a7396</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1062677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1062677%26sid%3Dliteratum%253Aachs%26aulast%3DSenftleben%26aufirst%3DU.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DKr%25C3%25A4hn%26aufirst%3DG.%26aulast%3DBonizzi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DActivation%2520by%2520IKK%25CE%25B1%2520of%2520a%2520second%252C%2520evolutionary%2520conserved%252C%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D1495%26epage%3D1499%26doi%3D10.1126%2Fscience.1062677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omary, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">Medullary thymic epithelial NF-kB-inducing kinase (NIK)/IKKalpha pathway shapes autoimmunity and liver and lung homeostasis in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">19090</span>– <span class="NLM_lpage">19097</span>, <span class="refDoi"> DOI: 10.1073/pnas.1901056116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1073%2Fpnas.1901056116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=31481626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSku7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=19090-19097&author=H.+Shenauthor=Y.+Jiauthor=Y.+Xiongauthor=H.+Kimauthor=X.+Zhongauthor=M.+G.+Jinauthor=Y.+M.+Shahauthor=M.+B.+Omaryauthor=Y.+Liuauthor=L.+Qiauthor=L.+Rui&title=Medullary+thymic+epithelial+NF-kB-inducing+kinase+%28NIK%29%2FIKKalpha+pathway+shapes+autoimmunity+and+liver+and+lung+homeostasis+in+mice&doi=10.1073%2Fpnas.1901056116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Medullary thymic epithelial NF-kB-inducing kinase (NIK)/IKKα pathway shapes autoimmunity and liver and lung homeostasis in mice</span></div><div class="casAuthors">Shen, Hong; Ji, Yewei; Xiong, Yi; Kim, Hana; Zhong, Xiao; Jin, Michelle G.; Shah, Yatrik M.; Omary, M. Bishr; Liu, Yong; Qi, Ling; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">19090-19097</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant T cell development is a pivotal risk factor for autoimmune disease; however, the underlying mol. mechanism of T cell overactivation is poorly understood.  Here, we identified NF-κB-inducing kinase (NIK) and IkB kinase Iα (IKKα) in thymic epithelial cells (TECs) as essential regulators of T cell development.  Mouse TEC-specific ablation of either NIK or IKKIα resulted in severe T cell-mediated inflammation, injury, and fibrosis in the liver and lung, leading to premature death within 18 d of age.  NIK or IKKIα deficiency abrogated medullary TEC development, and led to breakdown of central tolerance, prodn. of autoreactive T cells, and fatal autoimmune destruction in the liver and lung.  TEC-specific ablation of NIK or IKKIα also impaired thymic T cell development from the double-neg. through the double-pos. stages and inhibited peripheral B cell development.  These results unravel a hitherto unrecognized essential role of TEC-intrinsic NIK and IKKIα pathways in autoimmunity and T cell-instigated chronic liver and lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvkmvenoPPg7Vg90H21EOLACvtfcHk0lj3MqfN-bpoKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSku7vM&md5=f80e7ce836701b665a4f28d237dd2c23</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1901056116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1901056116%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DM.%2BG.%26aulast%3DShah%26aufirst%3DY.%2BM.%26aulast%3DOmary%26aufirst%3DM.%2BB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DMedullary%2520thymic%2520epithelial%2520NF-kB-inducing%2520kinase%2520%2528NIK%2529%252FIKKalpha%2520pathway%2520shapes%2520autoimmunity%2520and%2520liver%2520and%2520lung%2520homeostasis%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D19090%26epage%3D19097%26doi%3D10.1073%2Fpnas.1901056116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omary, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2076</span>, <span class="refDoi"> DOI: 10.1002/hep.27348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1002%2Fhep.27348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=25088600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCis73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=2065-2076&author=H.+Shenauthor=L.+Shengauthor=Z.+Chenauthor=L.+Jiangauthor=H.+Suauthor=L.+Yinauthor=M.+B.+Omaryauthor=L.+Rui&title=Mouse+hepatocyte+overexpression+of+NF-%CE%BAB-inducing+kinase+%28NIK%29+triggers+fatal+macrophage-dependent+liver+injury+and+fibrosis&doi=10.1002%2Fhep.27348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis</span></div><div class="casAuthors">Shen, Hong; Sheng, Liang; Chen, Zheng; Jiang, Lin; Su, Haoran; Yin, Lei; Omary, M. Bishr; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2065-2076</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Damaged, necrotic, or apoptotic hepatocytes release damage-assocd. mol. patterns that initiate sterile inflammation, and liver inflammation drives liver injury and fibrosis.  Here we identified hepatic nuclear factor kappa B (NF-κB)-inducing kinase (NIK), a Ser/Thr kinase, as a novel trigger of fatal liver inflammation.  NIK is activated by a broad spectrum of stimuli.  It was up-regulated in injured livers in both mice and humans.  In primary mouse hepatocytes, NIK overexpression stimulated, independently of cell injury and death, release of numerous chemokines and cytokines that activated bone marrow-derived macrophages (BMDMs).  BMDMs in turn secreted proapoptotic mols. that stimulated hepatocyte apoptosis.  Hepatocyte-specific expression of the NIK transgene triggered massive liver inflammation, oxidative stress, hepatocyte apoptosis, and liver fibrosis, leading to wt. loss, hypoglycemia, and death.  Depletion of Kupffer cells/macrophages reversed NIK-induced liver destruction and death.  Conclusion: the hepatocyte NIK-liver immune cell axis promotes liver inflammation, injury, and fibrosis, thus driving liver disease progression. (Hepatol. 2014;60:2064-2075).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgV39v_Rc3ObVg90H21EOLACvtfcHk0liuyq8yZsxwkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCis73L&md5=7aeccfee609708edca22548eab6eb6b0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fhep.27348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27348%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DOmary%26aufirst%3DM.%2BB.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DMouse%2520hepatocyte%2520overexpression%2520of%2520NF-%25CE%25BAB-inducing%2520kinase%2520%2528NIK%2529%2520triggers%2520fatal%2520macrophage-dependent%2520liver%2520injury%2520and%2520fibrosis%26jtitle%3DHepatology%26date%3D2014%26volume%3D60%26spage%3D2065%26epage%3D2076%26doi%3D10.1002%2Fhep.27348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">Liver NF-κB-inducing kinase promotes liver steatosis and glucose counterregulation in male mice with obesity</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">1207</span>– <span class="NLM_lpage">1216</span>, <span class="refDoi"> DOI: 10.1210/en.2016-1582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1210%2Fen.2016-1582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=28379340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVaqt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2017&pages=1207-1216&author=Y.+Liuauthor=L.+Shengauthor=Y.+Xiongauthor=H.+Shenauthor=Y.+Liuauthor=L.+Rui&title=Liver+NF-%CE%BAB-inducing+kinase+promotes+liver+steatosis+and+glucose+counterregulation+in+male+mice+with+obesity&doi=10.1210%2Fen.2016-1582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Liver NF-κB-inducing kinase promotes liver steatosis and glucose counterregulation in male mice with obesity</span></div><div class="casAuthors">Liu, Yan; Sheng, Liang; Xiong, Yi; Shen, Hong; Liu, Yong; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1207-1216</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Obesity is assocd. with chronic inflammation and liver steatoses.  Numerous proinflammatory cytokines have been reported to regulate liver glucose and lipid metab., thus contributing to the pathogenesis of liver steatosis and/or metabolic dysfunction.  Nuclear factor-κB-inducing kinase (NIK) is stimulated by many cytokines and mediates activation of the noncanonical nuclear factor-κB pathway.  We previously reported that liver NIK is aberrantly activated in obesity; inactivation of NIK by overexpressing dominant neg. NIK(KA) suppresses hepatic glucose prodn.  In the present study, we generated conditional NIK knockout mice using the Cre/loxp system.  Mice with hepatocyte-specific or hematopoietic lineage-specific deletion of NIK were normal with either normal chow diet or high-fat diet (HFD) conditions.  In contrast, deletion of NIK in the liver, including both hepatocytes and immune cells, protected against HFD-induced liver steatosis and attenuated hepatic glucose prodn.  Mechanistically, deletion of liver NIK suppressed liver inflammation and lipogenic programs, thus contributing to protection against liver steatosis.  Liver NIK also downregulated cyclic nucleotide phosphodiesterases, thereby augmenting the cyclic adenosine monophosphate/protein kinase A pathway and glucagon-stimulated hepatic glucose prodn.  Together, our data suggest that NIK pathways in both hepatocytes and immune cells act in concert to promote liver steatosis and glucose prodn. in the setting of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHIxFIYcaI3LVg90H21EOLACvtfcHk0liuyq8yZsxwkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVaqt7bJ&md5=b306428ae240819a48d9c456c69f6436</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1210%2Fen.2016-1582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2016-1582%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DLiver%2520NF-%25CE%25BAB-inducing%2520kinase%2520promotes%2520liver%2520steatosis%2520and%2520glucose%2520counterregulation%2520in%2520male%2520mice%2520with%2520obesity%26jtitle%3DEndocrinology%26date%3D2017%26volume%3D158%26spage%3D1207%26epage%3D1216%26doi%3D10.1210%2Fen.2016-1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valino-Rivas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaquero, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucunza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fresno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Nino, M. D.</span></span> <span> </span><span class="NLM_article-title">NIK as a druggable mediator of tissue injury</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2019.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.molmed.2019.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30926358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltVeru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=341-360&author=L.+Valino-Rivasauthor=J.+J.+Vaqueroauthor=D.+Sucunzaauthor=S.+Gutierrezauthor=A.+B.+Sanzauthor=M.+Fresnoauthor=A.+Ortizauthor=M.+D.+Sanchez-Nino&title=NIK+as+a+druggable+mediator+of+tissue+injury&doi=10.1016%2Fj.molmed.2019.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">NIK as a Druggable Mediator of Tissue Injury</span></div><div class="casAuthors">Valino-Rivas, Lara; Vaquero, Juan Jose; Sucunza, David; Gutierrez, Sara; Sanz, Ana B.; Fresno, Manuel; Ortiz, Alberto; Sanchez-Nino, Maria Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-360</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">NF-κB-inducing kinase (NIK, MAP3K14) is best known as the apical kinase that triggers non-canonical NF-κB activation and by its role in the immune system.  Recent data indicate a role for NIK expressed by non-lymphoid cells in cancer, kidney disease, liver injury, glucose homeostasis, osteosarcopenia, vascular calcification, hematopoiesis, and endothelial function.  The spectrum of NIK-assocd. disease now ranges from immunodeficiency (when NIK is defective) to autoimmunity, cancer, sterile inflammation, fibrosis, and metabolic disease when NIK is overactive.  The development of novel small-mol. NIK inhibitors has paved the way to test NIK targeting to treat disease in vivo, and may eventually lead to NIK targeting in the clinic.  In addn., NIK activators are being explored for specific conditions such as myeloid leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM16Ar9Bc8fbVg90H21EOLACvtfcHk0li5CFTIqmnLfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltVeru7o%253D&md5=e47fa848ac97b68c83c390aba8d99027</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2019.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2019.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DValino-Rivas%26aufirst%3DL.%26aulast%3DVaquero%26aufirst%3DJ.%2BJ.%26aulast%3DSucunza%26aufirst%3DD.%26aulast%3DGutierrez%26aufirst%3DS.%26aulast%3DSanz%26aufirst%3DA.%2BB.%26aulast%3DFresno%26aufirst%3DM.%26aulast%3DOrtiz%26aufirst%3DA.%26aulast%3DSanchez-Nino%26aufirst%3DM.%2BD.%26atitle%3DNIK%2520as%2520a%2520druggable%2520mediator%2520of%2520tissue%2520injury%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D341%26epage%3D360%26doi%3D10.1016%2Fj.molmed.2019.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annunziata, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demchenko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrea, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanamura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dave, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurt, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlogie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaughnessy, J. D.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuehl, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2007.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.ccr.2007.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=17692804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1art74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=115-130&author=C.+M.+Annunziataauthor=R.+E.+Davisauthor=Y.+Demchenkoauthor=W.+Bellamyauthor=A.+Gabreaauthor=F.+Zhanauthor=G.+Lenzauthor=I.+Hanamuraauthor=G.+Wrightauthor=W.+Xiaoauthor=S.+Daveauthor=E.+M.+Hurtauthor=B.+Tanauthor=H.+Zhaoauthor=O.+Stephensauthor=M.+Santraauthor=D.+R.+Williamsauthor=L.+Dangauthor=B.+Barlogieauthor=J.+D.+Shaughnessyauthor=W.+M.+Kuehlauthor=L.+M.+Staudt&title=Frequent+engagement+of+the+classical+and+alternative+NF-kappaB+pathways+by+diverse+genetic+abnormalities+in+multiple+myeloma&doi=10.1016%2Fj.ccr.2007.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma</span></div><div class="casAuthors">Annunziata, Christina M.; Davis, R. Eric; Demchenko, Yulia; Bellamy, William; Gabrea, Ana; Zhan, Fenghuang; Lenz, Georg; Hanamura, Ichiro; Wright, George; Xiao, Wenming; Dave, Sandeep; Hurt, Elaine M.; Tan, Bruce; Zhao, Hong; Stephens, Owen; Santra, Madhumita; Williams, David R.; Dang, Lenny; Barlogie, Bart; Shaughnessy, John D., Jr.; Kuehl, W. Michael; Staudt, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-130</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mechanisms of constitutive NF-κB signaling in multiple myeloma are unknown.  An inhibitor of IκB kinase β (IKKβ) targeting the classical NF-κB pathway was lethal to many myeloma cell lines.  Several cell lines had elevated expression of NIK due to genomic alterations or protein stabilization, while others had inactivating mutations of TRAF3; both kinds of abnormality triggered the classical and alternative NF-κB pathways.  A majority of primary myeloma patient samples and cell lines had elevated NF-κB target gene expression, often assocd. with genetic or epigenetic alteration of NIK, TRAF3, CYLD, BIRC2/BIRC3, CD40, NFKB1, or NFKB2.  These data demonstrate that addiction to the NF-κB pathway is frequent in myeloma and suggest that IKKβ inhibitors hold promise for the treatment of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobxLUR-8Aww7Vg90H21EOLACvtfcHk0li5CFTIqmnLfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1art74%253D&md5=fb1607976b9dc9188764ef4a88964e81</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DAnnunziata%26aufirst%3DC.%2BM.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DDemchenko%26aufirst%3DY.%26aulast%3DBellamy%26aufirst%3DW.%26aulast%3DGabrea%26aufirst%3DA.%26aulast%3DZhan%26aufirst%3DF.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DHanamura%26aufirst%3DI.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DDave%26aufirst%3DS.%26aulast%3DHurt%26aufirst%3DE.%2BM.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DStephens%26aufirst%3DO.%26aulast%3DSantra%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BR.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DShaughnessy%26aufirst%3DJ.%2BD.%26aulast%3DKuehl%26aufirst%3DW.%2BM.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DFrequent%2520engagement%2520of%2520the%2520classical%2520and%2520alternative%2520NF-kappaB%2520pathways%2520by%2520diverse%2520genetic%2520abnormalities%2520in%2520multiple%2520myeloma%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D115%26epage%3D130%26doi%3D10.1016%2Fj.ccr.2007.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keats, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schop, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chng, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiedemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price-Troska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brents, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greipp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dispenzieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruhn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, P. L.</span></span> <span> </span><span class="NLM_article-title">Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2007.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.ccr.2007.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=17692805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1art78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=131-144&author=J.+J.+Keatsauthor=R.+Fonsecaauthor=M.+Chesiauthor=R.+Schopauthor=A.+Bakerauthor=W.+J.+Chngauthor=S.+Van+Wierauthor=R.+Tiedemannauthor=C.+X.+Shiauthor=M.+Sebagauthor=E.+Braggioauthor=T.+Henryauthor=Y.+X.+Zhuauthor=H.+Fogleauthor=T.+Price-Troskaauthor=G.+Ahmannauthor=C.+Manciniauthor=L.+A.+Brentsauthor=S.+Kumarauthor=P.+Greippauthor=A.+Dispenzieriauthor=B.+Bryantauthor=G.+Mulliganauthor=L.+Bruhnauthor=M.+Barrettauthor=R.+Valdezauthor=J.+Trentauthor=A.+K.+Stewartauthor=J.+Carptenauthor=P.+L.+Bergsagel&title=Promiscuous+mutations+activate+the+noncanonical+NF-kappaB+pathway+in+multiple+myeloma&doi=10.1016%2Fj.ccr.2007.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma</span></div><div class="casAuthors">Keats, Jonathan J.; Fonseca, Rafael; Chesi, Marta; Schop, Roelandt; Baker, Angela; Chng, Wee-Joo; Van Wier, Scott; Tiedemann, Rodger; Shi, Chang-Xin; Sebag, Michael; Braggio, Esteban; Henry, Travis; Zhu, Yuan-Xiao; Fogle, Homer; Price-Troska, Tammy; Ahmann, Gregory; Mancini, Catherine; Brents, Leslie A.; Kumar, Shaji; Greipp, Philip; Dispenzieri, Angela; Bryant, Barb; Mulligan, George; Bruhn, Laurakay; Barrett, Michael; Valdez, Riccardo; Trent, Jeff; Stewart, A. Keith; Carpten, John; Bergsagel, P. Leif</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-144</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activation of NF-κB has been noted in many tumor types, however only rarely has this been linked to an underlying genetic mutation.  An integrated anal. of high-d. oligonucleotide array CGH and gene expression profiling data from 155 multiple myeloma samples identified a promiscuous array of abnormalities contributing to the dysregulation of NF-κB in approx. 20% of patients.  We report mutations in ten genes causing the inactivation of TRAF2, TRAF3, CYLD, cIAP1/cIAP2 and activation of NFKB1, NFKB2, CD40, LTBR, TACI, and NIK that result primarily in constitutive activation of the noncanonical NF-κB pathway, with the single most common abnormality being inactivation of TRAF3.  These results highlight the crit. importance of the NF-κB pathway in the pathogenesis of multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk19k4hmHAbrVg90H21EOLACvtfcHk0ljNdrAMhWU4cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1art78%253D&md5=9a3f06ac4cbe52b319f9073a03cb6ea0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DKeats%26aufirst%3DJ.%2BJ.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DSchop%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DA.%26aulast%3DChng%26aufirst%3DW.%2BJ.%26aulast%3DVan%2BWier%26aufirst%3DS.%26aulast%3DTiedemann%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DC.%2BX.%26aulast%3DSebag%26aufirst%3DM.%26aulast%3DBraggio%26aufirst%3DE.%26aulast%3DHenry%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DY.%2BX.%26aulast%3DFogle%26aufirst%3DH.%26aulast%3DPrice-Troska%26aufirst%3DT.%26aulast%3DAhmann%26aufirst%3DG.%26aulast%3DMancini%26aufirst%3DC.%26aulast%3DBrents%26aufirst%3DL.%2BA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DGreipp%26aufirst%3DP.%26aulast%3DDispenzieri%26aufirst%3DA.%26aulast%3DBryant%26aufirst%3DB.%26aulast%3DMulligan%26aufirst%3DG.%26aulast%3DBruhn%26aufirst%3DL.%26aulast%3DBarrett%26aufirst%3DM.%26aulast%3DValdez%26aufirst%3DR.%26aulast%3DTrent%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DCarpten%26aufirst%3DJ.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26atitle%3DPromiscuous%2520mutations%2520activate%2520the%2520noncanonical%2520NF-kappaB%2520pathway%2520in%2520multiple%2520myeloma%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D131%26epage%3D144%26doi%3D10.1016%2Fj.ccr.2007.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamoorthi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bents, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaochico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezhkovskiy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrusan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veliz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackney, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaoui Ismaili, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span> <span> </span><span class="NLM_article-title">NF-kappaB inducing kinase is a therapeutic target for systemic lupus erythematosus</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">179</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02672-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fs41467-017-02672-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=29330524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvgtlylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=179&author=H.+D.+Brightbillauthor=E.+Sutoauthor=N.+Blaquiereauthor=N.+Ramamoorthiauthor=S.+Sujatha-Bhaskarauthor=E.+B.+Gogolauthor=G.+M.+Castanedoauthor=B.+T.+Jacksonauthor=Y.+C.+Kwonauthor=S.+Hallerauthor=J.+Leschauthor=K.+Bentsauthor=C.+Everettauthor=P.+B.+Kohliauthor=S.+Lingeauthor=L.+Christianauthor=K.+Barrettauthor=A.+Jaochicoauthor=L.+M.+Berezhkovskiyauthor=P.+W.+Fanauthor=Z.+Modrusanauthor=K.+Velizauthor=M.+J.+Townsendauthor=J.+DeVossauthor=A.+R.+Johnsonauthor=R.+Godemannauthor=W.+P.+Leeauthor=C.+D.+Austinauthor=B.+S.+McKenzieauthor=J.+A.+Hackneyauthor=J.+J.+Crawfordauthor=S.+T.+Stabenauthor=M.+H.+Alaoui+Ismailiauthor=L.+C.+Wuauthor=N.+Ghilardi&title=NF-kappaB+inducing+kinase+is+a+therapeutic+target+for+systemic+lupus+erythematosus&doi=10.1038%2Fs41467-017-02672-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus</span></div><div class="casAuthors">Brightbill Hans D; Sujatha-Bhaskar Swathi; Gogol Emily B; Jackson Benjamin T; Christian Laura; Wu Lawren C; Ghilardi Nico; Suto Eric; Kwon Youngsu C; Lesch Justin; DeVoss Jason; Lee Wyne P; McKenzie Brent S; Blaquiere Nicole; Castanedo Georgette M; Crawford James J; Staben Steven T; Ramamoorthi Nandhini; Townsend Michael J; Haller Susan; Austin Cary D; Bents Karin; Linge Sandra; Godemann Robert; Everett Christine; Kohli Pawan Bir; Barrett Kathy; Johnson Adam R; Alaoui Ismaili Moulay H; Jaochico Allan; Berezhkovskiy Leonid M; Fan Peter W; Modrusan Zora; Veliz Kelli; Hackney Jason A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NF-κB-inducing kinase (NIK) mediates non-canonical NF-κB signaling downstream of multiple TNF family members, including BAFF, TWEAK, CD40, and OX40, which are implicated in the pathogenesis of systemic lupus erythematosus (SLE).  Here, we show that experimental lupus in NZB/W F1 mice can be treated with a highly selective and potent NIK small molecule inhibitor.  Both in vitro as well as in vivo, NIK inhibition recapitulates the pharmacological effects of BAFF blockade, which is clinically efficacious in SLE.  Furthermore, NIK inhibition also affects T cell parameters in the spleen and proinflammatory gene expression in the kidney, which may be attributable to inhibition of OX40 and TWEAK signaling, respectively.  As a consequence, NIK inhibition results in improved survival, reduced renal pathology, and lower proteinuria scores.  Collectively, our data suggest that NIK inhibition is a potential therapeutic approach for SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSowPmlnIWxaqcneEtCi92fW6udTcc2eZ458K7NbRsRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvgtlylug%253D%253D&md5=41a91514e1f4e8b2b44912ba6d6a4788</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02672-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02672-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrightbill%26aufirst%3DH.%2BD.%26aulast%3DSuto%26aufirst%3DE.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DRamamoorthi%26aufirst%3DN.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DGogol%26aufirst%3DE.%2BB.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DJackson%26aufirst%3DB.%2BT.%26aulast%3DKwon%26aufirst%3DY.%2BC.%26aulast%3DHaller%26aufirst%3DS.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DBents%26aufirst%3DK.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DLinge%26aufirst%3DS.%26aulast%3DChristian%26aufirst%3DL.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DJaochico%26aufirst%3DA.%26aulast%3DBerezhkovskiy%26aufirst%3DL.%2BM.%26aulast%3DFan%26aufirst%3DP.%2BW.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DVeliz%26aufirst%3DK.%26aulast%3DTownsend%26aufirst%3DM.%2BJ.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DAustin%26aufirst%3DC.%2BD.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DHackney%26aufirst%3DJ.%2BA.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DAlaoui%2BIsmaili%26aufirst%3DM.%2BH.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DGhilardi%26aufirst%3DN.%26atitle%3DNF-kappaB%2520inducing%2520kinase%2520is%2520a%2520therapeutic%2520target%2520for%2520systemic%2520lupus%2520erythematosus%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D179%26doi%3D10.1038%2Fs41467-017-02672-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">A small-molecule inhibitor of NF-kappaB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1096/fj.201600840R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1096%2Ffj.201600840R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=27871061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsleit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=711-718&author=X.+Renauthor=X.+Liauthor=L.+Jiaauthor=D.+Chenauthor=H.+Houauthor=L.+Ruiauthor=Y.+Zhaoauthor=Z.+Chen&title=A+small-molecule+inhibitor+of+NF-kappaB-inducing+kinase+%28NIK%29+protects+liver+from+toxin-induced+inflammation%2C+oxidative+stress%2C+and+injury&doi=10.1096%2Ffj.201600840R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule inhibitor of NF-κB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury</span></div><div class="casAuthors">Ren, Xiaomeng; Li, Xinzhi; Jia, Linna; Chen, Deheng; Hou, Hai; Rui, Liangyou; Zhao, Yujun; Chen, Zheng</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">711-718</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Potent and selective chem. probes are valuable tools for discovery of novel treatments for human diseases.  NF-κB-inducing kinase (NIK) is a key trigger in the development of liver injury and fibrosis.  Whether inhibition of NIK activity by chem. probes ameliorates liver inflammation and injury is largely unknown.  In this study, a small-mol. inhibitor of NIK, B022, was found to be a potent and selective chem. probe for liver inflammation and injury.  B022 inhibited the NIK signaling pathway, including NIK-induced p100-to-p52 processing and inflammatory gene expression, both in vitro and in vivo.  Furthermore, in vivo administration of B022 protected against not only NIK but also CCl4-induced liver inflammation and injury.  Our data suggest that inhibition of NIK is a novel strategy for treatment of liver inflammation, oxidative stress, and injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAtVxDU8yQibVg90H21EOLACvtfcHk0li1O-1bkY9TAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsleit78%253D&md5=84f05fa8fdf2fcfe79d167827ceea738</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1096%2Ffj.201600840R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201600840R%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DHou%26aufirst%3DH.%26aulast%3DRui%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520NF-kappaB-inducing%2520kinase%2520%2528NIK%2529%2520protects%2520liver%2520from%2520toxin-induced%2520inflammation%252C%2520oxidative%2520stress%252C%2520and%2520injury%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26spage%3D711%26epage%3D718%26doi%3D10.1096%2Ffj.201600840R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torsoni, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canet, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omary, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e34152</span> <span class="refDoi"> DOI: 10.7554/eLife.34152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.7554%2FeLife.34152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30070632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSisrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&author=Y.+Xiongauthor=A.+S.+Torsoniauthor=F.+Wuauthor=H.+Shenauthor=Y.+Liuauthor=X.+Zhongauthor=M.+J.+Canetauthor=Y.+M.+Shahauthor=M.+B.+Omaryauthor=Y.+Liuauthor=L.+Rui&title=Hepatic+NF-kB-inducing+kinase+%28NIK%29+suppresses+mouse+liver+regeneration+in+acute+and+chronic+liver+diseases&doi=10.7554%2FeLife.34152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases</span></div><div class="casAuthors">Xiong, Yi; Torsoni, Adriana Souza; Wu, Feihua; Shen, Hong; Liu, Yan; Zhong, Xiao; Canet, Mark J.; Shah, Yatrik M.; Omary, M. Bishr; Liu, Yong; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e34152/1-e34152/18</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Reparative hepatocyte replication is impaired in chronic liver disease, contributing to disease progression; however, the underlying mechanism remains elusive.  Here, we identify Map3k14 (also known as NIK) and its substrate Chuk (also called IKKα) as unrecognized suppressors of hepatocyte replication.  Chronic liver disease is assocd. with aberrant activation of hepatic NIK pathways.  We found that hepatocyte-specific deletion of Map3k14 or Chuk substantially accelerated mouse hepatocyte proliferation and liver regeneration following partial-hepatectomy.  Hepatotoxin treatment or high fat diet feeding inhibited the ability of partial-hepatectomy to stimulate hepatocyte replication; remarkably, inactivation of hepatic NIK markedly increased reparative hepatocyte proliferation under these liver disease conditions.  Mechanistically, NIK and IKKα suppressed the mitogenic JAK2/STAT3 pathway, thereby inhibiting cell cycle progression.  Our data suggest that hepatic NIK and IKKα act as rheostats for liver regeneration by restraining overgrowth.  Pathol. activation of hepatic NIK or IKKα likely blocks hepatocyte replication, contributing to liver disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog4CiRtIPKBbVg90H21EOLACvtfcHk0li1O-1bkY9TAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSisrrN&md5=470ee505640909822cd4e660e57ff9d7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.7554%2FeLife.34152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.34152%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DTorsoni%26aufirst%3DA.%2BS.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DX.%26aulast%3DCanet%26aufirst%3DM.%2BJ.%26aulast%3DShah%26aufirst%3DY.%2BM.%26aulast%3DOmary%26aufirst%3DM.%2BB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DHepatic%2520NF-kB-inducing%2520kinase%2520%2528NIK%2529%2520suppresses%2520mouse%2520liver%2520regeneration%2520in%2520acute%2520and%2520chronic%2520liver%2520diseases%26jtitle%3DeLife%26date%3D2018%26volume%3D7%26doi%3D10.7554%2FeLife.34152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parobchak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gololobova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, T.</span></span> <span> </span><span class="NLM_article-title">Screening a small molecule library to identify inhibitors of NF-κB inducing kinase and pro-labor genes in human placenta</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1657</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-20147-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fs41598-018-20147-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=29374256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A280%3ADC%252BC1MvkslemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1657&author=B.+Wangauthor=N.+Parobchakauthor=A.+Martinauthor=M.+Rosenauthor=L.+J.+Yuauthor=M.+Nguyenauthor=K.+Gololobovaauthor=T.+Rosen&title=Screening+a+small+molecule+library+to+identify+inhibitors+of+NF-%CE%BAB+inducing+kinase+and+pro-labor+genes+in+human+placenta&doi=10.1038%2Fs41598-018-20147-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Screening a small molecule library to identify inhibitors of NF-κB inducing kinase and pro-labor genes in human placenta</span></div><div class="casAuthors">Wang Bingbing; Parobchak Nataliya; Martin Adriana; Rosen Max; Yu Lumeng Jenny; Nguyen Mary; Gololobova Kseniya; Rosen Todd; Nguyen Mary</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1657</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The non-canonical NF-κB signaling (RelB/p52) pathway drives pro-labor genes in the human placenta, including corticotropin-releasing hormone (CRH) and cyclooxygenase-2 (COX-2), making this a potential therapeutic target to delay onset of labor.  Here we sought to identify small molecule compounds from a pre-existing chemical library of orally active drugs that can inhibit this NF-κB signaling, and in turn, human placental CRH and COX-2 production.  We used a cell-based assay coupled with a dual-luciferase reporter system to perform an in vitro screening of a small molecule library of 1,120 compounds for inhibition of the non-canonical NF-κB pathway.  Cell toxicity studies and drug efflux transport MRP1 assays were used to further characterize the lead compounds.  We have found that 14 drugs have selective inhibitory activity against lymphotoxin beta complex-induced activation of RelB/p52 in HEK293T cells, several of which also inhibited expression of CRH and COX-2 in human term trophoblast.  We identified sulfapyridine and propranolol with activity against CRH and COX-2 that deserve further study.  These drugs could serve as the basis for development of orally active drugs to affect length of gestation, first in an animal model, and then in clinical trials to prevent preterm birth during human pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbr8gYxuA1hkHdcurJClFcfW6udTcc2ebMnfme10wjILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvkslemsA%253D%253D&md5=1406dc5e121e84889d7b005fdfc2a7d9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-20147-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-20147-0%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DParobchak%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DRosen%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DL.%2BJ.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DGololobova%26aufirst%3DK.%26aulast%3DRosen%26aufirst%3DT.%26atitle%3DScreening%2520a%2520small%2520molecule%2520library%2520to%2520identify%2520inhibitors%2520of%2520NF-%25CE%25BAB%2520inducing%2520kinase%2520and%2520pro-labor%2520genes%2520in%2520human%2520placenta%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D1657%26doi%3D10.1038%2Fs41598-018-20147-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demchenko, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brents, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuehl, M. W.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">4554</span>– <span class="NLM_lpage">4566</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.18632%2Foncotarget.2128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=24980832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A280%3ADC%252BC2cfotVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4554-4566&author=Y.+N.+Demchenkoauthor=L.+A.+Brentsauthor=Z.+Liauthor=L.+P.+Bergsagelauthor=L.+R.+McGeeauthor=M.+W.+Kuehl&title=Novel+inhibitors+are+cytotoxic+for+myeloma+cells+with+NFkB+inducing+kinase-dependent+activation+of+NFkB&doi=10.18632%2Foncotarget.2128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB</span></div><div class="casAuthors">Demchenko Yulia N; Brents Leslie A; Kuehl Michael W; Li Zhihong; McGee Lawrence R; Bergsagel Leif P</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4554-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NFkB activity is critical for survival and proliferation of normal lymphoid cells and many kinds of B-cell tumors, including multiple myeloma (MM).  NFkB activating mutations, which are apparent progression events, enable MM tumors to become less dependent on bone marrow signals that activate NFkB.  Mutations that activate NFkB-inducing kinase (NIK) protein are the most prevalent among the many kinds of NFkB mutations in MM tumors.  NIK is the main activating kinase of the alternative NFkB pathway, although over-expression of NIK also can activate the classical pathway.  Two NIK inhibitors and an isomeric control were tested with human myeloma cell lines.  These specific NIK inhibitors are selectively cytotoxic for cells with NIK-dependent activation of NFkB.  Combination therapy targeting NIK and IKKbeta (as a main kinase of the classical NFkB pathway) represents a promising treatment strategy in MM.  NIK inhibitors can also be useful tool for assessing the role of NIK and alternative NFkB pathway in different cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdMjvs4g8EiVf1XRtfYM0dfW6udTcc2ebMnfme10wjILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfotVKjsQ%253D%253D&md5=ff9cd27be0fffdda47951e780f5996c1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2128%26sid%3Dliteratum%253Aachs%26aulast%3DDemchenko%26aufirst%3DY.%2BN.%26aulast%3DBrents%26aufirst%3DL.%2BA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBergsagel%26aufirst%3DL.%2BP.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DKuehl%26aufirst%3DM.%2BW.%26atitle%3DNovel%2520inhibitors%2520are%2520cytotoxic%2520for%2520myeloma%2520cells%2520with%2520NFkB%2520inducing%2520kinase-dependent%2520activation%2520of%2520NFkB%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D4554%26epage%3D4566%26doi%3D10.18632%2Foncotarget.2128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doppler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storz, P.</span></span> <span> </span><span class="NLM_article-title">Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e53676</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0053676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1371%2Fjournal.pone.0053676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=23301098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=H.+Dopplerauthor=G.+Y.+Liouauthor=P.+Storz&title=Downregulation+of+TRAF2+mediates+NIK-induced+pancreatic+cancer+cell+proliferation+and+tumorigenicity&doi=10.1371%2Fjournal.pone.0053676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity</span></div><div class="casAuthors">Doppler, Heike; Liou, Geou-Yarh; Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e53676</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Increased levels of NF-κB are hallmarks of pancreatic ductal adenocarcinoma (PDAC) and both classical and alternative NF-κB activation pathways have been implicated.  Methodol./Principal Findings: Here we show that activation of the alternative pathway is a source for the high basal NFκB activity in PDAC cell lines.  Increased activity of the p52/RelB NF-κB complex is mediated through stabilization and activation of NF-κB-inducing kinase (NIK).  We identify proteasomal downregulation of TNF receptor-assocd. factor 2 (TRAF2) as a mechanism by which levels of active NIK are increased in PDAC cell lines.  Such upregulation of NIK expression and activity levels relays to increased proliferation and anchorage-independent growth, but not migration or survival of PDAC cells.  Conclusions/Significance: Rapid growth is one characteristic of pancreatic cancer.  Our data indicates that the TRAF2/NIK/NF-κB2 pathway regulates PDAC cell tumorigenicity and could be a valuable target for therapy of this cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnrJZVjqbQzbVg90H21EOLACvtfcHk0lilo3N3iDLl9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFKhug%253D%253D&md5=e03970c3c2c199c764e479c528245692</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0053676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0053676%26sid%3Dliteratum%253Aachs%26aulast%3DDoppler%26aufirst%3DH.%26aulast%3DLiou%26aufirst%3DG.%2BY.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DDownregulation%2520of%2520TRAF2%2520mediates%2520NIK-induced%2520pancreatic%2520cancer%2520cell%2520proliferation%2520and%2520tumorigenicity%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0053676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Leon-Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of the catalytic domain of the NF-kappaB inducing kinase reveals a narrow but flexible active site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1704</span>– <span class="NLM_lpage">1714</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.str.2012.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=22921830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Glu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1704-1714&author=G.+de%0ALeon-Boenigauthor=K.+K.+Bowmanauthor=J.+A.+Fengauthor=T.+Crawfordauthor=C.+Everettauthor=Y.+Frankeauthor=A.+Ohauthor=M.+Stanleyauthor=S.+T.+Stabenauthor=M.+A.+Starovasnikauthor=H.+J.+Wallweberauthor=J.+Wuauthor=L.+C.+Wuauthor=A.+R.+Johnsonauthor=S.+G.+Hymowitz&title=The+crystal+structure+of+the+catalytic+domain+of+the+NF-kappaB+inducing+kinase+reveals+a+narrow+but+flexible+active+site&doi=10.1016%2Fj.str.2012.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site</span></div><div class="casAuthors">de Leon-Boenig, Gladys; Bowman, Krista K.; Feng, Jianwen A.; Crawford, Terry; Everett, Christine; Franke, Yvonne; Oh, Angela; Stanley, Mark; Staben, Steven T.; Starovasnik, Melissa A.; Wallweber, Heidi J. A.; Wu, Jiansheng; Wu, Lawren C.; Johnson, Adam R.; Hymowitz, Sarah G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1704-1714</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The NF-κB inducing kinase (NIP) regulates the non-canonical NF-κB pathway downstream of important clin. targets including BAFF, RANKL, and LTβ.  Despite numerous genetic studies assocg. dysregulation of this pathway with autoimmune diseases and hematol. cancers, detailed mol. characterization of this central signaling node has been lacking.  We undertook a systematic cloning and expression effort to generate sol., well-behaved proteins encompassing the kinase domains of human and murine NIK.  Structures of the apo NIK kinase domain from both species reveal an active-like conformation in the absence of phosphorylation.  ATP consumption and peptide phosphorylation assays confirm that phosphorylation of NIK does not increase enzymic activity.  Structures of murine NIK bound to inhibitors possessing two different chemotypes reveal conformational flexibility in the gatekeeper residue controlling access to a hydrophobic pocket.  Finally, a single amino acid difference affects the ability of some inhibitors to bind murine and human NIK with the same affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkN2Wi64mVzLVg90H21EOLACvtfcHk0lilo3N3iDLl9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Glu73P&md5=3f7d5bbd95066eb9d660ba810aba6e54</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.07.013%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLeon-Boenig%26aufirst%3DG.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DFeng%26aufirst%3DJ.%2BA.%26aulast%3DCrawford%26aufirst%3DT.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DM.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26atitle%3DThe%2520crystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520NF-kappaB%2520inducing%2520kinase%2520reveals%2520a%2520narrow%2520but%2520flexible%2520active%2520site%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D1704%26epage%3D1714%26doi%3D10.1016%2Fj.str.2012.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of tricyclic NF-kappaB inducing kinase (NIK) inhibitors that have high selectivity over phosphoinositide-3-kinase (PI3K)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01363</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCgs7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=627-640&author=G.+M.+Castanedoauthor=N.+Blaquiereauthor=M.+Beresiniauthor=B.+Bravoauthor=H.+Brightbillauthor=J.+Chenauthor=H.+F.+Cuiauthor=C.+Eigenbrotauthor=C.+Everettauthor=J.+Fengauthor=R.+Godemannauthor=E.+Gogolauthor=S.+Hymowitzauthor=A.+Johnsonauthor=N.+Kayagakiauthor=P.+B.+Kohliauthor=K.+Knuppelauthor=J.+Kraemerauthor=S.+Krugerauthor=P.+Lokeauthor=P.+McEwanauthor=C.+Montalbettiauthor=D.+A.+Robertsauthor=M.+Smithauthor=S.+Steinbacherauthor=S.+Sujatha-Bhaskarauthor=R.+Takahashiauthor=X.+Wangauthor=L.+C.+Wuauthor=Y.+Zhangauthor=S.+T.+Staben&title=Structure-based+design+of+tricyclic+NF-kappaB+inducing+kinase+%28NIK%29+inhibitors+that+have+high+selectivity+over+phosphoinositide-3-kinase+%28PI3K%29&doi=10.1021%2Facs.jmedchem.6b01363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)</span></div><div class="casAuthors">Castanedo, Georgette M.; Blaquiere, Nicole; Beresini, Maureen; Bravo, Brandon; Brightbill, Hans; Chen, Jacob; Cui, Hai-Feng; Eigenbrot, Charles; Everett, Christine; Feng, Jianwen; Godemann, Robert; Gogol, Emily; Hymowitz, Sarah; Johnson, Adam; Kayagaki, Nobuhiko; Kohli, Pawan Bir; Knuppel, Kathleen; Kraemer, Joachim; Kruger, Susan; Loke, Pui; McEwan, Paul; Montalbetti, Christian; Roberts, David A.; Smith, Myron; Steinbacher, Stefan; Sujatha-Bhaskar, Swathi; Takahashi, Ryan; Wang, Xiaolu; Wu, Lawren C.; Zhang, Yamin; Staben, Steven T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">627-640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a structure-guided optimization of a novel series of NF-κB inducing kinase (NIK) inhibitors.  Starting from a modestly potent, low mol. wt. lead, activity was improved by designing a type I1/2 binding mode that accessed a back pocket past the methionine-471 gatekeeper.  Divergent binding modes in NIK and PI3K were used to dampen PI3K-inhibition while maintaining NIK inhibition within these series.  Potent compds. were discovered that selectively inhibit the nuclear translocation of NF-kB2 (p52/REL-B) but not canonical NF-kB1 (REL-A/p50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrws-sPXJiSfLVg90H21EOLACvtfcHk0lixqQmyNxxPmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCgs7bK&md5=316b70f51a5b800ba810082d0b3862da</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01363%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DB.%26aulast%3DBrightbill%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DH.%2BF.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DGogol%26aufirst%3DE.%26aulast%3DHymowitz%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKnuppel%26aufirst%3DK.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DKruger%26aufirst%3DS.%26aulast%3DLoke%26aufirst%3DP.%26aulast%3DMcEwan%26aufirst%3DP.%26aulast%3DMontalbetti%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DStructure-based%2520design%2520of%2520tricyclic%2520NF-kappaB%2520inducing%2520kinase%2520%2528NIK%2529%2520inhibitors%2520that%2520have%2520high%2520selectivity%2520over%2520phosphoinositide-3-kinase%2520%2528PI3K%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D627%26epage%3D640%26doi%3D10.1021%2Facs.jmedchem.6b01363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezhkovskiy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabbe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaoui
Ismaili, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestre, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Scaffold-hopping approach to discover potent, selective, and efficacious inhibitors of NF-kappaB inducing kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6801</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00678</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00678" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6801-6813&author=N.+Blaquiereauthor=G.+M.+Castanedoauthor=J.+D.+Burchauthor=L.+M.+Berezhkovskiyauthor=H.+Brightbillauthor=S.+Brownauthor=C.+Chanauthor=P.+C.+Chiangauthor=J.+J.+Crawfordauthor=T.+Dongauthor=P.+Fanauthor=J.+Fengauthor=N.+Ghilardiauthor=R.+Godemannauthor=E.+Gogolauthor=A.+Grabbeauthor=A.+J.+Holeauthor=B.+Huauthor=S.+G.+Hymowitzauthor=M.+H.+Alaoui%0AIsmailiauthor=H.+Leauthor=P.+Leeauthor=W.+Leeauthor=X.+Linauthor=N.+Liuauthor=P.+A.+McEwanauthor=B.+McKenzieauthor=H.+L.+Silvestreauthor=E.+Sutoauthor=S.+Sujatha-Bhaskarauthor=G.+Wuauthor=L.+C.+Wuauthor=Y.+Zhangauthor=Z.+Zhongauthor=S.+T.+Staben&title=Scaffold-hopping+approach+to+discover+potent%2C+selective%2C+and+efficacious+inhibitors+of+NF-kappaB+inducing+kinase&doi=10.1021%2Facs.jmedchem.8b00678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase</span></div><div class="casAuthors">Blaquiere, Nicole; Castanedo, Georgette M.; Burch, Jason D.; Berezhkovskiy, Leonid M.; Brightbill, Hans; Brown, Suzanne; Chan, Connie; Chiang, Po-Chang; Crawford, James J.; Dong, Teresa; Fan, Peter; Feng, Jianwen; Ghilardi, Nico; Godemann, Robert; Gogol, Emily; Grabbe, Alice; Hole, Alison J.; Hu, Baihua; Hymowitz, Sarah G.; Alaoui Ismaili, Moulay Hicham; Le, Hoa; Lee, Patrick; Lee, Wyne; Lin, Xingyu; Liu, Ning; McEwan, Paul A.; McKenzie, Brent; Silvestre, Hernani L.; Suto, Eric; Sujatha-Bhaskar, Swathi; Wu, Guosheng; Wu, Lawren C.; Zhang, Yamin; Zhong, Zoe; Staben, Steven T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6801-6813</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been assocd. with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metab.  We report herein the discovery of lead chem. series of NIK inhibitors that were identified through a scaffold-hopping strategy using structure-based design.  Electronic and steric properties of lead compds. were modified to address glutathione conjugation and amide hydrolysis.  These highly potent compds. exhibited selective inhibition of LTβR-dependent p52 translocation and transcription of NF-κB2 related genes.  Compd. 4f is shown to have a favorable pharmacokinetic profile across species and to inhibit BAFF-induced B cell survival in vitro and reduce splenic marginal zone B cells in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FXb6VJDRqbVg90H21EOLACvtfcHk0lixqQmyNxxPmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73P&md5=5ff01b23d827b3d96078a17fff885aea</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00678%26sid%3Dliteratum%253Aachs%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DBurch%26aufirst%3DJ.%2BD.%26aulast%3DBerezhkovskiy%26aufirst%3DL.%2BM.%26aulast%3DBrightbill%26aufirst%3DH.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DChiang%26aufirst%3DP.%2BC.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DDong%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DP.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DGogol%26aufirst%3DE.%26aulast%3DGrabbe%26aufirst%3DA.%26aulast%3DHole%26aufirst%3DA.%2BJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DAlaoui%2BIsmaili%26aufirst%3DM.%2BH.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DMcEwan%26aufirst%3DP.%2BA.%26aulast%3DMcKenzie%26aufirst%3DB.%26aulast%3DSilvestre%26aufirst%3DH.%2BL.%26aulast%3DSuto%26aufirst%3DE.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DScaffold-hopping%2520approach%2520to%2520discover%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitors%2520of%2520NF-kappaB%2520inducing%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6801%26epage%3D6813%26doi%3D10.1021%2Facs.jmedchem.8b00678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pippione, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sainas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccinini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubbutat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morice, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducime, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boschi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Karadaghi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, M. L.</span></span> <span> </span><span class="NLM_article-title">N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1039/C8MD00068A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1039%2FC8MD00068A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30108985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=963-968&author=A.+C.+Pippioneauthor=S.+Sainasauthor=A.+Federicoauthor=E.+Lupinoauthor=M.+Piccininiauthor=M.+Kubbutatauthor=J.+M.+Contrerasauthor=C.+Moriceauthor=A.+Bargeauthor=A.+Ducimeauthor=D.+Boschiauthor=S.+Al-Karadaghiauthor=M.+L.+Lolli&title=N-Acetyl-3-aminopyrazoles+block+the+non-canonical+NF-kB+cascade+by+selectively+inhibiting+NIK&doi=10.1039%2FC8MD00068A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK</span></div><div class="casAuthors">Pippione, Agnese C.; Sainas, Stefano; Federico, Antonella; Lupino, Elisa; Piccinini, Marco; Kubbutat, Michael; Contreras, Jean-Marie; Morice, Christophe; Barge, Alessandro; Ducime, Alex; Boschi, Donatella; Al-Karadaghi, Salam; Lolli, Marco L.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">963-968</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">NF-κB-inducing kinase (NIK), an oncogenic drug target that is assocd. with various cancers, is a central signalling component of the non-canonical pathway.  A blind screening process, which established that amino pyrazole related scaffolds have an effect on IKKbeta, led to a hit-to-lead optimization process that identified the aminopyrazole 3a as a low μM selective NIK inhibitor.  Compd. 3a effectively inhibited the NIK-dependent activation of the NF-κB pathway in tumor cells, confirming its selective inhibitory profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8sxhc9e4QtLVg90H21EOLACvtfcHk0lixHl3zrYyp_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVKktL4%253D&md5=b3a8d7028a3365d230745b5497bf7464</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC8MD00068A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MD00068A%26sid%3Dliteratum%253Aachs%26aulast%3DPippione%26aufirst%3DA.%2BC.%26aulast%3DSainas%26aufirst%3DS.%26aulast%3DFederico%26aufirst%3DA.%26aulast%3DLupino%26aufirst%3DE.%26aulast%3DPiccinini%26aufirst%3DM.%26aulast%3DKubbutat%26aufirst%3DM.%26aulast%3DContreras%26aufirst%3DJ.%2BM.%26aulast%3DMorice%26aufirst%3DC.%26aulast%3DBarge%26aufirst%3DA.%26aulast%3DDucime%26aufirst%3DA.%26aulast%3DBoschi%26aufirst%3DD.%26aulast%3DAl-Karadaghi%26aufirst%3DS.%26aulast%3DLolli%26aufirst%3DM.%2BL.%26atitle%3DN-Acetyl-3-aminopyrazoles%2520block%2520the%2520non-canonical%2520NF-kB%2520cascade%2520by%2520selectively%2520inhibiting%2520NIK%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26spage%3D963%26epage%3D968%26doi%3D10.1039%2FC8MD00068A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubenstein, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eksterowicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Inhibiting NF-kappaB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1244</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.bmcl.2013.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=23374866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1238-1244&author=K.+Liauthor=L.+R.+McGeeauthor=B.+Fisherauthor=A.+Sudomauthor=J.+Liuauthor=S.+M.+Rubensteinauthor=M.+K.+Anwerauthor=T.+D.+Cushingauthor=Y.+Shinauthor=M.+Ayresauthor=F.+Leeauthor=J.+Eksterowiczauthor=P.+Faulderauthor=B.+Waszkowyczauthor=O.+Plotnikovaauthor=E.+Farrellyauthor=S.+H.+Xiaoauthor=G.+Chenauthor=Z.+Wang&title=Inhibiting+NF-kappaB-inducing+kinase+%28NIK%29%3A+discovery%2C+structure-based+design%2C+synthesis%2C+structure-activity+relationship%2C+and+co-crystal+structures&doi=10.1016%2Fj.bmcl.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures</span></div><div class="casAuthors">Li, Kexue; McGee, Lawrence R.; Fisher, Ben; Sudom, Athena; Liu, Jinsong; Rubenstein, Steven M.; Anwer, Mohmed K.; Cushing, Timothy D.; Shin, Youngsook; Ayres, Merrill; Lee, Fei; Eksterowicz, John; Faulder, Paul; Waszkowycz, Bohdan; Plotnikova, Olga; Farrelly, Ellyn; Xiao, Shou-Hua; Chen, Guoqing; Wang, Zhulun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1238-1244</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery, structure-based design, synthesis, and optimization of NIK inhibitors are described.  Our work began with an HTS hit, imidazopyridinyl pyrimidinamine I.  We utilized homol. modeling and conformational anal. to optimize the indole scaffold leading to the discovery of novel and potent conformationally constrained inhibitors such as compds. II [R1 = Br, C≡CCMe2OH].  Compds. II [R1 = Br] and III were co-crystd. with NIK kinase domain to provide structural insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5WqvTIrBqrVg90H21EOLACvtfcHk0lixHl3zrYyp_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGmt7s%253D&md5=a382078cf3bf84a41749783be33a5988</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DK.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DSudom%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRubenstein%26aufirst%3DS.%2BM.%26aulast%3DAnwer%26aufirst%3DM.%2BK.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DAyres%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DF.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DFarrelly%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DInhibiting%2520NF-kappaB-inducing%2520kinase%2520%2528NIK%2529%253A%2520discovery%252C%2520structure-based%2520design%252C%2520synthesis%252C%2520structure-activity%2520relationship%252C%2520and%2520co-crystal%2520structures%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1238%26epage%3D1244%26doi%3D10.1016%2Fj.bmcl.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calado, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derudder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajewsky, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt-Supprian, M.</span></span> <span> </span><span class="NLM_article-title">NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">10883</span>– <span class="NLM_lpage">10888</span>, <span class="refDoi"> DOI: 10.1073/pnas.0805186105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1073%2Fpnas.0805186105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=18663224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFOisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=10883-10888&author=Y.+Sasakiauthor=D.+P.+Caladoauthor=E.+Derudderauthor=B.+Zhangauthor=Y.+Shimizuauthor=F.+Mackayauthor=S.+Nishikawaauthor=K.+Rajewskyauthor=M.+Schmidt-Supprian&title=NIK+overexpression+amplifies%2C+whereas+ablation+of+its+TRAF3-binding+domain+replaces+BAFF%3ABAFF-R-mediated+survival+signals+in+B+cells&doi=10.1073%2Fpnas.0805186105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells</span></div><div class="casAuthors">Sasaki, Yoshiteru; Calado, Dinis P.; Derudder, Emmanuel; Zhang, Baochun; Shimizu, Yuri; Mackay, Fabienne; Nishikawa, Shin-ichi; Rajewsky, Klaus; Schmidt-Supprian, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">10883-10888</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">BAFF-R-dependent activation of the alternative NF-κB pathway plays an essential role in mature B cell survival.  Mutations leading to overexpression of NIK and deletion of the TRAF3 gene are implicated in human multiple myeloma.  We show that overexpression of NIK in mouse B lymphocytes amplifies alternative NF-κB activation and peripheral B cell nos. in a BAFF-R-dependent manner, whereas uncoupling NIK from TRAF3-mediated control causes maximal p100 processing and dramatic hyperplasia of BAFF-R-independent B cells.  NIK controls alternative NF-κB signaling by increasing the protein levels of its neg. regulator TRAF3 in a dose-dependent fashion.  This mechanism keeps NIK protein levels below detection even when they cause B cell hyperplasia, so that contributions of NIK to B cell pathologies can easily be overlooked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC4s0KtZsXFLVg90H21EOLACvtfcHk0lgnglR_KIWlsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFOisro%253D&md5=a94d9b5c5c7ac50169da8cea2f144209</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0805186105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0805186105%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DCalado%26aufirst%3DD.%2BP.%26aulast%3DDerudder%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DMackay%26aufirst%3DF.%26aulast%3DNishikawa%26aufirst%3DS.%26aulast%3DRajewsky%26aufirst%3DK.%26aulast%3DSchmidt-Supprian%26aufirst%3DM.%26atitle%3DNIK%2520overexpression%2520amplifies%252C%2520whereas%2520ablation%2520of%2520its%2520TRAF3-binding%2520domain%2520replaces%2520BAFF%253ABAFF-R-mediated%2520survival%2520signals%2520in%2520B%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D10883%26epage%3D10888%26doi%3D10.1073%2Fpnas.0805186105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polesso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span> <span> </span><span class="NLM_article-title">NIK overexpression intrinsically inhibits regulatory T cell function</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>186</i></span> (<span class="NLM_issue">Suppl.</span>),  <span class="NLM_fpage">168.9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=168.9&issue=Suppl.&author=F.+Polessoauthor=S.+Murrayauthor=A.+Roweauthor=D.+Parker&title=NIK+overexpression+intrinsically+inhibits+regulatory+T+cell+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolesso%26aufirst%3DF.%26aulast%3DMurray%26aufirst%3DS.%26aulast%3DRowe%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DD.%26atitle%3DNIK%2520overexpression%2520intrinsically%2520inhibits%2520regulatory%2520T%2520cell%2520function%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26issue%3DSuppl%26spage%3D168.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devenport, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortensen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascalho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wobus, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colacino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span> <span> </span><span class="NLM_article-title">Intestinal non-canonical NF kappa B signaling shapes the local and systemic immune response</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">660</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-08581-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fs41467-019-08581-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30737385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXns1Cqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=660&author=S.+K.+Ramakrishnanauthor=H.+B.+Zhangauthor=X.+Y.+Maauthor=I.+Jungauthor=A.+J.+Schwartzauthor=D.+Trinerauthor=S.+N.+Devenportauthor=N.+K.+Dasauthor=X.+Xueauthor=M.+Y.+Zengauthor=Y.+L.+Huauthor=R.+M.+Mortensenauthor=J.+K.+Greensonauthor=M.+Cascalhoauthor=C.+E.+Wobusauthor=J.+A.+Colacinoauthor=G.+Nunezauthor=L.+Y.+Ruiauthor=Y.+M.+Shah&title=Intestinal+non-canonical+NF+kappa+B+signaling+shapes+the+local+and+systemic+immune+response&doi=10.1038%2Fs41467-019-08581-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal non-canonical NFκB signaling shapes the local and systemic immune response</span></div><div class="casAuthors">Ramakrishnan, Sadeesh K.; Zhang, Huabing; Ma, Xiaoya; Jung, Inkyung; Schwartz, Andrew J.; Triner, Daniel; Devenport, Samantha N.; Das, Nupur K.; Xue, Xiang; Zeng, Melody Y.; Hu, Yinling; Mortensen, Richard M.; Greenson, Joel K.; Cascalho, Marilia; Wobus, Christiane E.; Colacino, Justin A.; Nunez, Gabriel; Rui, Liangyou; Shah, Yatrik M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">660</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Microfold cells (M-cells) are specialized cells of the intestine that sample luminal microbiota and dietary antigens to educate the immune cells of the intestinal lymphoid follicles.  The function of M-cells in systemic inflammatory responses are still unclear.  Here we show that epithelial non-canonical NFkB signaling mediated by NFkB-inducing kinase (NIK) is highly active in intestinal lymphoid follicles, and is required for M-cell maintenance.  Intestinal NIK signaling modulates M-cell differentiation and elicits both local and systemic IL-17A and IgA prodn.  Importantly, intestinal NIK signaling is active in mouse models of colitis and patients with inflammatory bowel diseases; meanwhile, constitutive NIK signaling increases the susceptibility to inflammatory injury by inducing ectopic M-cell differentiation and a chronic increase of IL-17A.  Our work thus defines an important function of non-canonical NFkB and M-cells in immune homeostasis, inflammation and polymicrobial sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOaVPXm0eE27Vg90H21EOLACvtfcHk0lh0SRLohV8bEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXns1Cqs7o%253D&md5=11b48d240c220c2243040acc457d224d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-08581-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-08581-8%26sid%3Dliteratum%253Aachs%26aulast%3DRamakrishnan%26aufirst%3DS.%2BK.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DMa%26aufirst%3DX.%2BY.%26aulast%3DJung%26aufirst%3DI.%26aulast%3DSchwartz%26aufirst%3DA.%2BJ.%26aulast%3DTriner%26aufirst%3DD.%26aulast%3DDevenport%26aufirst%3DS.%2BN.%26aulast%3DDas%26aufirst%3DN.%2BK.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DM.%2BY.%26aulast%3DHu%26aufirst%3DY.%2BL.%26aulast%3DMortensen%26aufirst%3DR.%2BM.%26aulast%3DGreenson%26aufirst%3DJ.%2BK.%26aulast%3DCascalho%26aufirst%3DM.%26aulast%3DWobus%26aufirst%3DC.%2BE.%26aulast%3DColacino%26aufirst%3DJ.%2BA.%26aulast%3DNunez%26aufirst%3DG.%26aulast%3DRui%26aufirst%3DL.%2BY.%26aulast%3DShah%26aufirst%3DY.%2BM.%26atitle%3DIntestinal%2520non-canonical%2520NF%2520kappa%2520B%2520signaling%2520shapes%2520the%2520local%2520and%2520systemic%2520immune%2520response%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D660%26doi%3D10.1038%2Fs41467-019-08581-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, S.</span></span> <span> </span><span class="NLM_article-title">Inhibitory-kappa B kinase (IKK) alpha and nuclear factor-kappa B (NF kappa B)-inducing kinase (NIK) as anti-cancer drug targets</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">176</span>, <span class="refDoi"> DOI: 10.3390/cells7100176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.3390%2Fcells7100176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVagurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=176&author=A.+Paulauthor=J.+Edwardsauthor=C.+Pepperauthor=S.+Mackay&title=Inhibitory-kappa+B+kinase+%28IKK%29+alpha+and+nuclear+factor-kappa+B+%28NF+kappa+B%29-inducing+kinase+%28NIK%29+as+anti-cancer+drug+targets&doi=10.3390%2Fcells7100176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory-κB kinase (IKK) and nuclear factor-κB (NFκB)-inducing kinase (NIK) as anti-cancer drug targets</span></div><div class="casAuthors">Paul, Andrew; Edwards, Joanne; Pepper, Christopher; Mackay, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">176</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The cellular kinases inhibitory-κB kinase (IKK) and Nuclear Factor-κB (NF-κB)-inducing kinase (NIK) are well recognized as key central regulators and drivers of the non-canonical NF-κB cascade and as such dictate the initiation and development of defined transcriptional responses assocd. with the liberation of p52-RelB and p52-p52 NF-κB dimer complexes.  While these kinases and downstream NF-κB complexes transduce pro-inflammatory and growth stimulating signals that contribute to major cellular processes, they also play a key role in the pathogenesis of a no. of inflammatory-based conditions and diverse cancer types, which for the latter may be a result of background mutational status.  IKKα and NIK, therefore, represent attractive targets for pharmacol. intervention.  Here, specifically in the cancer setting, we reflect on the potential pathophysiol. role(s) of each of these kinases, their assocd. downstream signalling outcomes and the stimulatory and mutational mechanisms leading to their increased activation.  We also consider the downstream coordination of transcriptional events and phenotypic outcomes illustrative of key cancer 'Hallmarks' that are now increasingly perceived to be due to the coordinated recruitment of both NF-κB-dependent as well as NF-κB-independent signalling.  Furthermore, as these kinases regulate the transition from hormone-dependent to hormone-independent growth in defined tumor subsets, potential tumor reactivation and major cytokine and chemokine species that may have significant bearing upon tumor-stromal communication and tumor microenvironment it reiterates their potential to be drug targets.  Therefore, with the emergence of small mol. kinase inhibitors targeting each of these kinases, we consider medicinal chem. efforts to date and those evolving that may contribute to the development of viable pharmacol. intervention strategies to target a variety of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTdGyUaXyjN7Vg90H21EOLACvtfcHk0lh0SRLohV8bEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVagurnP&md5=b001524ba18de5d0b396c78e4a697977</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3390%2Fcells7100176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells7100176%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DA.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DPepper%26aufirst%3DC.%26aulast%3DMackay%26aufirst%3DS.%26atitle%3DInhibitory-kappa%2520B%2520kinase%2520%2528IKK%2529%2520alpha%2520and%2520nuclear%2520factor-kappa%2520B%2520%2528NF%2520kappa%2520B%2529-inducing%2520kinase%2520%2528NIK%2529%2520as%2520anti-cancer%2520drug%2520targets%26jtitle%3DCells%26date%3D2018%26volume%3D7%26spage%3D176%26doi%3D10.3390%2Fcells7100176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laskowski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swindells, M. B.</span></span> <span> </span><span class="NLM_article-title">LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2778</span>– <span class="NLM_lpage">2786</span>, <span class="refDoi"> DOI: 10.1021/ci200227u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200227u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2778-2786&author=R.+A.+Laskowskiauthor=M.+B.+Swindells&title=LigPlot%2B%3A+multiple+ligand-protein+interaction+diagrams+for+drug+discovery&doi=10.1021%2Fci200227u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery</span></div><div class="casAuthors">Laskowski, Roman A.; Swindells, Mark B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2778-2786</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe a graphical system for automatically generating multiple 2D diagrams of ligand-protein interactions from 3D coordinates.  The diagrams portray the hydrogen-bond interaction patterns and hydrophobic contacts between the ligand(s) and the main-chain or side-chain elements of the protein.  The system is able to plot, in the same orientation, related sets of ligand-protein interactions.  This facilitates popular research tasks, such as analyzing a series of small mols. binding to the same protein target, a single ligand binding to homologous proteins, or the completely general case where both protein and ligand change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYuWvYH7Nel7Vg90H21EOLACvtfcHk0lh0SRLohV8bEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP&md5=576e59ad4f0c4304d01c6c80301ecf39</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fci200227u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200227u%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DSwindells%26aufirst%3DM.%2BB.%26atitle%3DLigPlot%252B%253A%2520multiple%2520ligand-protein%2520interaction%2520diagrams%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2778%26epage%3D2786%26doi%3D10.1021%2Fci200227u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrante, A. W.</span></span> <span> </span><span class="NLM_article-title">Obesity is associated with macrophage accumulation in adipose tissue</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1796</span>– <span class="NLM_lpage">1808</span>, <span class="refDoi"> DOI: 10.1172/JCI200319246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1172%2FJCI200319246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=14679176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSmtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=1796-1808&author=S.+P.+Weisbergauthor=D.+McCannauthor=M.+Desaiauthor=M.+Rosenbaumauthor=R.+L.+Leibelauthor=A.+W.+Ferrante&title=Obesity+is+associated+with+macrophage+accumulation+in+adipose+tissue&doi=10.1172%2FJCI200319246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Obesity is associated with macrophage accumulation in adipose tissue</span></div><div class="casAuthors">Weisberg, Stuart P.; McCann, Daniel; Desai, Manisha; Rosenbaum, Michael; Leibel, Rudolph L.; Ferrante, Anthony W., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1796-1808</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Obesity alters adipose tissue metabolic and endocrine function and leads to an increased release of fatty acids, hormones, and proinflammatory mols. that contribute to obesity assocd. complications.  To further characterize the changes that occur in adipose tissue with increasing adiposity, we profiled transcript expression in perigonadal adipose tissue from groups of mice in which adiposity varied due to sex, diet, and the obesity-related mutations agouti (Ay) and obese (Lepob).  We found that the expression of 1,304 transcripts correlated significantly with body mass.  Of the 100 most significantly correlated genes, 30% encoded proteins that are characteristic of macrophages and are pos. correlated with body mass.  Immunohistochem. anal. of perigonadal, perirenal, mesenteric, and s.c. adipose tissue revealed that the percentage of cells expressing the macrophage marker F4/80 (F4/80+) was significantly and pos. correlated with both adipocyte size and body mass.  Similar relationships were found in human s.c. adipose tissue stained for the macrophage antigen CD68.  Bone marrow transplant studies and quantitation of macrophage no. in adipose tissue from macrophage-deficient (Csf1op/op)mice suggest that these F4/80+ cells are CSF-1 dependent, bone marrow-derived adipose tissue macrophages.  Expression anal. of macrophage and nonmacrophage cell populations isolated from adipose tissue demonstrates that adipose tissue macrophages are responsible for almost all adipose tissue TNF-α expression and significant amts. of iNOS and IL-6 expression.  Adipose tissue macrophage nos. increase in obesity and participate in inflammatory pathways that are activated in adipose tissues of obese individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmO9SQ6PLDDbVg90H21EOLACvtfcHk0lhHiaOIO1mK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSmtLvO&md5=5737fc015b73f7fc180664b93c63dc48</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1172%2FJCI200319246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200319246%26sid%3Dliteratum%253Aachs%26aulast%3DWeisberg%26aufirst%3DS.%2BP.%26aulast%3DMcCann%26aufirst%3DD.%26aulast%3DDesai%26aufirst%3DM.%26aulast%3DRosenbaum%26aufirst%3DM.%26aulast%3DLeibel%26aufirst%3DR.%2BL.%26aulast%3DFerrante%26aufirst%3DA.%2BW.%26atitle%3DObesity%2520is%2520associated%2520with%2520macrophage%2520accumulation%2520in%2520adipose%2520tissue%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26spage%3D1796%26epage%3D1808%26doi%3D10.1172%2FJCI200319246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardet, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span> <span> </span><span class="NLM_article-title">Design and evaluation of a potential mutagen for Hepatitis C virus</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5261</span>– <span class="NLM_lpage">5264</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.bmcl.2007.03.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=17689246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1elsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5261-5264&author=Y.+H.+Kohauthor=J.+H.+Shimauthor=J.+L.+Girardetauthor=Z.+Hong&title=Design+and+evaluation+of+a+potential+mutagen+for+Hepatitis+C+virus&doi=10.1016%2Fj.bmcl.2007.03.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design and evaluation of a potential mutagen for Hepatitis C virus</span></div><div class="casAuthors">Koh, Yung-Hyo; Shim, Jae Hoon; Girardet, Jean-Luc; Hong, Zhi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5261-5264</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pyrrolopyrimidine nucleoside 1 was designed and synthesized as a potential mutagen for HCV.  An in vitro HCV NS5B enzymic assay indicated that pyrrolopyrimidine triphosphate acts as a CTP analog rather than a UTP analog.  The SATE-prodrug of pyrrolopyrimidine monophosphate showed a weak inhibitory activity in an HCV replicon system (EC50 = 60 μM) and did not exhibit cytotoxicity (CC50 > 100 μM).  Investigation of phosphorylation events using nucleoside kinases and LC-MS anal. revealed that the second phosphorylation step, from monophosphate ester to diphosphate ester, is unfavorable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUfn3C36AUELVg90H21EOLACvtfcHk0lhHiaOIO1mK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1elsrw%253D&md5=bc362262ac39a823c93cddbff57b2d19</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.091%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DY.%2BH.%26aulast%3DShim%26aufirst%3DJ.%2BH.%26aulast%3DGirardet%26aufirst%3DJ.%2BL.%26aulast%3DHong%26aufirst%3DZ.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520a%2520potential%2520mutagen%2520for%2520Hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5261%26epage%3D5264%26doi%3D10.1016%2Fj.bmcl.2007.03.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Mild Method for Ullmann Coupling Reaction of Amines and Aryl Halides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2453</span>– <span class="NLM_lpage">2455</span>, <span class="refDoi"> DOI: 10.1021/ol0346584</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0346584" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVGmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=2453-2455&author=D.+Maauthor=Q.+Caiauthor=H.+Zhang&title=Mild+Method+for+Ullmann+Coupling+Reaction+of+Amines+and+Aryl+Halides&doi=10.1021%2Fol0346584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mild Method for Ullmann Coupling Reaction of Amines and Aryl Halides</span></div><div class="casAuthors">Ma, Dawei; Cai, Qian; Zhang, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2453-2455</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Copper(I)-catalyzed Ullmann-type arom. amination of aryl iodides and aryl bromides in DMSO at 40-90° gave the corresponding N-aryl or N,N-diaryl amines in good to excellent yields by using either N-methylglycine or L-proline as a ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX5ndEYPU6SLVg90H21EOLACvtfcHk0lh5op-hnlOWJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVGmsL0%253D&md5=bc5b519b822d571da47dc09725177447</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fol0346584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0346584%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DMild%2520Method%2520for%2520Ullmann%2520Coupling%2520Reaction%2520of%2520Amines%2520and%2520Aryl%2520Halides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D2453%26epage%3D2455%26doi%3D10.1021%2Fol0346584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beveridge, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstenberger, B. S.</span></span> <span> </span><span class="NLM_article-title">A direct copper-catalyzed route to pyrrolo-fused heterocycles from boronic acids</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.11.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.tetlet.2011.11.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OlsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=564-569&author=R.+E.+Beveridgeauthor=B.+S.+Gerstenberger&title=A+direct+copper-catalyzed+route+to+pyrrolo-fused+heterocycles+from+boronic+acids&doi=10.1016%2Fj.tetlet.2011.11.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A direct copper-catalyzed route to pyrrolo-fused heterocycles from boronic acids</span></div><div class="casAuthors">Beveridge, Ramsay E.; Gerstenberger, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">564-569</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A convenient route to prep. azaindoles and related pyrrolo-fused heterocycles from boronic acids, DBAD (di-tert-Bu diazodicarboxylate), and enolizable aldehydes and ketones is presented.  E.g., reaction of 6-methoxy-3-pyridineboronic acid, DMAD, and PhCH2CHO, catalyzed by Cu(OAc)2, gave 70% azaindole deriv. I.  The reaction proceeds via a one-pot four-step cascade sequence with key steps involving a copper-catalyzed boronic acid coupling to DBAD and a Fischer indolization providing access to a variety of pharmaceutically interesting heterocycles including pyrrolopyridines, -pyrimidines, -quinolines, and -isoquinolines from readily available aza-aryl boronic acid precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHwILfeahtlLVg90H21EOLACvtfcHk0lh5op-hnlOWJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OlsL%252FO&md5=8228679938fb89609ae64cb65c65f8ed</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.11.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.11.091%26sid%3Dliteratum%253Aachs%26aulast%3DBeveridge%26aufirst%3DR.%2BE.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26atitle%3DA%2520direct%2520copper-catalyzed%2520route%2520to%2520pyrrolo-fused%2520heterocycles%2520from%2520boronic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D564%26epage%3D569%26doi%3D10.1016%2Fj.tetlet.2011.11.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Purbeta promotes hepatic glucose production by increasing Adcy6 transcription</span>. <i>Mol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.molmet.2019.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.molmet.2019.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=31918924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOgsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=85-97&author=L.+Jiaauthor=Y.+Jiangauthor=X.+Liauthor=Z.+Chen&title=Purbeta+promotes+hepatic+glucose+production+by+increasing+Adcy6+transcription&doi=10.1016%2Fj.molmet.2019.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Purβ promotes hepatic glucose production by increasing Adcy6 transcription</span></div><div class="casAuthors">Jia, Linna; Jiang, Yunfeng; Li, Xinzhi; Chen, Zheng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-97</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Enhanced glucagon signaling and hepatic glucose prodn. (HGP) can account for hyperglycemia in patients with obesity and type 2 diabetes.  However, the detailed mol. mechanisms underlying the enhanced HGP in these patients are not fully understood.  Here, we identify Purβ as a pos. regulator of HGP and study its mol. mechanisms in the regulation of HGP both in vivo and in vitro. Adenovirus-mediated knockdown or overexpression of Purβ was performed in either primary hepatocytes or the livers of db/db mice.  Glucose metab., insulin sensitivity, and HGP were detd. by glucose, insulin, and lactate tolerance tests, resp.  Purβ/ADCY6 protein levels, glucagon signaling (p-CREB/CREB), and insulin signaling (p-Akt/Akt) were measured by immunoblotting.  Gene expression was measured by RNA-seq and real-time quant. polymerase chain reaction.  Luciferase reporter and chromatin immunopptn. assays were used to study the interaction between Purβ and the Adcy6 promoter. Purβ was abnormally elevated in obese mice and was also increased under fasting conditions or via the glucagon signaling pathway, which promoted HGP by increasing Adcy6 expression.  Liver-specific knockdown of Purβ in db/db mice significantly ameliorated hyperglycemia and glucose intolerance by suppressing the glucagon/ADCY6/cAMP/PKA/CREB signaling pathway.  Consistent with this observation, the knockdown of Purβ also inhibited glucose prodn. in isolated primary hepatocytes by inhibiting the glucagon/ADCY6/cAMP/PKA/CREB signaling pathway, whereas the overexpression of Purβ promoted glucose prodn. by activating this signaling pathway.  Mechanistically, Purβ directly binds to the promoter of the Adcy6 gene and thereby promotes its transcription. Taken together, these results illustrate a new model in which Purβ functions to regulate the glucagon/ADCY6/cAMP/PKA/CREB signaling pathway to help maintain glucose homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5WSFaj0Tc-LVg90H21EOLACvtfcHk0lh5op-hnlOWJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOgsL3M&md5=709b7fbbea8bbe3cf39ea86280b25bbb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2019.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2019.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DPurbeta%2520promotes%2520hepatic%2520glucose%2520production%2520by%2520increasing%2520Adcy6%2520transcription%26jtitle%3DMol.%2520Metab.%26date%3D2020%26volume%3D31%26spage%3D85%26epage%3D97%26doi%3D10.1016%2Fj.molmet.2019.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1038/nm.2756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fnm.2756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=22581287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFeqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=943-949&author=L.+Shengauthor=Y.+Zhouauthor=Z.+Chenauthor=D.+Renauthor=K.+W.+Choauthor=L.+Jiangauthor=H.+Shenauthor=Y.+Sasakiauthor=L.+Rui&title=NF-kappaB-inducing+kinase+%28NIK%29+promotes+hyperglycemia+and+glucose+intolerance+in+obesity+by+augmenting+glucagon+action&doi=10.1038%2Fnm.2756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action</span></div><div class="casAuthors">Sheng, Liang; Zhou, Yingjiang; Chen, Zheng; Ren, Decheng; Cho, Kae Won; Jiang, Lin; Shen, Hong; Sasaki, Yoshiteru; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">943-949</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The canonical inhibitor of nuclear factor κB kinase subunit β (IKK-β)-nuclear factor of κ light polypeptide gene enhancer in B cells 1 (NF-κB1) pathway has been well documented to promote insulin resistance; however, the noncanonical NF-κB-inducing kinase (NIK)-NF-κB2 pathway is not well understood in obesity.  Addnl., the contribution of counter-regulatory hormones, particularly glucagon, to hyperglycemia in obesity is unclear.  Here we show that NIK promotes glucagon responses in obesity.  Hepatic NIK was abnormally activated in mice with dietary or genetic obesity.  Systemic deletion of Map3k14, encoding NIK, resulted in reduced glucagon responses and hepatic glucose prodn. (HGP).  Obesity is assocd. with high glucagon responses, and liver-specific inhibition of NIK led to lower glucagon responses and HGP and protected against hyperglycemia and glucose intolerance in obese mice.  Conversely, hepatocyte-specific overexpression of NIK resulted in higher glucagon responses and HGP.  In isolated mouse livers and primary hepatocytes, NIK also promoted glucagon action and glucose prodn., at least in part by increasing cAMP response element-binding (CREB) stability.  Therefore, overactivation of liver NIK in obesity promotes hyperglycemia and glucose intolerance by increasing the hyperglycemic response to glucagon and other factors that activate CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcOdoju-8CbVg90H21EOLACvtfcHk0liYLgXvwayg3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFeqs7g%253D&md5=62840c2d7f7ddfac5d251f6ade9149f0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnm.2756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2756%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DD.%26aulast%3DCho%26aufirst%3DK.%2BW.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DNF-kappaB-inducing%2520kinase%2520%2528NIK%2529%2520promotes%2520hyperglycemia%2520and%2520glucose%2520intolerance%2520in%2520obesity%2520by%2520augmenting%2520glucagon%2520action%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D943%26epage%3D949%26doi%3D10.1038%2Fnm.2756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gittes, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Islet alpha-cell inflammation induced by NF-kappaB inducing kinase (NIK) leads to hypoglycemia, pancreatitis, growth retardation, and postnatal death in mice</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5960</span>– <span class="NLM_lpage">5971</span>, <span class="refDoi"> DOI: 10.7150/thno.28960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.7150%2Fthno.28960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30613274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1Oqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=5960-5971&author=X.+Liauthor=L.+Jiaauthor=X.+Chenauthor=Y.+Dongauthor=X.+Renauthor=Y.+Dongauthor=Y.+Chenauthor=L.+Xieauthor=M.+Liuauthor=C.+Shiotaauthor=G.+K.+Gittesauthor=L.+Ruiauthor=Z.+Chen&title=Islet+alpha-cell+inflammation+induced+by+NF-kappaB+inducing+kinase+%28NIK%29+leads+to+hypoglycemia%2C+pancreatitis%2C+growth+retardation%2C+and+postnatal+death+in+mice&doi=10.7150%2Fthno.28960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Islet α-cell inflammation induced by NF-κB inducing kinase (NIK) leads to hypoglycemia, pancreatitis, growth retardation, and postnatal death in mice</span></div><div class="casAuthors">Li, Xinzhi; Jia, Linna; Chen, Xiaoyue; Dong, Ying; Ren, Xiaomeng; Dong, Yuefan; Chen, Ying; Xie, Liwei; Liu, Ming; Shiota, Chiyo; Gittes, George K.; Rui, Liangyou; Chen, Zheng</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5960-5971</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Islet α-cell dysfunction has been shown to contribute to type 2 diabetes; however, whether islet α-cell inflammation is involved in the occurrence of pancreatitis is largely unknown.  The aims of this study were to investigate how NF-κB inducing kinase (NIK) regulates pancreatic α-cell function, both in vitro and in vivo, and to assess how islet α-cell inflammation induced by NIK affects the development of pancreatitis.  Methods: We utilized adenovirus-mediated NIK overexpression, ELISA, qPCR, RNA-seq, and Western blot analyses to study the role of NIK in islet α cells in vitro.  Islet α-cell-specific NIK overexpressing (α-NIK-OE) mice were generated, and pancreatic α/β-cell function and the occurrence of pancreatitis in these mice were assessed via ELISA, qPCR, and immunohistochem. analyses.  Results: The LTβR/noncanonical NF-κB signaling pathway is present in islet α cells.  Overexpression of NIK in αTC1-6 cells induces inflammation and cell death, contributing to a decrease in the expression and secretion of glucagon.  Addnl., α-cell specific overexpression of NIK (α-NIK-OE) results in α-cell death, lower serum glucagon levels, and hypoglycemia in mice.  Strikingly, α-NIK-OE mice also display a reduced β-cell mass, growth retardation, pancreatitis, and postnatal death.  Conclusions: Islet α-cell specific overexpression of NIK results in islet α-cell dysfunction and causes islet β-cell death and pancreatitis, which are most likely due to paracrine secretion of cytokines and chemokines from islet α cells, thus leading to hypoglycemia, growth retardation, and postnatal death in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplJmXIblTd1rVg90H21EOLACvtfcHk0liYLgXvwayg3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1Oqsbk%253D&md5=9ca73a1cdaa350057bd5d1d9d033f8e6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.7150%2Fthno.28960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.28960%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DShiota%26aufirst%3DC.%26aulast%3DGittes%26aufirst%3DG.%2BK.%26aulast%3DRui%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DIslet%2520alpha-cell%2520inflammation%2520induced%2520by%2520NF-kappaB%2520inducing%2520kinase%2520%2528NIK%2529%2520leads%2520to%2520hypoglycemia%252C%2520pancreatitis%252C%2520growth%2520retardation%252C%2520and%2520postnatal%2520death%2520in%2520mice%26jtitle%3DTheranostics%26date%3D2018%26volume%3D8%26spage%3D5960%26epage%3D5971%26doi%3D10.7150%2Fthno.28960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack A.  Prescott</span>, <span class="hlFld-ContribAuthor ">Jennifer P.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Simon J.  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory feedback control of NF-κB signalling in health and disease. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2021,</strong> <em>478 </em>
                                    (13)
                                     , 2619-2664. <a href="https://doi.org/10.1042/BCJ20210139" title="DOI URL">https://doi.org/10.1042/BCJ20210139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20210139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20210139%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DInhibitory%252Bfeedback%252Bcontrol%252Bof%252BNF-%2525CE%2525BAB%252Bsignalling%252Bin%252Bhealth%252Band%252Bdisease%26aulast%3DPrescott%26aufirst%3DJack%2BA.%26date%3D2021%26date%3D2021%26volume%3D478%26issue%3D13%26spage%3D2619%26epage%3D2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong  Zhang</span>, <span class="hlFld-ContribAuthor ">Heng  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Moting  Liu</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Kai-Xian  Chen</span>, <span class="hlFld-ContribAuthor ">Yue-Wei  Guo</span>, <span class="hlFld-ContribAuthor ">Wei  Tang</span>, <span class="hlFld-ContribAuthor ">Xu-Wen  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-oriented synthesis of cembranoid derivatives as potential anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>111 </em>, 104887. <a href="https://doi.org/10.1016/j.bioorg.2021.104887" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104887%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiversity-oriented%252Bsynthesis%252Bof%252Bcembranoid%252Bderivatives%252Bas%252Bpotential%252Banti-inflammatory%252Bagents%26aulast%3DZhang%26aufirst%3DCong%26date%3D2021%26volume%3D111%26spage%3D104887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Cheng</span>, <span class="hlFld-ContribAuthor ">Xuexin  Feng</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Li</span>, <span class="hlFld-ContribAuthor ">Feilong  Zhou</span>, <span class="hlFld-ContribAuthor ">Jin-Ming  Yang</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 552-565. <a href="https://doi.org/10.1039/D0MD00361A" title="DOI URL">https://doi.org/10.1039/D0MD00361A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00361A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00361A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPharmacological%252Binhibition%252Bof%252BNF-%2525CE%2525BAB-inducing%252Bkinase%252B%252528NIK%252529%252Bwith%252Bsmall%252Bmolecules%252Bfor%252Bthe%252Btreatment%252Bof%252Bhuman%252Bdiseases%26aulast%3DCheng%26aufirst%3DJing%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D552%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiamin  Zheng</span>, <span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Ge  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127862. <a href="https://doi.org/10.1016/j.bmcl.2021.127862" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127862%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bapproaches%252Bto%252Btreat%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%252B%252528Part%252BI%252529%25253A%252BKinase%252Binhibitors%26aulast%3DZheng%26aufirst%3DJiamin%26date%3D2021%26volume%3D38%26spage%3D127862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yonghai  Hui</span>, <span class="hlFld-ContribAuthor ">Yongfei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongyue  Luo</span>, <span class="hlFld-ContribAuthor ">Jianpeng  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Wang</span>, <span class="hlFld-ContribAuthor ">Tianming  Gao</span>, <span class="hlFld-ContribAuthor ">Jialiang  Xia</span>, <span class="hlFld-ContribAuthor ">Sheng  Wang</span>, <span class="hlFld-ContribAuthor ">Shiqi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of spiro thiazolidinone via cyclic ketones, amines and thioglycolic acid by MCM-41-Schiff base-CuSO4·5H2O. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2021,</strong> <em>47 </em>
                                    (2)
                                     , 521-532. <a href="https://doi.org/10.1007/s11164-020-04283-9" title="DOI URL">https://doi.org/10.1007/s11164-020-04283-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-020-04283-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-020-04283-9%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DFacile%252Bsynthesis%252Bof%252Bspiro%252Bthiazolidinone%252Bvia%252Bcyclic%252Bketones%25252C%252Bamines%252Band%252Bthioglycolic%252Bacid%252Bby%252BMCM-41-Schiff%252Bbase-CuSO4%2525C2%2525B75H2O%26aulast%3DHui%26aufirst%3DYonghai%26date%3D2021%26date%3D2020%26volume%3D47%26issue%3D2%26spage%3D521%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianing  Song</span>, <span class="hlFld-ContribAuthor ">Yuqin  Zhu</span>, <span class="hlFld-ContribAuthor ">Weidong  Zu</span>, <span class="hlFld-ContribAuthor ">Chunqi  Duan</span>, <span class="hlFld-ContribAuthor ">Junyu  Xu</span>, <span class="hlFld-ContribAuthor ">Fei  Jiang</span>, <span class="hlFld-ContribAuthor ">Xinren  Wang</span>, <span class="hlFld-ContribAuthor ">Shuwen  Li</span>, <span class="hlFld-ContribAuthor ">Chenhe  Liu</span>, <span class="hlFld-ContribAuthor ">Qianqian  Gao</span>, <span class="hlFld-ContribAuthor ">Hongmei  Li</span>, <span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Weifang  Tang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115856. <a href="https://doi.org/10.1016/j.bmc.2020.115856" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115856%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Bof%252Bquinoline%252Bderivatives%25252C%252Bas%252BNF-%2525CE%2525BAB%252Binducing%252Bkinase%252B%252528NIK%252529%252Binhibitors%252Bwith%252Banti-inflammatory%252Beffects%252Bin%252Bvitro%25252C%252Blow%252Btoxicities%252Bagainst%252BT%252Bcell%252Bgrowth%26aulast%3DSong%26aufirst%3DJianing%26date%3D2021%26volume%3D29%26spage%3D115856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianhui  Chen</span>, <span class="hlFld-ContribAuthor ">Xinyu  Lu</span>, <span class="hlFld-ContribAuthor ">Xiaoyong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Noncanonical NF-κB Signaling Pathway in Liver Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical and Translational Hepatology</span><span> <strong>2020,</strong> <em>000 </em>
                                    (000)
                                     , 1-9. <a href="https://doi.org/10.14218/JCTH.2020.00063" title="DOI URL">https://doi.org/10.14218/JCTH.2020.00063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14218/JCTH.2020.00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14218%2FJCTH.2020.00063%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520and%2520Translational%2520Hepatology%26atitle%3DNoncanonical%252BNF-%2525CE%2525BAB%252BSignaling%252BPathway%252Bin%252BLiver%252BDiseases%26aulast%3DChen%26aufirst%3DQianhui%26date%3D2020%26date%3D2020%26volume%3D000%26issue%3D000%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhakshayini  Morgan</span>, <span class="hlFld-ContribAuthor ">Manoj  Garg</span>, <span class="hlFld-ContribAuthor ">Vinay  Tergaonkar</span>, <span class="hlFld-ContribAuthor ">Soo Yong  Tan</span>, <span class="hlFld-ContribAuthor ">Gautam  Sethi</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesis. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2020,</strong> <em>1874 </em>
                                    (2)
                                     , 188449. <a href="https://doi.org/10.1016/j.bbcan.2020.188449" title="DOI URL">https://doi.org/10.1016/j.bbcan.2020.188449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2020.188449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2020.188449%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DPharmacological%252Bsignificance%252Bof%252Bthe%252Bnon-canonical%252BNF-%2525CE%2525BAB%252Bpathway%252Bin%252Btumorigenesis%26aulast%3DMorgan%26aufirst%3DDhakshayini%26date%3D2020%26volume%3D1874%26issue%3D2%26spage%3D188449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinzhi  Li</span>, <span class="hlFld-ContribAuthor ">Yongsen  Wu</span>, <span class="hlFld-ContribAuthor ">Yue  Song</span>, <span class="hlFld-ContribAuthor ">Na  Ding</span>, <span class="hlFld-ContribAuthor ">Min  Lu</span>, <span class="hlFld-ContribAuthor ">Linna  Jia</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>, <span class="hlFld-ContribAuthor ">Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Zheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of NF-κB-Inducing Kinase in Islet β Cells Causes β Cell Failure and Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Molecular Therapy</span><span> <strong>2020,</strong> <em>28 </em>
                                    (11)
                                     , 2430-2441. <a href="https://doi.org/10.1016/j.ymthe.2020.07.016" title="DOI URL">https://doi.org/10.1016/j.ymthe.2020.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ymthe.2020.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ymthe.2020.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Therapy%26atitle%3DActivation%252Bof%252BNF-%2525CE%2525BAB-Inducing%252BKinase%252Bin%252BIslet%252B%2525CE%2525B2%252BCells%252BCauses%252B%2525CE%2525B2%252BCell%252BFailure%252Band%252BDiabetes%26aulast%3DLi%26aufirst%3DXinzhi%26date%3D2020%26volume%3D28%26issue%3D11%26spage%3D2430%26epage%3D2441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Daohong  Liao</span>, <span class="hlFld-ContribAuthor ">Aleksandr  Kolesnikov</span>, <span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Matthew L.  Landry</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of an Azabicyclo[3.1.0]hexanone-Containing Inhibitor of NF-κΒ Inducing Kinase via Catalytic C–H Activation. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2020,</strong> <em>52 </em>
                                    (22)
                                     , 3420-3426. <a href="https://doi.org/10.1055/s-0040-1707279" title="DOI URL">https://doi.org/10.1055/s-0040-1707279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1707279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1707279%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DSynthesis%252Bof%252Ban%252BAzabicyclo%25255B3.1.0%25255Dhexanone-Containing%252BInhibitor%252Bof%252BNF-%2525CE%2525BA%2525CE%252592%252BInducing%252BKinase%252Bvia%252BCatalytic%252BC%2525E2%252580%252593H%252BActivation%26aulast%3DCrawford%26aufirst%3DJames%2BJ.%26date%3D2020%26date%3D2020%26volume%3D52%26issue%3D22%26spage%3D3420%26epage%3D3426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn M.  Pflug</span>, <span class="hlFld-ContribAuthor ">Raquel  Sitcheran</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (22)
                                     , 8470. <a href="https://doi.org/10.3390/ijms21228470" title="DOI URL">https://doi.org/10.3390/ijms21228470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21228470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21228470%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTargeting%252BNF-%2525CE%2525BAB-Inducing%252BKinase%252B%252528NIK%252529%252Bin%252BImmunity%25252C%252BInflammation%25252C%252Band%252BCancer%26aulast%3DPflug%26aufirst%3DKathryn%2BM.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D22%26spage%3D8470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ada Hang-Heng  Wong</span>, <span class="hlFld-ContribAuthor ">Eun Myoung  Shin</span>, <span class="hlFld-ContribAuthor ">Vinay  Tergaonkar</span>, <span class="hlFld-ContribAuthor ">Wee-Joo  Chng</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting NF-κB Signaling for Multiple Myeloma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2203. <a href="https://doi.org/10.3390/cancers12082203" title="DOI URL">https://doi.org/10.3390/cancers12082203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12082203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12082203%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252BNF-%2525CE%2525BAB%252BSignaling%252Bfor%252BMultiple%252BMyeloma%26aulast%3DWong%26aufirst%3DAda%2BHang-Heng%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected examples of reported inhibitors of the NIK kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Putative binding mode of <b>7</b> and NIK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G3E">4G3E</a>). (A) <b>7</b> (yellow) and <b>1</b> (cyan) were superimposed in the docking models. (B) LIGPLOT<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> of the putative <b>7</b> and NIK interactions. <b>7</b> carbon atoms are shown as black, nitrogen atoms as blue, oxygen atoms as red, and sulfur atoms as yellow spheres. (C) The distance between the oxygen of Asp536 and the benzene moiety of <b>7</b> is 3.5 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Putative binding mode of <b>41</b> and NIK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G3E">4G3E</a>). (A) <b>41</b> (yellow) and <b>1</b> (cyan) were superimposed in the docking models. (B) LIGPLOT<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> of the putative <b>41</b> and NIK interactions. <b>41</b> carbon atoms are shown as black, nitrogen atoms as blue, oxygen atoms as red, and sulfur atoms as yellow spheres.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition curves (<i>K</i><sub>d</sub>) of the NIK kinase by <b>46</b> in the KINOMEscan assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kinome map of <b>46</b> against 98 kinases at 500 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>46</b> (XT2) suppressed NIK mediated proteolysis of p100 to p52 in primary hepatocytes infected with the p100 and Flag-tagged NIK adenovirus. The primary hepatocytes were infected with p100 and Flag-tagged NIK adenovirus in the presence of <b>46</b> (0, 1, or 10 μM) or B022 (5 μM) for 16 h. The cell lysate extracts were immunblotted with antibodies for Flag, NF-κB2, or tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0007.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>46</b> (XT2) suppressed NIK-induced gene expression in primary hepatocytes infected with NIK adenovirus. The primary hepatocytes were infected with the NIK adenovirus in the presence of <b>46</b> (0, 1, or 10 μM) or B022 (5 μM) for 16 h. The relative mRNA levels of TNFα, CCL2, CCL5, CXCL5, and NOS2 were measured by qPCR (<i>N</i> = 6). **<i>P</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0008.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Anti-inflammatory effects of <b>46</b> (XT2) in a CCl<sub>4</sub>-induced mouse liver injury model. (A) Serum ALT activity. (B) The relative mRNA levels of TNFα, NOS2, CCL5, CXCL5, and CCL2 in liver tissues were measured by qPCR (<i>N</i> = 8–10). Wild-type (WT) C57BL/6 mice were intravenously injected with XT2 (40 mg/kg), B022 (25 mg/kg), or an equal volume of vehicle via the tail veins. Half an hour later, mice were intraperitoneally injected with CCl<sub>4</sub> (2.5 mL/kg, 10% in olive oil) followed by XT2 (40 mg/kg), B022 (25 mg/kg), or an equal volume of vehicle via the tail veins at 3, 6, and 9 h. The mice were euthanized at 12 h after the CCl<sub>4</sub> injection, and the blood samples and liver tissue were harvested for analysis. <i>N</i> = 8–10 per group. *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0009.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Immunofluorescent detection of the macrophage-specific antigen F4/80 and DAPI staining of liver tissues upon treatment of <b>46</b> (XT2) or B022 in a CCl<sub>4</sub>-induced mouse liver injury model. Macrophages are stained green and the nucleus blue. <i>N</i> = 5 per group, *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0010.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Intermediates <b>7c</b>–<b>23c</b> and Final Compounds <b>7</b>–<b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CuI, K<sub>2</sub>CO<sub>3</sub>, <span class="smallcaps smallerCapital">l</span>-proline, DMSO, 90 °C, 16 h; (b) NCS, DMF, rt, 12 h; (c) MeONa (30% in MeOH), MeOH, 70 °C, 12 h; (d) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, PPh<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NH, DMSO, 80 °C, overnight.</p></p></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0011.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Intermediates <b>24c</b>, <b>36c</b>–<b>40c</b>, and Final Compounds <b>24</b>–<b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) CuI, K<sub>2</sub>CO<sub>3</sub>, <span class="smallcaps smallerCapital">l</span>-proline, DMSO, 90 °C, 16 h; (b) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, PPh<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NH, DMSO, 80 °C, overnight.</p></p></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0012.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Intermediates <b>41c</b>–<b>50c</b> and Final Compounds <b>41</b>–<b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) (4-aminophenyl)boronic acid, di-<i>tert</i>-butyl azodicarboxylate, Cu(OAc)<sub>2</sub>, MeOH, 65 °C, 1 h; (b) <b>S9a–S9h</b>, 4 N HCl/1,4-dioxane, 80 °C, 16 h; (c) Boc<sub>2</sub>O, DMAP, THF, rt, overnight; (d) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, PPh<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NH, DMSO, 80 °C, overnight; (e) TFA, DCM, rt, 1 h.</p></p></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/medium/jm0c00396_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0013.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Intermediate <b>S11</b> and Final Compounds <b>51</b>–<b>61</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.0c00396/20200416/images/large/jm0c00396_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00396&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: (a) (4-aminophenyl)boronic acid, di-<i>tert</i>-butyl azodicarboxylate, Cu(OAc)<sub>2</sub>, MeOH, 65 °C, 1 h; (b) <b>S10</b>, 4 N HCl/1,4-dioxane, 80 °C, 16 h; (c) Boc<sub>2</sub>O, DMAP, THF, rt, overnight; (d) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, PPh<sub>3</sub>, <i>i</i>-Pr<sub>2</sub>NH, DMSO, 80 °C, overnight; (e) TFA, DCM, rt, 1 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i125">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08354" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08354" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brink, R.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-kappaB signaling initiated by BAFF influences B cell biology at multiple junctures</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">509</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2013.00509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.3389%2Ffimmu.2013.00509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=24432023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A280%3ADC%252BC2cflsFChtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=509&author=S.+Gardamauthor=R.+Brink&title=Non-canonical+NF-kappaB+signaling+initiated+by+BAFF+influences+B+cell+biology+at+multiple+junctures&doi=10.3389%2Ffimmu.2013.00509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures</span></div><div class="casAuthors">Gardam Sandra; Brink Robert</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">509</span>
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    </div><div class="casAbstract">It has been more than a decade since it was recognized that the nuclear factor of kappa light polypeptide gene enhancer in B cells (NF-κB) transcription factor family was activated by two distinct pathways: the canonical pathway involving NF-κB1 and the non-canonical pathway involving NF-κB2.  During this time a great deal of evidence has been amassed on the ligands and receptors that activate these pathways, the cytoplasmic adapter molecules involved in transducing the signals from receptors to nucleus, and the resulting physiological outcomes within body tissues.  In contrast to NF-κB1 signaling, which can be activated by a wide variety of receptors, the NF-κB2 pathway is typically only activated by a subset of receptor and ligand pairs belonging to the tumor necrosis factor (TNF) family.  Amongst these is B cell activating factor of the TNF family (BAFF) and its receptor BAFFR.  Whilst BAFF is produced by many cell types throughout the body, BAFFR expression appears to be restricted to the hematopoietic lineage and B cells in particular.  For this reason, the main physiological outcomes of BAFF mediated NF-κB2 activation are confined to B cells.  Indeed BAFF mediated NF-κB2 signaling contributes to peripheral B cell survival and maturation as well as playing a role in antibody responses and long term maintenance plasma cells.  Thus the importance BAFF and NF-κB2 permeates the entire B cell lifespan and impacts on this important component of the immune system in a variety of ways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRZYu_AE1Nlz0O18WR3iAofW6udTcc2eYOwV-7W0I4KLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cflsFChtg%253D%253D&md5=8533ec7c1fc24e6f66b35d491a8c98b1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2013.00509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2013.00509%26sid%3Dliteratum%253Aachs%26aulast%3DGardam%26aufirst%3DS.%26aulast%3DBrink%26aufirst%3DR.%26atitle%3DNon-canonical%2520NF-kappaB%2520signaling%2520initiated%2520by%2520BAFF%2520influences%2520B%2520cell%2520biology%2520at%2520multiple%2520junctures%26jtitle%3DFront.%2520Immunol.%26date%3D2014%26volume%3D4%26spage%3D509%26doi%3D10.3389%2Ffimmu.2013.00509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Storz, P.</span></span> <span> </span><span class="NLM_article-title">Targeting the alternative NF-kappaB pathway in pancreatic cancer: a new direction for therapy?</span>. <i>Expert Rev. Anticancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1586/era.13.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1586%2Fera.13.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=23617340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFWlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=501-504&author=P.+Storz&title=Targeting+the+alternative+NF-kappaB+pathway+in+pancreatic+cancer%3A+a+new+direction+for+therapy%3F&doi=10.1586%2Fera.13.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?</span></div><div class="casAuthors">Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-504</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer, due to its late diagnosis,is difficult to treat.  In addn., current therapy options are insufficient and new approaches for combination treatment are required.  Recent demonstration of the importance of constitutive signaling of NF-κB-inducing kinase (NIK,also named MAP3K14) in maintaining the high basal activity of the alternative NF-κB pathway in pancreatic cancer suggests novel possibilities for therapeutic intervention.  Strategies to target the alternative NF-κB pathway include not only the use of small mol. inhibitors for NIK and IκB kinase a (IKKa), but also broad spectrum approaches such as using proteasome inhibitors or combinatorial approaches targeting both alternative and canonical pathways.  These may also act synergistically with currently used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkO5O_6UCQkrVg90H21EOLACvtfcHk0lh2yBgErQeIBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFWlsL4%253D&md5=a4945c62cf71cb211141608f6790b853</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1586%2Fera.13.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.13.28%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520alternative%2520NF-kappaB%2520pathway%2520in%2520pancreatic%2520cancer%253A%2520a%2520new%2520direction%2520for%2520therapy%253F%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2013%26volume%3D13%26spage%3D501%26epage%3D504%26doi%3D10.1586%2Fera.13.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenardo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltimore, D.</span></span> <span> </span><span class="NLM_article-title">30 Years of NF-kappaB: A blossoming of relevance to human pathobiology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.cell.2016.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=28086098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=37-57&author=Q.+Zhangauthor=M.+J.+Lenardoauthor=D.+Baltimore&title=30+Years+of+NF-kappaB%3A+A+blossoming+of+relevance+to+human+pathobiology&doi=10.1016%2Fj.cell.2016.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology</span></div><div class="casAuthors">Zhang, Qian; Lenardo, Michael J.; Baltimore, David</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">37-57</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  NF-κB was discovered 30 years ago as a rapidly inducible transcription factor.  Since that time, it has been found to have a broad role in gene induction in diverse cellular responses, particularly throughout the immune system.  Here, we summarize elaborate regulatory pathways involving this transcription factor and use recent discoveries in human genetic diseases to place specific proteins within their relevant medical and biol. contexts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4iAPEV1Opt7Vg90H21EOLACvtfcHk0lh2yBgErQeIBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOjurw%253D&md5=5d2314414a07418d6d5bdcdda2ab03a7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLenardo%26aufirst%3DM.%2BJ.%26aulast%3DBaltimore%26aufirst%3DD.%26atitle%3D30%2520Years%2520of%2520NF-kappaB%253A%2520A%2520blossoming%2520of%2520relevance%2520to%2520human%2520pathobiology%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D37%26epage%3D57%26doi%3D10.1016%2Fj.cell.2016.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span> <span> </span><span class="NLM_article-title">Non-canonical NF-κB signaling pathway</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1038/cr.2010.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fcr.2010.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=21173796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=71-85&author=S.-C.+Sun&title=Non-canonical+NF-%CE%BAB+signaling+pathway&doi=10.1038%2Fcr.2010.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical NF-κB signaling pathway</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-85</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The non-canonical NF-κB pathway is an important arm of NF-κB signaling that predominantly targets activation of the p52/RelB NF-κB complex.  This pathway depends on the inducible processing of p100, a mol. functioning as both the precursor of p52 and a RelB-specific inhibitor.  A central signaling component of the non-canonical pathway is NF-κB-inducing kinase (NIK), which integrates signals from a subset of TNF receptor family members and activates a downstream kinase, IκB kinase-α (IKKα), for triggering p100 phosphorylation and processing.  A unique mechanism of NIK regulation is through its fate control: the basal level of NIK is kept low by a TRAF-cIAP destruction complex and signal-induced non-canonical NF-κB signaling involves NIK stabilization.  Tight control of the fate of NIK is important, since deregulated NIK accumulation is assocd. with lymphoid malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiQeRjZvae3LVg90H21EOLACvtfcHk0lh2yBgErQeIBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlartw%253D%253D&md5=20244440c91b4a4355f60e4ffd23119a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.177%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.-C.%26atitle%3DNon-canonical%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D71%26epage%3D85%26doi%3D10.1038%2Fcr.2010.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span> <span> </span><span class="NLM_article-title">The non-canonical NF-κB pathway in immunity and inflammation</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1038/nri.2017.52</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fnri.2017.52" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=28580957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1OgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=545-558&author=S.-C.+Sun&title=The+non-canonical+NF-%CE%BAB+pathway+in+immunity+and+inflammation&doi=10.1038%2Fnri.2017.52"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The non-canonical NF-κB pathway in immunity and inflammation</span></div><div class="casAuthors">Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">545-558</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The nuclear factor-κB (NF-κB) family of transcription factors is activated by canonical and non-canonical signalling pathways, which differ in both signalling components and biol. functions.  Recent studies have revealed important roles for the non-canonical NF-κB pathway in regulating different aspects of immune functions.  Defects in non-canonical NF-κB signalling are assocd. with severe immune deficiencies, whereas dysregulated activation of this pathway contributes to the pathogenesis of various autoimmune and inflammatory diseases.  Here we review the signalling mechanisms and the biol. function of the non-canonical NF-κB pathway.  We also discuss recent progress in elucidating the mol. mechanisms regulating non-canonical NF-κB pathway activation, which may provide new opportunities for therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz7QEbrIECD7Vg90H21EOLACvtfcHk0lgBqBg1hbLnSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1OgsLw%253D&md5=b28dd6a87e76f3b61b5e108a24cf62f9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnri.2017.52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri.2017.52%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.-C.%26atitle%3DThe%2520non-canonical%2520NF-%25CE%25BAB%2520pathway%2520in%2520immunity%2520and%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2017%26volume%3D17%26spage%3D545%26epage%3D558%26doi%3D10.1038%2Fnri.2017.52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cildir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Low, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tergaonkar, V.</span></span> <span> </span><span class="NLM_article-title">Noncanonical NF-kappaB signaling in health and disease</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">414</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.molmed.2016.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=27068135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC28Xksl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=414-429&author=G.+Cildirauthor=K.+C.+Lowauthor=V.+Tergaonkar&title=Noncanonical+NF-kappaB+signaling+in+health+and+disease&doi=10.1016%2Fj.molmed.2016.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Noncanonical NF-κB Signaling in Health and Disease</span></div><div class="casAuthors">Cildir, Gokhan; Low, Kee Chung; Tergaonkar, Vinay</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">414-429</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Noncanonical NF-κB signaling differs from canonical NF-κB signaling by being activated through different cell surface receptors, cytoplasmic adaptors, and NF-κB dimers.  Under normal physiol. conditions, this noncanonical pathway has been implicated in diverse biol. processes, including lymphoid organogenesis, B cell maturation, osteoclast differentiation, and various functions of other immune cells.  Recently, dysfunction of this pathway has also been causally assocd. with numerous immune-mediated pathologies and human malignancies.  Here, we summarize the core elements as well as the recently identified novel regulators of the noncanonical NF-κB signaling pathway.  The involvement of this pathway in different pathologies and the potential therapeutic options that are currently envisaged are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQEKnTsSKRcLVg90H21EOLACvtfcHk0lgBqBg1hbLnSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xksl2gs7g%253D&md5=dd1360156a7b67455d8c04cca385c310</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DCildir%26aufirst%3DG.%26aulast%3DLow%26aufirst%3DK.%2BC.%26aulast%3DTergaonkar%26aufirst%3DV.%26atitle%3DNoncanonical%2520NF-kappaB%2520signaling%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D414%26epage%3D429%26doi%3D10.1016%2Fj.molmed.2016.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baud, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Is NF-κB a good target for cancer therapy? Hopes and pitfalls</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1038/nrd2781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fnrd2781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=19116625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCku7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=33-40&author=V.+Baudauthor=M.+Karin&title=Is+NF-%CE%BAB+a+good+target+for+cancer+therapy%3F+Hopes+and+pitfalls&doi=10.1038%2Fnrd2781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Is NF-κB a good target for cancer therapy? Hopes and pitfalls</span></div><div class="casAuthors">Baud, Veronique; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear factor κB (NF-κB) transcription factors have a key role in many physiol. processes such as innate and adaptive immune responses, cell proliferation, cell death, and inflammation.  It has become clear that aberrant regulation of NF-κB and the signaling pathways that control its activity are involved in cancer development and progression, as well as in resistance to chemotherapy and radiotherapy.  This article discusses recent evidence from cancer genetics and cancer genome studies that support the involvement of NF-κB in human cancer, particularly in multiple myeloma.  The therapeutic potential and benefit of targeting NF-κB in cancer, and the possible complications and pitfalls of such an approach, are explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWTMItNVBQzrVg90H21EOLACvtfcHk0lgBqBg1hbLnSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCku7%252FM&md5=dfc230dd77b8fd4989907eee889b8a2a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd2781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2781%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DV.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DIs%2520NF-%25CE%25BAB%2520a%2520good%2520target%2520for%2520cancer%2520therapy%253F%2520Hopes%2520and%2520pitfalls%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D33%26epage%3D40%26doi%3D10.1038%2Fnrd2781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallabhapurapu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignali, D. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1364</span>– <span class="NLM_lpage">1370</span>, <span class="refDoi"> DOI: 10.1038/ni.1678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fni.1678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=18997792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1364-1370&author=S.+Vallabhapurapuauthor=A.+Matsuzawaauthor=W.+Zhangauthor=P.-H.+Tsengauthor=J.+J.+Keatsauthor=H.+Wangauthor=D.+A.+A.+Vignaliauthor=P.+L.+Bergsagelauthor=M.+Karin&title=Nonredundant+and+complementary+functions+of+TRAF2+and+TRAF3+in+a+ubiquitination+cascade+that+activates+NIK-dependent+alternative+NF-%CE%BAB+signaling&doi=10.1038%2Fni.1678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling</span></div><div class="casAuthors">Vallabhapurapu, Sivakumar; Matsuzawa, Atsushi; Zhang, WeiZhou; Tseng, Ping-Hui; Keats, Jonathan J.; Wang, Haopeng; Vignali, Dario A. A.; Bergsagel, P. Leif; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1364-1370</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-κB (NF-κB) signaling in resting cells by targeting NF-κB-inducing kinase (NIK) for ubiquitin-dependent degrdn., thus preventing processing of the NF-κB2 precursor protein p100 to release p52.  However, the resp. functions of TRAF2 and TRAF3 in NIK degrdn. and activation of alternative NF-κB signaling have remained elusive.  We now show that CD40 or BAFF receptor activation result in TRAF3 degrdn. in a cIAP1-cIAP2- and TRAF2-dependent way owing to enhanced cIAP1, cIAP2 TRAF3-directed ubiquitin ligase activity.  Receptor-induced activation of cIAP1 and cIAP2 correlated with their K63-linked ubiquitination by TRAF2.  Degrdn. of TRAF3 prevented assocn. of NIK with the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, which resulted in NIK stabilization and NF-κB2-p100 processing.  Constitutive activation of this pathway causes perinatal lethality and lymphoid defects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohqDvmlMG8NrVg90H21EOLACvtfcHk0lihX2FSFb0JfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlOjsb3K&md5=37793636ab6dd59cfc73a923b5f22702</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fni.1678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1678%26sid%3Dliteratum%253Aachs%26aulast%3DVallabhapurapu%26aufirst%3DS.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTseng%26aufirst%3DP.-H.%26aulast%3DKeats%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DVignali%26aufirst%3DD.%2BA.%2BA.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DNonredundant%2520and%2520complementary%2520functions%2520of%2520TRAF2%2520and%2520TRAF3%2520in%2520a%2520ubiquitination%2520cascade%2520that%2520activates%2520NIK-dependent%2520alternative%2520NF-%25CE%25BAB%2520signaling%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1364%26epage%3D1370%26doi%3D10.1038%2Fni.1678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goeddel, D. V.</span></span> <span> </span><span class="NLM_article-title">NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">3792</span>– <span class="NLM_lpage">3797</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.7.3792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1073%2Fpnas.95.7.3792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=9520446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADyaK1cXitlKjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3792-3797&author=L.+Lingauthor=Z.+Caoauthor=D.+V.+Goeddel&title=NF-%CE%BAB-inducing+kinase+activates+IKK-%CE%B1+by+phosphorylation+of+Ser-176&doi=10.1073%2Fpnas.95.7.3792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176</span></div><div class="casAuthors">Ling, Lei; Cao, Zhaodan; Goeddel, David V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3792-3797</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activation of the transcription factor NF-κB by inflammatory cytokines involves the successive action of NF-κB-inducing kinase (NIK) and two IκB kinases, IKK-α and IKK-β.  Here we show that NIK preferentially phosphorylates IKK-α over IKK-β, leading to the activation of IKK-α kinase activity.  This phosphorylation of IKK-α occurs specifically on Ser-176 in the activation loop between kinase subdomains VII and VIII.  A mutant form of IKK-α contg. alanine at residue 176 cannot be phosphorylated or activated by NIK and acts as a dominant neg. inhibitor of interleukin 1-and tumor necrosis factor-induced NF-κB activation.  Conversely, a mutant form of IKK-α contg. glutamic acid at residue 176 is constitutively active.  Thus, the phosphorylation of IKK-α on Ser-176 by NIK may be required for cytokine-mediated NF-κB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhsT-T6KrzObVg90H21EOLACvtfcHk0lihX2FSFb0JfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitlKjtLo%253D&md5=3d5f01f4187051b2df02d6bc5327fb61</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.7.3792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.7.3792%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DGoeddel%26aufirst%3DD.%2BV.%26atitle%3DNF-%25CE%25BAB-inducing%2520kinase%2520activates%2520IKK-%25CE%25B1%2520by%2520phosphorylation%2520of%2520Ser-176%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D3792%26epage%3D3797%26doi%3D10.1073%2Fpnas.95.7.3792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harhaj, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span> <span> </span><span class="NLM_article-title">NF-κB-inducing kinase regulates the processing of NF-κB2 p100</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(01)00187-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2FS1097-2765%2801%2900187-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=11239468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1KitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=401-409&author=G.+Xiaoauthor=E.+W.+Harhajauthor=S.-C.+Sun&title=NF-%CE%BAB-inducing+kinase+regulates+the+processing+of+NF-%CE%BAB2+p100&doi=10.1016%2FS1097-2765%2801%2900187-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB-inducing kinase regulates the processing of NF-κB2 p100</span></div><div class="casAuthors">Xiao, Gutian; Harhaj, Edward W.; Sun, Shao-Cong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">401-409</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Processing of the nfκb2 gene product p100 to generate p52 is an important step in NF-κB regulation.  We show that this step is neg. regulated by a processing-inhibitory domain (PID) within p100 and pos. regulated by the NF-κB-inducing kinase (NIK).  While the PID suppresses the constitutive processing of p100, NIK induces p100 processing by stimulating site-specific phosphorylation and ubiquitination of this precursor protein.  Further, a natural mutation of the gene encoding NIK in alymphoplasia (aly) mice cripples the function of NIK in p100 processing, causing a severe defect in p52 prodn.  These data suggest that NIK is a specific kinase regulating p100 processing and explain why the aly and nfκb2 knockout mice exhibit similar immune deficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMGXPp8bnACLVg90H21EOLACvtfcHk0lgPRQESJzoFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1KitL8%253D&md5=e2e56951018f599fa9df60f3ca72b262</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2801%2900187-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252801%252900187-3%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DHarhaj%26aufirst%3DE.%2BW.%26aulast%3DSun%26aufirst%3DS.-C.%26atitle%3DNF-%25CE%25BAB-inducing%2520kinase%2520regulates%2520the%2520processing%2520of%2520NF-%25CE%25BAB2%2520p100%26jtitle%3DMol.%2520Cell%26date%3D2001%26volume%3D7%26spage%3D401%26epage%3D409%26doi%3D10.1016%2FS1097-2765%2801%2900187-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Senftleben, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greten, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krähn, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonizzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karin, M.</span></span> <span> </span><span class="NLM_article-title">Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">1495</span>– <span class="NLM_lpage">1499</span>, <span class="refDoi"> DOI: 10.1126/science.1062677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1126%2Fscience.1062677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=11520989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVeqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=1495-1499&author=U.+Senftlebenauthor=Y.+Caoauthor=G.+Xiaoauthor=F.+R.+Gretenauthor=G.+Kr%C3%A4hnauthor=G.+Bonizziauthor=Y.+Chenauthor=Y.+Huauthor=A.+Fongauthor=S.-C.+Sunauthor=M.+Karin&title=Activation+by+IKK%CE%B1+of+a+second%2C+evolutionary+conserved%2C+NF-%CE%BAB+signaling+pathway&doi=10.1126%2Fscience.1062677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway</span></div><div class="casAuthors">Senftleben, Uwe; Cao, Yixue; Xiao, Gutian; Greten, Florian R.; Kraehn, Gertraud; Bonizzi, Giuseppina; Chen, Yi; Hu, Yinling; Fong, Abraham; Sun, Shao-Cong; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5534</span>),
    <span class="NLM_cas:pages">1495-1499</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">In mammals, the canonical nuclear factor κB (NF-κB) signaling pathway activated in response to infections is based on degrdn. of IκB inhibitors.  This pathway depends on the IκB kinase (IKK), which contains two catalytic subunits, IKKα and IKKβ.  IKKβ is essential for inducible IκB phosphorylation and degrdn., whereas IKKα is not.  Here the authors show that IKKα is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-κB target genes, and processing of the NF-κB2 (p100) precursor.  IKKα preferentially phosphorylates NF-κB2, and this activity requires its phosphorylation by upstream kinases, one of which may be NF-κB-inducing kinase (NIK).  IKKα is therefore a pivotal component of a second NF-κB activation pathway based on regulated NF-κB2 processing rather than IκB degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL1TLJXkDAYrVg90H21EOLACvtfcHk0lgPRQESJzoFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVeqs7s%253D&md5=fbd1395649a813a75e82a154543a7396</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1062677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1062677%26sid%3Dliteratum%253Aachs%26aulast%3DSenftleben%26aufirst%3DU.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DKr%25C3%25A4hn%26aufirst%3DG.%26aulast%3DBonizzi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DActivation%2520by%2520IKK%25CE%25B1%2520of%2520a%2520second%252C%2520evolutionary%2520conserved%252C%2520NF-%25CE%25BAB%2520signaling%2520pathway%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D1495%26epage%3D1499%26doi%3D10.1126%2Fscience.1062677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omary, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">Medullary thymic epithelial NF-kB-inducing kinase (NIK)/IKKalpha pathway shapes autoimmunity and liver and lung homeostasis in mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">19090</span>– <span class="NLM_lpage">19097</span>, <span class="refDoi"> DOI: 10.1073/pnas.1901056116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1073%2Fpnas.1901056116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=31481626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSku7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=19090-19097&author=H.+Shenauthor=Y.+Jiauthor=Y.+Xiongauthor=H.+Kimauthor=X.+Zhongauthor=M.+G.+Jinauthor=Y.+M.+Shahauthor=M.+B.+Omaryauthor=Y.+Liuauthor=L.+Qiauthor=L.+Rui&title=Medullary+thymic+epithelial+NF-kB-inducing+kinase+%28NIK%29%2FIKKalpha+pathway+shapes+autoimmunity+and+liver+and+lung+homeostasis+in+mice&doi=10.1073%2Fpnas.1901056116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Medullary thymic epithelial NF-kB-inducing kinase (NIK)/IKKα pathway shapes autoimmunity and liver and lung homeostasis in mice</span></div><div class="casAuthors">Shen, Hong; Ji, Yewei; Xiong, Yi; Kim, Hana; Zhong, Xiao; Jin, Michelle G.; Shah, Yatrik M.; Omary, M. Bishr; Liu, Yong; Qi, Ling; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">19090-19097</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant T cell development is a pivotal risk factor for autoimmune disease; however, the underlying mol. mechanism of T cell overactivation is poorly understood.  Here, we identified NF-κB-inducing kinase (NIK) and IkB kinase Iα (IKKα) in thymic epithelial cells (TECs) as essential regulators of T cell development.  Mouse TEC-specific ablation of either NIK or IKKIα resulted in severe T cell-mediated inflammation, injury, and fibrosis in the liver and lung, leading to premature death within 18 d of age.  NIK or IKKIα deficiency abrogated medullary TEC development, and led to breakdown of central tolerance, prodn. of autoreactive T cells, and fatal autoimmune destruction in the liver and lung.  TEC-specific ablation of NIK or IKKIα also impaired thymic T cell development from the double-neg. through the double-pos. stages and inhibited peripheral B cell development.  These results unravel a hitherto unrecognized essential role of TEC-intrinsic NIK and IKKIα pathways in autoimmunity and T cell-instigated chronic liver and lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvkmvenoPPg7Vg90H21EOLACvtfcHk0lgPRQESJzoFfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSku7vM&md5=f80e7ce836701b665a4f28d237dd2c23</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1901056116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1901056116%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DM.%2BG.%26aulast%3DShah%26aufirst%3DY.%2BM.%26aulast%3DOmary%26aufirst%3DM.%2BB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DL.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DMedullary%2520thymic%2520epithelial%2520NF-kB-inducing%2520kinase%2520%2528NIK%2529%252FIKKalpha%2520pathway%2520shapes%2520autoimmunity%2520and%2520liver%2520and%2520lung%2520homeostasis%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26spage%3D19090%26epage%3D19097%26doi%3D10.1073%2Fpnas.1901056116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omary, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2076</span>, <span class="refDoi"> DOI: 10.1002/hep.27348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1002%2Fhep.27348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=25088600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVCis73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2014&pages=2065-2076&author=H.+Shenauthor=L.+Shengauthor=Z.+Chenauthor=L.+Jiangauthor=H.+Suauthor=L.+Yinauthor=M.+B.+Omaryauthor=L.+Rui&title=Mouse+hepatocyte+overexpression+of+NF-%CE%BAB-inducing+kinase+%28NIK%29+triggers+fatal+macrophage-dependent+liver+injury+and+fibrosis&doi=10.1002%2Fhep.27348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis</span></div><div class="casAuthors">Shen, Hong; Sheng, Liang; Chen, Zheng; Jiang, Lin; Su, Haoran; Yin, Lei; Omary, M. Bishr; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2065-2076</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Damaged, necrotic, or apoptotic hepatocytes release damage-assocd. mol. patterns that initiate sterile inflammation, and liver inflammation drives liver injury and fibrosis.  Here we identified hepatic nuclear factor kappa B (NF-κB)-inducing kinase (NIK), a Ser/Thr kinase, as a novel trigger of fatal liver inflammation.  NIK is activated by a broad spectrum of stimuli.  It was up-regulated in injured livers in both mice and humans.  In primary mouse hepatocytes, NIK overexpression stimulated, independently of cell injury and death, release of numerous chemokines and cytokines that activated bone marrow-derived macrophages (BMDMs).  BMDMs in turn secreted proapoptotic mols. that stimulated hepatocyte apoptosis.  Hepatocyte-specific expression of the NIK transgene triggered massive liver inflammation, oxidative stress, hepatocyte apoptosis, and liver fibrosis, leading to wt. loss, hypoglycemia, and death.  Depletion of Kupffer cells/macrophages reversed NIK-induced liver destruction and death.  Conclusion: the hepatocyte NIK-liver immune cell axis promotes liver inflammation, injury, and fibrosis, thus driving liver disease progression. (Hepatol. 2014;60:2064-2075).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgV39v_Rc3ObVg90H21EOLACvtfcHk0liKjPjhTS193g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVCis73L&md5=7aeccfee609708edca22548eab6eb6b0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fhep.27348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27348%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DOmary%26aufirst%3DM.%2BB.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DMouse%2520hepatocyte%2520overexpression%2520of%2520NF-%25CE%25BAB-inducing%2520kinase%2520%2528NIK%2529%2520triggers%2520fatal%2520macrophage-dependent%2520liver%2520injury%2520and%2520fibrosis%26jtitle%3DHepatology%26date%3D2014%26volume%3D60%26spage%3D2065%26epage%3D2076%26doi%3D10.1002%2Fhep.27348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">Liver NF-κB-inducing kinase promotes liver steatosis and glucose counterregulation in male mice with obesity</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">1207</span>– <span class="NLM_lpage">1216</span>, <span class="refDoi"> DOI: 10.1210/en.2016-1582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1210%2Fen.2016-1582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=28379340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVaqt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2017&pages=1207-1216&author=Y.+Liuauthor=L.+Shengauthor=Y.+Xiongauthor=H.+Shenauthor=Y.+Liuauthor=L.+Rui&title=Liver+NF-%CE%BAB-inducing+kinase+promotes+liver+steatosis+and+glucose+counterregulation+in+male+mice+with+obesity&doi=10.1210%2Fen.2016-1582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Liver NF-κB-inducing kinase promotes liver steatosis and glucose counterregulation in male mice with obesity</span></div><div class="casAuthors">Liu, Yan; Sheng, Liang; Xiong, Yi; Shen, Hong; Liu, Yong; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1207-1216</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Obesity is assocd. with chronic inflammation and liver steatoses.  Numerous proinflammatory cytokines have been reported to regulate liver glucose and lipid metab., thus contributing to the pathogenesis of liver steatosis and/or metabolic dysfunction.  Nuclear factor-κB-inducing kinase (NIK) is stimulated by many cytokines and mediates activation of the noncanonical nuclear factor-κB pathway.  We previously reported that liver NIK is aberrantly activated in obesity; inactivation of NIK by overexpressing dominant neg. NIK(KA) suppresses hepatic glucose prodn.  In the present study, we generated conditional NIK knockout mice using the Cre/loxp system.  Mice with hepatocyte-specific or hematopoietic lineage-specific deletion of NIK were normal with either normal chow diet or high-fat diet (HFD) conditions.  In contrast, deletion of NIK in the liver, including both hepatocytes and immune cells, protected against HFD-induced liver steatosis and attenuated hepatic glucose prodn.  Mechanistically, deletion of liver NIK suppressed liver inflammation and lipogenic programs, thus contributing to protection against liver steatosis.  Liver NIK also downregulated cyclic nucleotide phosphodiesterases, thereby augmenting the cyclic adenosine monophosphate/protein kinase A pathway and glucagon-stimulated hepatic glucose prodn.  Together, our data suggest that NIK pathways in both hepatocytes and immune cells act in concert to promote liver steatosis and glucose prodn. in the setting of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHIxFIYcaI3LVg90H21EOLACvtfcHk0lib3Wm8oj1O8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVaqt7bJ&md5=b306428ae240819a48d9c456c69f6436</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1210%2Fen.2016-1582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2016-1582%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DLiver%2520NF-%25CE%25BAB-inducing%2520kinase%2520promotes%2520liver%2520steatosis%2520and%2520glucose%2520counterregulation%2520in%2520male%2520mice%2520with%2520obesity%26jtitle%3DEndocrinology%26date%3D2017%26volume%3D158%26spage%3D1207%26epage%3D1216%26doi%3D10.1210%2Fen.2016-1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valino-Rivas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaquero, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sucunza, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fresno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Nino, M. D.</span></span> <span> </span><span class="NLM_article-title">NIK as a druggable mediator of tissue injury</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2019.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.molmed.2019.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30926358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltVeru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=341-360&author=L.+Valino-Rivasauthor=J.+J.+Vaqueroauthor=D.+Sucunzaauthor=S.+Gutierrezauthor=A.+B.+Sanzauthor=M.+Fresnoauthor=A.+Ortizauthor=M.+D.+Sanchez-Nino&title=NIK+as+a+druggable+mediator+of+tissue+injury&doi=10.1016%2Fj.molmed.2019.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">NIK as a Druggable Mediator of Tissue Injury</span></div><div class="casAuthors">Valino-Rivas, Lara; Vaquero, Juan Jose; Sucunza, David; Gutierrez, Sara; Sanz, Ana B.; Fresno, Manuel; Ortiz, Alberto; Sanchez-Nino, Maria Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-360</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">NF-κB-inducing kinase (NIK, MAP3K14) is best known as the apical kinase that triggers non-canonical NF-κB activation and by its role in the immune system.  Recent data indicate a role for NIK expressed by non-lymphoid cells in cancer, kidney disease, liver injury, glucose homeostasis, osteosarcopenia, vascular calcification, hematopoiesis, and endothelial function.  The spectrum of NIK-assocd. disease now ranges from immunodeficiency (when NIK is defective) to autoimmunity, cancer, sterile inflammation, fibrosis, and metabolic disease when NIK is overactive.  The development of novel small-mol. NIK inhibitors has paved the way to test NIK targeting to treat disease in vivo, and may eventually lead to NIK targeting in the clinic.  In addn., NIK activators are being explored for specific conditions such as myeloid leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM16Ar9Bc8fbVg90H21EOLACvtfcHk0lg0jsiB5CnxgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltVeru7o%253D&md5=e47fa848ac97b68c83c390aba8d99027</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2019.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2019.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DValino-Rivas%26aufirst%3DL.%26aulast%3DVaquero%26aufirst%3DJ.%2BJ.%26aulast%3DSucunza%26aufirst%3DD.%26aulast%3DGutierrez%26aufirst%3DS.%26aulast%3DSanz%26aufirst%3DA.%2BB.%26aulast%3DFresno%26aufirst%3DM.%26aulast%3DOrtiz%26aufirst%3DA.%26aulast%3DSanchez-Nino%26aufirst%3DM.%2BD.%26atitle%3DNIK%2520as%2520a%2520druggable%2520mediator%2520of%2520tissue%2520injury%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D341%26epage%3D360%26doi%3D10.1016%2Fj.molmed.2019.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Annunziata, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demchenko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellamy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrea, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanamura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dave, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurt, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlogie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaughnessy, J. D.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuehl, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2007.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.ccr.2007.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=17692804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1art74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=115-130&author=C.+M.+Annunziataauthor=R.+E.+Davisauthor=Y.+Demchenkoauthor=W.+Bellamyauthor=A.+Gabreaauthor=F.+Zhanauthor=G.+Lenzauthor=I.+Hanamuraauthor=G.+Wrightauthor=W.+Xiaoauthor=S.+Daveauthor=E.+M.+Hurtauthor=B.+Tanauthor=H.+Zhaoauthor=O.+Stephensauthor=M.+Santraauthor=D.+R.+Williamsauthor=L.+Dangauthor=B.+Barlogieauthor=J.+D.+Shaughnessyauthor=W.+M.+Kuehlauthor=L.+M.+Staudt&title=Frequent+engagement+of+the+classical+and+alternative+NF-kappaB+pathways+by+diverse+genetic+abnormalities+in+multiple+myeloma&doi=10.1016%2Fj.ccr.2007.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma</span></div><div class="casAuthors">Annunziata, Christina M.; Davis, R. Eric; Demchenko, Yulia; Bellamy, William; Gabrea, Ana; Zhan, Fenghuang; Lenz, Georg; Hanamura, Ichiro; Wright, George; Xiao, Wenming; Dave, Sandeep; Hurt, Elaine M.; Tan, Bruce; Zhao, Hong; Stephens, Owen; Santra, Madhumita; Williams, David R.; Dang, Lenny; Barlogie, Bart; Shaughnessy, John D., Jr.; Kuehl, W. Michael; Staudt, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-130</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Mechanisms of constitutive NF-κB signaling in multiple myeloma are unknown.  An inhibitor of IκB kinase β (IKKβ) targeting the classical NF-κB pathway was lethal to many myeloma cell lines.  Several cell lines had elevated expression of NIK due to genomic alterations or protein stabilization, while others had inactivating mutations of TRAF3; both kinds of abnormality triggered the classical and alternative NF-κB pathways.  A majority of primary myeloma patient samples and cell lines had elevated NF-κB target gene expression, often assocd. with genetic or epigenetic alteration of NIK, TRAF3, CYLD, BIRC2/BIRC3, CD40, NFKB1, or NFKB2.  These data demonstrate that addiction to the NF-κB pathway is frequent in myeloma and suggest that IKKβ inhibitors hold promise for the treatment of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobxLUR-8Aww7Vg90H21EOLACvtfcHk0lixzrjSR6CKNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1art74%253D&md5=fb1607976b9dc9188764ef4a88964e81</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DAnnunziata%26aufirst%3DC.%2BM.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DDemchenko%26aufirst%3DY.%26aulast%3DBellamy%26aufirst%3DW.%26aulast%3DGabrea%26aufirst%3DA.%26aulast%3DZhan%26aufirst%3DF.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DHanamura%26aufirst%3DI.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DDave%26aufirst%3DS.%26aulast%3DHurt%26aufirst%3DE.%2BM.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DStephens%26aufirst%3DO.%26aulast%3DSantra%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BR.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DBarlogie%26aufirst%3DB.%26aulast%3DShaughnessy%26aufirst%3DJ.%2BD.%26aulast%3DKuehl%26aufirst%3DW.%2BM.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DFrequent%2520engagement%2520of%2520the%2520classical%2520and%2520alternative%2520NF-kappaB%2520pathways%2520by%2520diverse%2520genetic%2520abnormalities%2520in%2520multiple%2520myeloma%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D115%26epage%3D130%26doi%3D10.1016%2Fj.ccr.2007.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keats, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schop, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chng, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiedemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebag, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braggio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price-Troska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brents, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greipp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dispenzieri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulligan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruhn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, P. L.</span></span> <span> </span><span class="NLM_article-title">Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2007.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.ccr.2007.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=17692805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD2sXps1art78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=131-144&author=J.+J.+Keatsauthor=R.+Fonsecaauthor=M.+Chesiauthor=R.+Schopauthor=A.+Bakerauthor=W.+J.+Chngauthor=S.+Van+Wierauthor=R.+Tiedemannauthor=C.+X.+Shiauthor=M.+Sebagauthor=E.+Braggioauthor=T.+Henryauthor=Y.+X.+Zhuauthor=H.+Fogleauthor=T.+Price-Troskaauthor=G.+Ahmannauthor=C.+Manciniauthor=L.+A.+Brentsauthor=S.+Kumarauthor=P.+Greippauthor=A.+Dispenzieriauthor=B.+Bryantauthor=G.+Mulliganauthor=L.+Bruhnauthor=M.+Barrettauthor=R.+Valdezauthor=J.+Trentauthor=A.+K.+Stewartauthor=J.+Carptenauthor=P.+L.+Bergsagel&title=Promiscuous+mutations+activate+the+noncanonical+NF-kappaB+pathway+in+multiple+myeloma&doi=10.1016%2Fj.ccr.2007.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma</span></div><div class="casAuthors">Keats, Jonathan J.; Fonseca, Rafael; Chesi, Marta; Schop, Roelandt; Baker, Angela; Chng, Wee-Joo; Van Wier, Scott; Tiedemann, Rodger; Shi, Chang-Xin; Sebag, Michael; Braggio, Esteban; Henry, Travis; Zhu, Yuan-Xiao; Fogle, Homer; Price-Troska, Tammy; Ahmann, Gregory; Mancini, Catherine; Brents, Leslie A.; Kumar, Shaji; Greipp, Philip; Dispenzieri, Angela; Bryant, Barb; Mulligan, George; Bruhn, Laurakay; Barrett, Michael; Valdez, Riccardo; Trent, Jeff; Stewart, A. Keith; Carpten, John; Bergsagel, P. Leif</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-144</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activation of NF-κB has been noted in many tumor types, however only rarely has this been linked to an underlying genetic mutation.  An integrated anal. of high-d. oligonucleotide array CGH and gene expression profiling data from 155 multiple myeloma samples identified a promiscuous array of abnormalities contributing to the dysregulation of NF-κB in approx. 20% of patients.  We report mutations in ten genes causing the inactivation of TRAF2, TRAF3, CYLD, cIAP1/cIAP2 and activation of NFKB1, NFKB2, CD40, LTBR, TACI, and NIK that result primarily in constitutive activation of the noncanonical NF-κB pathway, with the single most common abnormality being inactivation of TRAF3.  These results highlight the crit. importance of the NF-κB pathway in the pathogenesis of multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk19k4hmHAbrVg90H21EOLACvtfcHk0lixzrjSR6CKNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXps1art78%253D&md5=9a3f06ac4cbe52b319f9073a03cb6ea0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DKeats%26aufirst%3DJ.%2BJ.%26aulast%3DFonseca%26aufirst%3DR.%26aulast%3DChesi%26aufirst%3DM.%26aulast%3DSchop%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DA.%26aulast%3DChng%26aufirst%3DW.%2BJ.%26aulast%3DVan%2BWier%26aufirst%3DS.%26aulast%3DTiedemann%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DC.%2BX.%26aulast%3DSebag%26aufirst%3DM.%26aulast%3DBraggio%26aufirst%3DE.%26aulast%3DHenry%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DY.%2BX.%26aulast%3DFogle%26aufirst%3DH.%26aulast%3DPrice-Troska%26aufirst%3DT.%26aulast%3DAhmann%26aufirst%3DG.%26aulast%3DMancini%26aufirst%3DC.%26aulast%3DBrents%26aufirst%3DL.%2BA.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DGreipp%26aufirst%3DP.%26aulast%3DDispenzieri%26aufirst%3DA.%26aulast%3DBryant%26aufirst%3DB.%26aulast%3DMulligan%26aufirst%3DG.%26aulast%3DBruhn%26aufirst%3DL.%26aulast%3DBarrett%26aufirst%3DM.%26aulast%3DValdez%26aufirst%3DR.%26aulast%3DTrent%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26aulast%3DCarpten%26aufirst%3DJ.%26aulast%3DBergsagel%26aufirst%3DP.%2BL.%26atitle%3DPromiscuous%2520mutations%2520activate%2520the%2520noncanonical%2520NF-kappaB%2520pathway%2520in%2520multiple%2520myeloma%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D131%26epage%3D144%26doi%3D10.1016%2Fj.ccr.2007.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamoorthi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bents, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaochico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezhkovskiy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modrusan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veliz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackney, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaoui Ismaili, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span> <span> </span><span class="NLM_article-title">NF-kappaB inducing kinase is a therapeutic target for systemic lupus erythematosus</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">179</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02672-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fs41467-017-02672-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=29330524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A280%3ADC%252BC1Mvgtlylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=179&author=H.+D.+Brightbillauthor=E.+Sutoauthor=N.+Blaquiereauthor=N.+Ramamoorthiauthor=S.+Sujatha-Bhaskarauthor=E.+B.+Gogolauthor=G.+M.+Castanedoauthor=B.+T.+Jacksonauthor=Y.+C.+Kwonauthor=S.+Hallerauthor=J.+Leschauthor=K.+Bentsauthor=C.+Everettauthor=P.+B.+Kohliauthor=S.+Lingeauthor=L.+Christianauthor=K.+Barrettauthor=A.+Jaochicoauthor=L.+M.+Berezhkovskiyauthor=P.+W.+Fanauthor=Z.+Modrusanauthor=K.+Velizauthor=M.+J.+Townsendauthor=J.+DeVossauthor=A.+R.+Johnsonauthor=R.+Godemannauthor=W.+P.+Leeauthor=C.+D.+Austinauthor=B.+S.+McKenzieauthor=J.+A.+Hackneyauthor=J.+J.+Crawfordauthor=S.+T.+Stabenauthor=M.+H.+Alaoui+Ismailiauthor=L.+C.+Wuauthor=N.+Ghilardi&title=NF-kappaB+inducing+kinase+is+a+therapeutic+target+for+systemic+lupus+erythematosus&doi=10.1038%2Fs41467-017-02672-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus</span></div><div class="casAuthors">Brightbill Hans D; Sujatha-Bhaskar Swathi; Gogol Emily B; Jackson Benjamin T; Christian Laura; Wu Lawren C; Ghilardi Nico; Suto Eric; Kwon Youngsu C; Lesch Justin; DeVoss Jason; Lee Wyne P; McKenzie Brent S; Blaquiere Nicole; Castanedo Georgette M; Crawford James J; Staben Steven T; Ramamoorthi Nandhini; Townsend Michael J; Haller Susan; Austin Cary D; Bents Karin; Linge Sandra; Godemann Robert; Everett Christine; Kohli Pawan Bir; Barrett Kathy; Johnson Adam R; Alaoui Ismaili Moulay H; Jaochico Allan; Berezhkovskiy Leonid M; Fan Peter W; Modrusan Zora; Veliz Kelli; Hackney Jason A</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NF-κB-inducing kinase (NIK) mediates non-canonical NF-κB signaling downstream of multiple TNF family members, including BAFF, TWEAK, CD40, and OX40, which are implicated in the pathogenesis of systemic lupus erythematosus (SLE).  Here, we show that experimental lupus in NZB/W F1 mice can be treated with a highly selective and potent NIK small molecule inhibitor.  Both in vitro as well as in vivo, NIK inhibition recapitulates the pharmacological effects of BAFF blockade, which is clinically efficacious in SLE.  Furthermore, NIK inhibition also affects T cell parameters in the spleen and proinflammatory gene expression in the kidney, which may be attributable to inhibition of OX40 and TWEAK signaling, respectively.  As a consequence, NIK inhibition results in improved survival, reduced renal pathology, and lower proteinuria scores.  Collectively, our data suggest that NIK inhibition is a potential therapeutic approach for SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRSowPmlnIWxaqcneEtCi92fW6udTcc2eZ8PvhiWVP49rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mvgtlylug%253D%253D&md5=41a91514e1f4e8b2b44912ba6d6a4788</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02672-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02672-0%26sid%3Dliteratum%253Aachs%26aulast%3DBrightbill%26aufirst%3DH.%2BD.%26aulast%3DSuto%26aufirst%3DE.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DRamamoorthi%26aufirst%3DN.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DGogol%26aufirst%3DE.%2BB.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DJackson%26aufirst%3DB.%2BT.%26aulast%3DKwon%26aufirst%3DY.%2BC.%26aulast%3DHaller%26aufirst%3DS.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DBents%26aufirst%3DK.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DLinge%26aufirst%3DS.%26aulast%3DChristian%26aufirst%3DL.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DJaochico%26aufirst%3DA.%26aulast%3DBerezhkovskiy%26aufirst%3DL.%2BM.%26aulast%3DFan%26aufirst%3DP.%2BW.%26aulast%3DModrusan%26aufirst%3DZ.%26aulast%3DVeliz%26aufirst%3DK.%26aulast%3DTownsend%26aufirst%3DM.%2BJ.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DW.%2BP.%26aulast%3DAustin%26aufirst%3DC.%2BD.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DHackney%26aufirst%3DJ.%2BA.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DAlaoui%2BIsmaili%26aufirst%3DM.%2BH.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DGhilardi%26aufirst%3DN.%26atitle%3DNF-kappaB%2520inducing%2520kinase%2520is%2520a%2520therapeutic%2520target%2520for%2520systemic%2520lupus%2520erythematosus%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D179%26doi%3D10.1038%2Fs41467-017-02672-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">A small-molecule inhibitor of NF-kappaB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">718</span>, <span class="refDoi"> DOI: 10.1096/fj.201600840R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1096%2Ffj.201600840R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=27871061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpsleit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=711-718&author=X.+Renauthor=X.+Liauthor=L.+Jiaauthor=D.+Chenauthor=H.+Houauthor=L.+Ruiauthor=Y.+Zhaoauthor=Z.+Chen&title=A+small-molecule+inhibitor+of+NF-kappaB-inducing+kinase+%28NIK%29+protects+liver+from+toxin-induced+inflammation%2C+oxidative+stress%2C+and+injury&doi=10.1096%2Ffj.201600840R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A small-molecule inhibitor of NF-κB-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury</span></div><div class="casAuthors">Ren, Xiaomeng; Li, Xinzhi; Jia, Linna; Chen, Deheng; Hou, Hai; Rui, Liangyou; Zhao, Yujun; Chen, Zheng</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">711-718</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Potent and selective chem. probes are valuable tools for discovery of novel treatments for human diseases.  NF-κB-inducing kinase (NIK) is a key trigger in the development of liver injury and fibrosis.  Whether inhibition of NIK activity by chem. probes ameliorates liver inflammation and injury is largely unknown.  In this study, a small-mol. inhibitor of NIK, B022, was found to be a potent and selective chem. probe for liver inflammation and injury.  B022 inhibited the NIK signaling pathway, including NIK-induced p100-to-p52 processing and inflammatory gene expression, both in vitro and in vivo.  Furthermore, in vivo administration of B022 protected against not only NIK but also CCl4-induced liver inflammation and injury.  Our data suggest that inhibition of NIK is a novel strategy for treatment of liver inflammation, oxidative stress, and injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAtVxDU8yQibVg90H21EOLACvtfcHk0lgQTtEo15TlOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpsleit78%253D&md5=84f05fa8fdf2fcfe79d167827ceea738</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1096%2Ffj.201600840R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201600840R%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DHou%26aufirst%3DH.%26aulast%3DRui%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520NF-kappaB-inducing%2520kinase%2520%2528NIK%2529%2520protects%2520liver%2520from%2520toxin-induced%2520inflammation%252C%2520oxidative%2520stress%252C%2520and%2520injury%26jtitle%3DFASEB%2520J.%26date%3D2017%26volume%3D31%26spage%3D711%26epage%3D718%26doi%3D10.1096%2Ffj.201600840R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torsoni, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canet, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omary, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e34152</span> <span class="refDoi"> DOI: 10.7554/eLife.34152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.7554%2FeLife.34152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30070632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSisrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&author=Y.+Xiongauthor=A.+S.+Torsoniauthor=F.+Wuauthor=H.+Shenauthor=Y.+Liuauthor=X.+Zhongauthor=M.+J.+Canetauthor=Y.+M.+Shahauthor=M.+B.+Omaryauthor=Y.+Liuauthor=L.+Rui&title=Hepatic+NF-kB-inducing+kinase+%28NIK%29+suppresses+mouse+liver+regeneration+in+acute+and+chronic+liver+diseases&doi=10.7554%2FeLife.34152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases</span></div><div class="casAuthors">Xiong, Yi; Torsoni, Adriana Souza; Wu, Feihua; Shen, Hong; Liu, Yan; Zhong, Xiao; Canet, Mark J.; Shah, Yatrik M.; Omary, M. Bishr; Liu, Yong; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e34152/1-e34152/18</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Reparative hepatocyte replication is impaired in chronic liver disease, contributing to disease progression; however, the underlying mechanism remains elusive.  Here, we identify Map3k14 (also known as NIK) and its substrate Chuk (also called IKKα) as unrecognized suppressors of hepatocyte replication.  Chronic liver disease is assocd. with aberrant activation of hepatic NIK pathways.  We found that hepatocyte-specific deletion of Map3k14 or Chuk substantially accelerated mouse hepatocyte proliferation and liver regeneration following partial-hepatectomy.  Hepatotoxin treatment or high fat diet feeding inhibited the ability of partial-hepatectomy to stimulate hepatocyte replication; remarkably, inactivation of hepatic NIK markedly increased reparative hepatocyte proliferation under these liver disease conditions.  Mechanistically, NIK and IKKα suppressed the mitogenic JAK2/STAT3 pathway, thereby inhibiting cell cycle progression.  Our data suggest that hepatic NIK and IKKα act as rheostats for liver regeneration by restraining overgrowth.  Pathol. activation of hepatic NIK or IKKα likely blocks hepatocyte replication, contributing to liver disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog4CiRtIPKBbVg90H21EOLACvtfcHk0lhu0UD1ooRnHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSisrrN&md5=470ee505640909822cd4e660e57ff9d7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.7554%2FeLife.34152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.34152%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DTorsoni%26aufirst%3DA.%2BS.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DX.%26aulast%3DCanet%26aufirst%3DM.%2BJ.%26aulast%3DShah%26aufirst%3DY.%2BM.%26aulast%3DOmary%26aufirst%3DM.%2BB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DHepatic%2520NF-kB-inducing%2520kinase%2520%2528NIK%2529%2520suppresses%2520mouse%2520liver%2520regeneration%2520in%2520acute%2520and%2520chronic%2520liver%2520diseases%26jtitle%3DeLife%26date%3D2018%26volume%3D7%26doi%3D10.7554%2FeLife.34152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parobchak, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gololobova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, T.</span></span> <span> </span><span class="NLM_article-title">Screening a small molecule library to identify inhibitors of NF-κB inducing kinase and pro-labor genes in human placenta</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1657</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-20147-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fs41598-018-20147-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=29374256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A280%3ADC%252BC1MvkslemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1657&author=B.+Wangauthor=N.+Parobchakauthor=A.+Martinauthor=M.+Rosenauthor=L.+J.+Yuauthor=M.+Nguyenauthor=K.+Gololobovaauthor=T.+Rosen&title=Screening+a+small+molecule+library+to+identify+inhibitors+of+NF-%CE%BAB+inducing+kinase+and+pro-labor+genes+in+human+placenta&doi=10.1038%2Fs41598-018-20147-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Screening a small molecule library to identify inhibitors of NF-κB inducing kinase and pro-labor genes in human placenta</span></div><div class="casAuthors">Wang Bingbing; Parobchak Nataliya; Martin Adriana; Rosen Max; Yu Lumeng Jenny; Nguyen Mary; Gololobova Kseniya; Rosen Todd; Nguyen Mary</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1657</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The non-canonical NF-κB signaling (RelB/p52) pathway drives pro-labor genes in the human placenta, including corticotropin-releasing hormone (CRH) and cyclooxygenase-2 (COX-2), making this a potential therapeutic target to delay onset of labor.  Here we sought to identify small molecule compounds from a pre-existing chemical library of orally active drugs that can inhibit this NF-κB signaling, and in turn, human placental CRH and COX-2 production.  We used a cell-based assay coupled with a dual-luciferase reporter system to perform an in vitro screening of a small molecule library of 1,120 compounds for inhibition of the non-canonical NF-κB pathway.  Cell toxicity studies and drug efflux transport MRP1 assays were used to further characterize the lead compounds.  We have found that 14 drugs have selective inhibitory activity against lymphotoxin beta complex-induced activation of RelB/p52 in HEK293T cells, several of which also inhibited expression of CRH and COX-2 in human term trophoblast.  We identified sulfapyridine and propranolol with activity against CRH and COX-2 that deserve further study.  These drugs could serve as the basis for development of orally active drugs to affect length of gestation, first in an animal model, and then in clinical trials to prevent preterm birth during human pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbr8gYxuA1hkHdcurJClFcfW6udTcc2ebehY8nGLkVErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvkslemsA%253D%253D&md5=1406dc5e121e84889d7b005fdfc2a7d9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-20147-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-20147-0%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DParobchak%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DRosen%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DL.%2BJ.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DGololobova%26aufirst%3DK.%26aulast%3DRosen%26aufirst%3DT.%26atitle%3DScreening%2520a%2520small%2520molecule%2520library%2520to%2520identify%2520inhibitors%2520of%2520NF-%25CE%25BAB%2520inducing%2520kinase%2520and%2520pro-labor%2520genes%2520in%2520human%2520placenta%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D1657%26doi%3D10.1038%2Fs41598-018-20147-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demchenko, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brents, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergsagel, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuehl, M. W.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">4554</span>– <span class="NLM_lpage">4566</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.18632%2Foncotarget.2128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=24980832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A280%3ADC%252BC2cfotVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=4554-4566&author=Y.+N.+Demchenkoauthor=L.+A.+Brentsauthor=Z.+Liauthor=L.+P.+Bergsagelauthor=L.+R.+McGeeauthor=M.+W.+Kuehl&title=Novel+inhibitors+are+cytotoxic+for+myeloma+cells+with+NFkB+inducing+kinase-dependent+activation+of+NFkB&doi=10.18632%2Foncotarget.2128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB</span></div><div class="casAuthors">Demchenko Yulia N; Brents Leslie A; Kuehl Michael W; Li Zhihong; McGee Lawrence R; Bergsagel Leif P</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4554-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NFkB activity is critical for survival and proliferation of normal lymphoid cells and many kinds of B-cell tumors, including multiple myeloma (MM).  NFkB activating mutations, which are apparent progression events, enable MM tumors to become less dependent on bone marrow signals that activate NFkB.  Mutations that activate NFkB-inducing kinase (NIK) protein are the most prevalent among the many kinds of NFkB mutations in MM tumors.  NIK is the main activating kinase of the alternative NFkB pathway, although over-expression of NIK also can activate the classical pathway.  Two NIK inhibitors and an isomeric control were tested with human myeloma cell lines.  These specific NIK inhibitors are selectively cytotoxic for cells with NIK-dependent activation of NFkB.  Combination therapy targeting NIK and IKKbeta (as a main kinase of the classical NFkB pathway) represents a promising treatment strategy in MM.  NIK inhibitors can also be useful tool for assessing the role of NIK and alternative NFkB pathway in different cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQdMjvs4g8EiVf1XRtfYM0dfW6udTcc2eZTP9c1Cpk2K7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfotVKjsQ%253D%253D&md5=ff9cd27be0fffdda47951e780f5996c1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2128%26sid%3Dliteratum%253Aachs%26aulast%3DDemchenko%26aufirst%3DY.%2BN.%26aulast%3DBrents%26aufirst%3DL.%2BA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBergsagel%26aufirst%3DL.%2BP.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DKuehl%26aufirst%3DM.%2BW.%26atitle%3DNovel%2520inhibitors%2520are%2520cytotoxic%2520for%2520myeloma%2520cells%2520with%2520NFkB%2520inducing%2520kinase-dependent%2520activation%2520of%2520NFkB%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D4554%26epage%3D4566%26doi%3D10.18632%2Foncotarget.2128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doppler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storz, P.</span></span> <span> </span><span class="NLM_article-title">Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e53676</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0053676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1371%2Fjournal.pone.0053676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=23301098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=H.+Dopplerauthor=G.+Y.+Liouauthor=P.+Storz&title=Downregulation+of+TRAF2+mediates+NIK-induced+pancreatic+cancer+cell+proliferation+and+tumorigenicity&doi=10.1371%2Fjournal.pone.0053676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity</span></div><div class="casAuthors">Doppler, Heike; Liou, Geou-Yarh; Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e53676</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Increased levels of NF-κB are hallmarks of pancreatic ductal adenocarcinoma (PDAC) and both classical and alternative NF-κB activation pathways have been implicated.  Methodol./Principal Findings: Here we show that activation of the alternative pathway is a source for the high basal NFκB activity in PDAC cell lines.  Increased activity of the p52/RelB NF-κB complex is mediated through stabilization and activation of NF-κB-inducing kinase (NIK).  We identify proteasomal downregulation of TNF receptor-assocd. factor 2 (TRAF2) as a mechanism by which levels of active NIK are increased in PDAC cell lines.  Such upregulation of NIK expression and activity levels relays to increased proliferation and anchorage-independent growth, but not migration or survival of PDAC cells.  Conclusions/Significance: Rapid growth is one characteristic of pancreatic cancer.  Our data indicates that the TRAF2/NIK/NF-κB2 pathway regulates PDAC cell tumorigenicity and could be a valuable target for therapy of this cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnrJZVjqbQzbVg90H21EOLACvtfcHk0liuWCPdkZlrHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFKhug%253D%253D&md5=e03970c3c2c199c764e479c528245692</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0053676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0053676%26sid%3Dliteratum%253Aachs%26aulast%3DDoppler%26aufirst%3DH.%26aulast%3DLiou%26aufirst%3DG.%2BY.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DDownregulation%2520of%2520TRAF2%2520mediates%2520NIK-induced%2520pancreatic%2520cancer%2520cell%2520proliferation%2520and%2520tumorigenicity%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0053676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Leon-Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of the catalytic domain of the NF-kappaB inducing kinase reveals a narrow but flexible active site</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1704</span>– <span class="NLM_lpage">1714</span>, <span class="refDoi"> DOI: 10.1016/j.str.2012.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.str.2012.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=22921830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Glu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=1704-1714&author=G.+de%0ALeon-Boenigauthor=K.+K.+Bowmanauthor=J.+A.+Fengauthor=T.+Crawfordauthor=C.+Everettauthor=Y.+Frankeauthor=A.+Ohauthor=M.+Stanleyauthor=S.+T.+Stabenauthor=M.+A.+Starovasnikauthor=H.+J.+Wallweberauthor=J.+Wuauthor=L.+C.+Wuauthor=A.+R.+Johnsonauthor=S.+G.+Hymowitz&title=The+crystal+structure+of+the+catalytic+domain+of+the+NF-kappaB+inducing+kinase+reveals+a+narrow+but+flexible+active+site&doi=10.1016%2Fj.str.2012.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site</span></div><div class="casAuthors">de Leon-Boenig, Gladys; Bowman, Krista K.; Feng, Jianwen A.; Crawford, Terry; Everett, Christine; Franke, Yvonne; Oh, Angela; Stanley, Mark; Staben, Steven T.; Starovasnik, Melissa A.; Wallweber, Heidi J. A.; Wu, Jiansheng; Wu, Lawren C.; Johnson, Adam R.; Hymowitz, Sarah G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1704-1714</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The NF-κB inducing kinase (NIP) regulates the non-canonical NF-κB pathway downstream of important clin. targets including BAFF, RANKL, and LTβ.  Despite numerous genetic studies assocg. dysregulation of this pathway with autoimmune diseases and hematol. cancers, detailed mol. characterization of this central signaling node has been lacking.  We undertook a systematic cloning and expression effort to generate sol., well-behaved proteins encompassing the kinase domains of human and murine NIK.  Structures of the apo NIK kinase domain from both species reveal an active-like conformation in the absence of phosphorylation.  ATP consumption and peptide phosphorylation assays confirm that phosphorylation of NIK does not increase enzymic activity.  Structures of murine NIK bound to inhibitors possessing two different chemotypes reveal conformational flexibility in the gatekeeper residue controlling access to a hydrophobic pocket.  Finally, a single amino acid difference affects the ability of some inhibitors to bind murine and human NIK with the same affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkN2Wi64mVzLVg90H21EOLACvtfcHk0liuWCPdkZlrHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Glu73P&md5=3f7d5bbd95066eb9d660ba810aba6e54</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2012.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2012.07.013%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLeon-Boenig%26aufirst%3DG.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DFeng%26aufirst%3DJ.%2BA.%26aulast%3DCrawford%26aufirst%3DT.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DM.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26atitle%3DThe%2520crystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520NF-kappaB%2520inducing%2520kinase%2520reveals%2520a%2520narrow%2520but%2520flexible%2520active%2520site%26jtitle%3DStructure%26date%3D2012%26volume%3D20%26spage%3D1704%26epage%3D1714%26doi%3D10.1016%2Fj.str.2012.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayagaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of tricyclic NF-kappaB inducing kinase (NIK) inhibitors that have high selectivity over phosphoinositide-3-kinase (PI3K)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01363</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01363" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCgs7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=627-640&author=G.+M.+Castanedoauthor=N.+Blaquiereauthor=M.+Beresiniauthor=B.+Bravoauthor=H.+Brightbillauthor=J.+Chenauthor=H.+F.+Cuiauthor=C.+Eigenbrotauthor=C.+Everettauthor=J.+Fengauthor=R.+Godemannauthor=E.+Gogolauthor=S.+Hymowitzauthor=A.+Johnsonauthor=N.+Kayagakiauthor=P.+B.+Kohliauthor=K.+Knuppelauthor=J.+Kraemerauthor=S.+Krugerauthor=P.+Lokeauthor=P.+McEwanauthor=C.+Montalbettiauthor=D.+A.+Robertsauthor=M.+Smithauthor=S.+Steinbacherauthor=S.+Sujatha-Bhaskarauthor=R.+Takahashiauthor=X.+Wangauthor=L.+C.+Wuauthor=Y.+Zhangauthor=S.+T.+Staben&title=Structure-based+design+of+tricyclic+NF-kappaB+inducing+kinase+%28NIK%29+inhibitors+that+have+high+selectivity+over+phosphoinositide-3-kinase+%28PI3K%29&doi=10.1021%2Facs.jmedchem.6b01363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K)</span></div><div class="casAuthors">Castanedo, Georgette M.; Blaquiere, Nicole; Beresini, Maureen; Bravo, Brandon; Brightbill, Hans; Chen, Jacob; Cui, Hai-Feng; Eigenbrot, Charles; Everett, Christine; Feng, Jianwen; Godemann, Robert; Gogol, Emily; Hymowitz, Sarah; Johnson, Adam; Kayagaki, Nobuhiko; Kohli, Pawan Bir; Knuppel, Kathleen; Kraemer, Joachim; Kruger, Susan; Loke, Pui; McEwan, Paul; Montalbetti, Christian; Roberts, David A.; Smith, Myron; Steinbacher, Stefan; Sujatha-Bhaskar, Swathi; Takahashi, Ryan; Wang, Xiaolu; Wu, Lawren C.; Zhang, Yamin; Staben, Steven T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">627-640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a structure-guided optimization of a novel series of NF-κB inducing kinase (NIK) inhibitors.  Starting from a modestly potent, low mol. wt. lead, activity was improved by designing a type I1/2 binding mode that accessed a back pocket past the methionine-471 gatekeeper.  Divergent binding modes in NIK and PI3K were used to dampen PI3K-inhibition while maintaining NIK inhibition within these series.  Potent compds. were discovered that selectively inhibit the nuclear translocation of NF-kB2 (p52/REL-B) but not canonical NF-kB1 (REL-A/p50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrws-sPXJiSfLVg90H21EOLACvtfcHk0lhG3Sggu-pVXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCgs7bK&md5=316b70f51a5b800ba810082d0b3862da</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01363%26sid%3Dliteratum%253Aachs%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DBeresini%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DB.%26aulast%3DBrightbill%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DH.%2BF.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DGogol%26aufirst%3DE.%26aulast%3DHymowitz%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKnuppel%26aufirst%3DK.%26aulast%3DKraemer%26aufirst%3DJ.%26aulast%3DKruger%26aufirst%3DS.%26aulast%3DLoke%26aufirst%3DP.%26aulast%3DMcEwan%26aufirst%3DP.%26aulast%3DMontalbetti%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DStructure-based%2520design%2520of%2520tricyclic%2520NF-kappaB%2520inducing%2520kinase%2520%2528NIK%2529%2520inhibitors%2520that%2520have%2520high%2520selectivity%2520over%2520phosphoinositide-3-kinase%2520%2528PI3K%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D627%26epage%3D640%26doi%3D10.1021%2Facs.jmedchem.6b01363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blaquiere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanedo, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezhkovskiy, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightbill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godemann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabbe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hole, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alaoui
Ismaili, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEwan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestre, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujatha-Bhaskar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span> <span> </span><span class="NLM_article-title">Scaffold-hopping approach to discover potent, selective, and efficacious inhibitors of NF-kappaB inducing kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6801</span>– <span class="NLM_lpage">6813</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00678</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00678" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6801-6813&author=N.+Blaquiereauthor=G.+M.+Castanedoauthor=J.+D.+Burchauthor=L.+M.+Berezhkovskiyauthor=H.+Brightbillauthor=S.+Brownauthor=C.+Chanauthor=P.+C.+Chiangauthor=J.+J.+Crawfordauthor=T.+Dongauthor=P.+Fanauthor=J.+Fengauthor=N.+Ghilardiauthor=R.+Godemannauthor=E.+Gogolauthor=A.+Grabbeauthor=A.+J.+Holeauthor=B.+Huauthor=S.+G.+Hymowitzauthor=M.+H.+Alaoui%0AIsmailiauthor=H.+Leauthor=P.+Leeauthor=W.+Leeauthor=X.+Linauthor=N.+Liuauthor=P.+A.+McEwanauthor=B.+McKenzieauthor=H.+L.+Silvestreauthor=E.+Sutoauthor=S.+Sujatha-Bhaskarauthor=G.+Wuauthor=L.+C.+Wuauthor=Y.+Zhangauthor=Z.+Zhongauthor=S.+T.+Staben&title=Scaffold-hopping+approach+to+discover+potent%2C+selective%2C+and+efficacious+inhibitors+of+NF-kappaB+inducing+kinase&doi=10.1021%2Facs.jmedchem.8b00678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase</span></div><div class="casAuthors">Blaquiere, Nicole; Castanedo, Georgette M.; Burch, Jason D.; Berezhkovskiy, Leonid M.; Brightbill, Hans; Brown, Suzanne; Chan, Connie; Chiang, Po-Chang; Crawford, James J.; Dong, Teresa; Fan, Peter; Feng, Jianwen; Ghilardi, Nico; Godemann, Robert; Gogol, Emily; Grabbe, Alice; Hole, Alison J.; Hu, Baihua; Hymowitz, Sarah G.; Alaoui Ismaili, Moulay Hicham; Le, Hoa; Lee, Patrick; Lee, Wyne; Lin, Xingyu; Liu, Ning; McEwan, Paul A.; McKenzie, Brent; Silvestre, Hernani L.; Suto, Eric; Sujatha-Bhaskar, Swathi; Wu, Guosheng; Wu, Lawren C.; Zhang, Yamin; Zhong, Zoe; Staben, Steven T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6801-6813</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NF-κB-inducing kinase (NIK) is a protein kinase central to the noncanonical NF-κB pathway downstream from multiple TNF receptor family members, including BAFF, which has been assocd. with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metab.  We report herein the discovery of lead chem. series of NIK inhibitors that were identified through a scaffold-hopping strategy using structure-based design.  Electronic and steric properties of lead compds. were modified to address glutathione conjugation and amide hydrolysis.  These highly potent compds. exhibited selective inhibition of LTβR-dependent p52 translocation and transcription of NF-κB2 related genes.  Compd. 4f is shown to have a favorable pharmacokinetic profile across species and to inhibit BAFF-induced B cell survival in vitro and reduce splenic marginal zone B cells in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FXb6VJDRqbVg90H21EOLACvtfcHk0lhG3Sggu-pVXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73P&md5=5ff01b23d827b3d96078a17fff885aea</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00678%26sid%3Dliteratum%253Aachs%26aulast%3DBlaquiere%26aufirst%3DN.%26aulast%3DCastanedo%26aufirst%3DG.%2BM.%26aulast%3DBurch%26aufirst%3DJ.%2BD.%26aulast%3DBerezhkovskiy%26aufirst%3DL.%2BM.%26aulast%3DBrightbill%26aufirst%3DH.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DC.%26aulast%3DChiang%26aufirst%3DP.%2BC.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26aulast%3DDong%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DP.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGodemann%26aufirst%3DR.%26aulast%3DGogol%26aufirst%3DE.%26aulast%3DGrabbe%26aufirst%3DA.%26aulast%3DHole%26aufirst%3DA.%2BJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DAlaoui%2BIsmaili%26aufirst%3DM.%2BH.%26aulast%3DLe%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DMcEwan%26aufirst%3DP.%2BA.%26aulast%3DMcKenzie%26aufirst%3DB.%26aulast%3DSilvestre%26aufirst%3DH.%2BL.%26aulast%3DSuto%26aufirst%3DE.%26aulast%3DSujatha-Bhaskar%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26atitle%3DScaffold-hopping%2520approach%2520to%2520discover%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitors%2520of%2520NF-kappaB%2520inducing%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6801%26epage%3D6813%26doi%3D10.1021%2Facs.jmedchem.8b00678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pippione, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sainas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccinini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubbutat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morice, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducime, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boschi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Karadaghi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lolli, M. L.</span></span> <span> </span><span class="NLM_article-title">N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">963</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1039/C8MD00068A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1039%2FC8MD00068A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30108985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=963-968&author=A.+C.+Pippioneauthor=S.+Sainasauthor=A.+Federicoauthor=E.+Lupinoauthor=M.+Piccininiauthor=M.+Kubbutatauthor=J.+M.+Contrerasauthor=C.+Moriceauthor=A.+Bargeauthor=A.+Ducimeauthor=D.+Boschiauthor=S.+Al-Karadaghiauthor=M.+L.+Lolli&title=N-Acetyl-3-aminopyrazoles+block+the+non-canonical+NF-kB+cascade+by+selectively+inhibiting+NIK&doi=10.1039%2FC8MD00068A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">N-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIK</span></div><div class="casAuthors">Pippione, Agnese C.; Sainas, Stefano; Federico, Antonella; Lupino, Elisa; Piccinini, Marco; Kubbutat, Michael; Contreras, Jean-Marie; Morice, Christophe; Barge, Alessandro; Ducime, Alex; Boschi, Donatella; Al-Karadaghi, Salam; Lolli, Marco L.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">963-968</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">NF-κB-inducing kinase (NIK), an oncogenic drug target that is assocd. with various cancers, is a central signalling component of the non-canonical pathway.  A blind screening process, which established that amino pyrazole related scaffolds have an effect on IKKbeta, led to a hit-to-lead optimization process that identified the aminopyrazole 3a as a low μM selective NIK inhibitor.  Compd. 3a effectively inhibited the NIK-dependent activation of the NF-κB pathway in tumor cells, confirming its selective inhibitory profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8sxhc9e4QtLVg90H21EOLACvtfcHk0lgjnnntGCiHYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVKktL4%253D&md5=b3a8d7028a3365d230745b5497bf7464</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2FC8MD00068A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MD00068A%26sid%3Dliteratum%253Aachs%26aulast%3DPippione%26aufirst%3DA.%2BC.%26aulast%3DSainas%26aufirst%3DS.%26aulast%3DFederico%26aufirst%3DA.%26aulast%3DLupino%26aufirst%3DE.%26aulast%3DPiccinini%26aufirst%3DM.%26aulast%3DKubbutat%26aufirst%3DM.%26aulast%3DContreras%26aufirst%3DJ.%2BM.%26aulast%3DMorice%26aufirst%3DC.%26aulast%3DBarge%26aufirst%3DA.%26aulast%3DDucime%26aufirst%3DA.%26aulast%3DBoschi%26aufirst%3DD.%26aulast%3DAl-Karadaghi%26aufirst%3DS.%26aulast%3DLolli%26aufirst%3DM.%2BL.%26atitle%3DN-Acetyl-3-aminopyrazoles%2520block%2520the%2520non-canonical%2520NF-kB%2520cascade%2520by%2520selectively%2520inhibiting%2520NIK%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26spage%3D963%26epage%3D968%26doi%3D10.1039%2FC8MD00068A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubenstein, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushing, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eksterowicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plotnikova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Inhibiting NF-kappaB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1244</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.bmcl.2013.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=23374866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1238-1244&author=K.+Liauthor=L.+R.+McGeeauthor=B.+Fisherauthor=A.+Sudomauthor=J.+Liuauthor=S.+M.+Rubensteinauthor=M.+K.+Anwerauthor=T.+D.+Cushingauthor=Y.+Shinauthor=M.+Ayresauthor=F.+Leeauthor=J.+Eksterowiczauthor=P.+Faulderauthor=B.+Waszkowyczauthor=O.+Plotnikovaauthor=E.+Farrellyauthor=S.+H.+Xiaoauthor=G.+Chenauthor=Z.+Wang&title=Inhibiting+NF-kappaB-inducing+kinase+%28NIK%29%3A+discovery%2C+structure-based+design%2C+synthesis%2C+structure-activity+relationship%2C+and+co-crystal+structures&doi=10.1016%2Fj.bmcl.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures</span></div><div class="casAuthors">Li, Kexue; McGee, Lawrence R.; Fisher, Ben; Sudom, Athena; Liu, Jinsong; Rubenstein, Steven M.; Anwer, Mohmed K.; Cushing, Timothy D.; Shin, Youngsook; Ayres, Merrill; Lee, Fei; Eksterowicz, John; Faulder, Paul; Waszkowycz, Bohdan; Plotnikova, Olga; Farrelly, Ellyn; Xiao, Shou-Hua; Chen, Guoqing; Wang, Zhulun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1238-1244</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery, structure-based design, synthesis, and optimization of NIK inhibitors are described.  Our work began with an HTS hit, imidazopyridinyl pyrimidinamine I.  We utilized homol. modeling and conformational anal. to optimize the indole scaffold leading to the discovery of novel and potent conformationally constrained inhibitors such as compds. II [R1 = Br, C≡CCMe2OH].  Compds. II [R1 = Br] and III were co-crystd. with NIK kinase domain to provide structural insights.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5WqvTIrBqrVg90H21EOLACvtfcHk0lgjnnntGCiHYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGmt7s%253D&md5=a382078cf3bf84a41749783be33a5988</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DK.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DSudom%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DRubenstein%26aufirst%3DS.%2BM.%26aulast%3DAnwer%26aufirst%3DM.%2BK.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DAyres%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DF.%26aulast%3DEksterowicz%26aufirst%3DJ.%26aulast%3DFaulder%26aufirst%3DP.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DFarrelly%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DInhibiting%2520NF-kappaB-inducing%2520kinase%2520%2528NIK%2529%253A%2520discovery%252C%2520structure-based%2520design%252C%2520synthesis%252C%2520structure-activity%2520relationship%252C%2520and%2520co-crystal%2520structures%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1238%26epage%3D1244%26doi%3D10.1016%2Fj.bmcl.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calado, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derudder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajewsky, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt-Supprian, M.</span></span> <span> </span><span class="NLM_article-title">NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">10883</span>– <span class="NLM_lpage">10888</span>, <span class="refDoi"> DOI: 10.1073/pnas.0805186105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1073%2Fpnas.0805186105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=18663224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFOisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=10883-10888&author=Y.+Sasakiauthor=D.+P.+Caladoauthor=E.+Derudderauthor=B.+Zhangauthor=Y.+Shimizuauthor=F.+Mackayauthor=S.+Nishikawaauthor=K.+Rajewskyauthor=M.+Schmidt-Supprian&title=NIK+overexpression+amplifies%2C+whereas+ablation+of+its+TRAF3-binding+domain+replaces+BAFF%3ABAFF-R-mediated+survival+signals+in+B+cells&doi=10.1073%2Fpnas.0805186105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells</span></div><div class="casAuthors">Sasaki, Yoshiteru; Calado, Dinis P.; Derudder, Emmanuel; Zhang, Baochun; Shimizu, Yuri; Mackay, Fabienne; Nishikawa, Shin-ichi; Rajewsky, Klaus; Schmidt-Supprian, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">10883-10888</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">BAFF-R-dependent activation of the alternative NF-κB pathway plays an essential role in mature B cell survival.  Mutations leading to overexpression of NIK and deletion of the TRAF3 gene are implicated in human multiple myeloma.  We show that overexpression of NIK in mouse B lymphocytes amplifies alternative NF-κB activation and peripheral B cell nos. in a BAFF-R-dependent manner, whereas uncoupling NIK from TRAF3-mediated control causes maximal p100 processing and dramatic hyperplasia of BAFF-R-independent B cells.  NIK controls alternative NF-κB signaling by increasing the protein levels of its neg. regulator TRAF3 in a dose-dependent fashion.  This mechanism keeps NIK protein levels below detection even when they cause B cell hyperplasia, so that contributions of NIK to B cell pathologies can easily be overlooked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC4s0KtZsXFLVg90H21EOLACvtfcHk0ljZ0V__Jhm6wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFOisro%253D&md5=a94d9b5c5c7ac50169da8cea2f144209</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0805186105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0805186105%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DCalado%26aufirst%3DD.%2BP.%26aulast%3DDerudder%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DMackay%26aufirst%3DF.%26aulast%3DNishikawa%26aufirst%3DS.%26aulast%3DRajewsky%26aufirst%3DK.%26aulast%3DSchmidt-Supprian%26aufirst%3DM.%26atitle%3DNIK%2520overexpression%2520amplifies%252C%2520whereas%2520ablation%2520of%2520its%2520TRAF3-binding%2520domain%2520replaces%2520BAFF%253ABAFF-R-mediated%2520survival%2520signals%2520in%2520B%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D10883%26epage%3D10888%26doi%3D10.1073%2Fpnas.0805186105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polesso, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span> <span> </span><span class="NLM_article-title">NIK overexpression intrinsically inhibits regulatory T cell function</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>186</i></span> (<span class="NLM_issue">Suppl.</span>),  <span class="NLM_fpage">168.9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=168.9&issue=Suppl.&author=F.+Polessoauthor=S.+Murrayauthor=A.+Roweauthor=D.+Parker&title=NIK+overexpression+intrinsically+inhibits+regulatory+T+cell+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolesso%26aufirst%3DF.%26aulast%3DMurray%26aufirst%3DS.%26aulast%3DRowe%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DD.%26atitle%3DNIK%2520overexpression%2520intrinsically%2520inhibits%2520regulatory%2520T%2520cell%2520function%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26issue%3DSuppl%26spage%3D168.9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devenport, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortensen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascalho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wobus, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colacino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span> <span> </span><span class="NLM_article-title">Intestinal non-canonical NF kappa B signaling shapes the local and systemic immune response</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">660</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-08581-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fs41467-019-08581-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30737385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXns1Cqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=660&author=S.+K.+Ramakrishnanauthor=H.+B.+Zhangauthor=X.+Y.+Maauthor=I.+Jungauthor=A.+J.+Schwartzauthor=D.+Trinerauthor=S.+N.+Devenportauthor=N.+K.+Dasauthor=X.+Xueauthor=M.+Y.+Zengauthor=Y.+L.+Huauthor=R.+M.+Mortensenauthor=J.+K.+Greensonauthor=M.+Cascalhoauthor=C.+E.+Wobusauthor=J.+A.+Colacinoauthor=G.+Nunezauthor=L.+Y.+Ruiauthor=Y.+M.+Shah&title=Intestinal+non-canonical+NF+kappa+B+signaling+shapes+the+local+and+systemic+immune+response&doi=10.1038%2Fs41467-019-08581-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinal non-canonical NFκB signaling shapes the local and systemic immune response</span></div><div class="casAuthors">Ramakrishnan, Sadeesh K.; Zhang, Huabing; Ma, Xiaoya; Jung, Inkyung; Schwartz, Andrew J.; Triner, Daniel; Devenport, Samantha N.; Das, Nupur K.; Xue, Xiang; Zeng, Melody Y.; Hu, Yinling; Mortensen, Richard M.; Greenson, Joel K.; Cascalho, Marilia; Wobus, Christiane E.; Colacino, Justin A.; Nunez, Gabriel; Rui, Liangyou; Shah, Yatrik M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">660</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Microfold cells (M-cells) are specialized cells of the intestine that sample luminal microbiota and dietary antigens to educate the immune cells of the intestinal lymphoid follicles.  The function of M-cells in systemic inflammatory responses are still unclear.  Here we show that epithelial non-canonical NFkB signaling mediated by NFkB-inducing kinase (NIK) is highly active in intestinal lymphoid follicles, and is required for M-cell maintenance.  Intestinal NIK signaling modulates M-cell differentiation and elicits both local and systemic IL-17A and IgA prodn.  Importantly, intestinal NIK signaling is active in mouse models of colitis and patients with inflammatory bowel diseases; meanwhile, constitutive NIK signaling increases the susceptibility to inflammatory injury by inducing ectopic M-cell differentiation and a chronic increase of IL-17A.  Our work thus defines an important function of non-canonical NFkB and M-cells in immune homeostasis, inflammation and polymicrobial sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOaVPXm0eE27Vg90H21EOLACvtfcHk0ljZ0V__Jhm6wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXns1Cqs7o%253D&md5=11b48d240c220c2243040acc457d224d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-08581-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-08581-8%26sid%3Dliteratum%253Aachs%26aulast%3DRamakrishnan%26aufirst%3DS.%2BK.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DMa%26aufirst%3DX.%2BY.%26aulast%3DJung%26aufirst%3DI.%26aulast%3DSchwartz%26aufirst%3DA.%2BJ.%26aulast%3DTriner%26aufirst%3DD.%26aulast%3DDevenport%26aufirst%3DS.%2BN.%26aulast%3DDas%26aufirst%3DN.%2BK.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DM.%2BY.%26aulast%3DHu%26aufirst%3DY.%2BL.%26aulast%3DMortensen%26aufirst%3DR.%2BM.%26aulast%3DGreenson%26aufirst%3DJ.%2BK.%26aulast%3DCascalho%26aufirst%3DM.%26aulast%3DWobus%26aufirst%3DC.%2BE.%26aulast%3DColacino%26aufirst%3DJ.%2BA.%26aulast%3DNunez%26aufirst%3DG.%26aulast%3DRui%26aufirst%3DL.%2BY.%26aulast%3DShah%26aufirst%3DY.%2BM.%26atitle%3DIntestinal%2520non-canonical%2520NF%2520kappa%2520B%2520signaling%2520shapes%2520the%2520local%2520and%2520systemic%2520immune%2520response%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D660%26doi%3D10.1038%2Fs41467-019-08581-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepper, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackay, S.</span></span> <span> </span><span class="NLM_article-title">Inhibitory-kappa B kinase (IKK) alpha and nuclear factor-kappa B (NF kappa B)-inducing kinase (NIK) as anti-cancer drug targets</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">176</span>, <span class="refDoi"> DOI: 10.3390/cells7100176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.3390%2Fcells7100176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVagurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=176&author=A.+Paulauthor=J.+Edwardsauthor=C.+Pepperauthor=S.+Mackay&title=Inhibitory-kappa+B+kinase+%28IKK%29+alpha+and+nuclear+factor-kappa+B+%28NF+kappa+B%29-inducing+kinase+%28NIK%29+as+anti-cancer+drug+targets&doi=10.3390%2Fcells7100176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory-κB kinase (IKK) and nuclear factor-κB (NFκB)-inducing kinase (NIK) as anti-cancer drug targets</span></div><div class="casAuthors">Paul, Andrew; Edwards, Joanne; Pepper, Christopher; Mackay, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">176</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The cellular kinases inhibitory-κB kinase (IKK) and Nuclear Factor-κB (NF-κB)-inducing kinase (NIK) are well recognized as key central regulators and drivers of the non-canonical NF-κB cascade and as such dictate the initiation and development of defined transcriptional responses assocd. with the liberation of p52-RelB and p52-p52 NF-κB dimer complexes.  While these kinases and downstream NF-κB complexes transduce pro-inflammatory and growth stimulating signals that contribute to major cellular processes, they also play a key role in the pathogenesis of a no. of inflammatory-based conditions and diverse cancer types, which for the latter may be a result of background mutational status.  IKKα and NIK, therefore, represent attractive targets for pharmacol. intervention.  Here, specifically in the cancer setting, we reflect on the potential pathophysiol. role(s) of each of these kinases, their assocd. downstream signalling outcomes and the stimulatory and mutational mechanisms leading to their increased activation.  We also consider the downstream coordination of transcriptional events and phenotypic outcomes illustrative of key cancer 'Hallmarks' that are now increasingly perceived to be due to the coordinated recruitment of both NF-κB-dependent as well as NF-κB-independent signalling.  Furthermore, as these kinases regulate the transition from hormone-dependent to hormone-independent growth in defined tumor subsets, potential tumor reactivation and major cytokine and chemokine species that may have significant bearing upon tumor-stromal communication and tumor microenvironment it reiterates their potential to be drug targets.  Therefore, with the emergence of small mol. kinase inhibitors targeting each of these kinases, we consider medicinal chem. efforts to date and those evolving that may contribute to the development of viable pharmacol. intervention strategies to target a variety of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTdGyUaXyjN7Vg90H21EOLACvtfcHk0lgmu_lJGkrwiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVagurnP&md5=b001524ba18de5d0b396c78e4a697977</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3390%2Fcells7100176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells7100176%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DA.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DPepper%26aufirst%3DC.%26aulast%3DMackay%26aufirst%3DS.%26atitle%3DInhibitory-kappa%2520B%2520kinase%2520%2528IKK%2529%2520alpha%2520and%2520nuclear%2520factor-kappa%2520B%2520%2528NF%2520kappa%2520B%2529-inducing%2520kinase%2520%2528NIK%2529%2520as%2520anti-cancer%2520drug%2520targets%26jtitle%3DCells%26date%3D2018%26volume%3D7%26spage%3D176%26doi%3D10.3390%2Fcells7100176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laskowski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swindells, M. B.</span></span> <span> </span><span class="NLM_article-title">LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2778</span>– <span class="NLM_lpage">2786</span>, <span class="refDoi"> DOI: 10.1021/ci200227u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200227u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2778-2786&author=R.+A.+Laskowskiauthor=M.+B.+Swindells&title=LigPlot%2B%3A+multiple+ligand-protein+interaction+diagrams+for+drug+discovery&doi=10.1021%2Fci200227u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery</span></div><div class="casAuthors">Laskowski, Roman A.; Swindells, Mark B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2778-2786</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe a graphical system for automatically generating multiple 2D diagrams of ligand-protein interactions from 3D coordinates.  The diagrams portray the hydrogen-bond interaction patterns and hydrophobic contacts between the ligand(s) and the main-chain or side-chain elements of the protein.  The system is able to plot, in the same orientation, related sets of ligand-protein interactions.  This facilitates popular research tasks, such as analyzing a series of small mols. binding to the same protein target, a single ligand binding to homologous proteins, or the completely general case where both protein and ligand change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYuWvYH7Nel7Vg90H21EOLACvtfcHk0lgmu_lJGkrwiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP&md5=576e59ad4f0c4304d01c6c80301ecf39</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fci200227u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200227u%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DSwindells%26aufirst%3DM.%2BB.%26atitle%3DLigPlot%252B%253A%2520multiple%2520ligand-protein%2520interaction%2520diagrams%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2778%26epage%3D2786%26doi%3D10.1021%2Fci200227u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leibel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrante, A. W.</span></span> <span> </span><span class="NLM_article-title">Obesity is associated with macrophage accumulation in adipose tissue</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1796</span>– <span class="NLM_lpage">1808</span>, <span class="refDoi"> DOI: 10.1172/JCI200319246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1172%2FJCI200319246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=14679176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVSmtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=1796-1808&author=S.+P.+Weisbergauthor=D.+McCannauthor=M.+Desaiauthor=M.+Rosenbaumauthor=R.+L.+Leibelauthor=A.+W.+Ferrante&title=Obesity+is+associated+with+macrophage+accumulation+in+adipose+tissue&doi=10.1172%2FJCI200319246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Obesity is associated with macrophage accumulation in adipose tissue</span></div><div class="casAuthors">Weisberg, Stuart P.; McCann, Daniel; Desai, Manisha; Rosenbaum, Michael; Leibel, Rudolph L.; Ferrante, Anthony W., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1796-1808</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Obesity alters adipose tissue metabolic and endocrine function and leads to an increased release of fatty acids, hormones, and proinflammatory mols. that contribute to obesity assocd. complications.  To further characterize the changes that occur in adipose tissue with increasing adiposity, we profiled transcript expression in perigonadal adipose tissue from groups of mice in which adiposity varied due to sex, diet, and the obesity-related mutations agouti (Ay) and obese (Lepob).  We found that the expression of 1,304 transcripts correlated significantly with body mass.  Of the 100 most significantly correlated genes, 30% encoded proteins that are characteristic of macrophages and are pos. correlated with body mass.  Immunohistochem. anal. of perigonadal, perirenal, mesenteric, and s.c. adipose tissue revealed that the percentage of cells expressing the macrophage marker F4/80 (F4/80+) was significantly and pos. correlated with both adipocyte size and body mass.  Similar relationships were found in human s.c. adipose tissue stained for the macrophage antigen CD68.  Bone marrow transplant studies and quantitation of macrophage no. in adipose tissue from macrophage-deficient (Csf1op/op)mice suggest that these F4/80+ cells are CSF-1 dependent, bone marrow-derived adipose tissue macrophages.  Expression anal. of macrophage and nonmacrophage cell populations isolated from adipose tissue demonstrates that adipose tissue macrophages are responsible for almost all adipose tissue TNF-α expression and significant amts. of iNOS and IL-6 expression.  Adipose tissue macrophage nos. increase in obesity and participate in inflammatory pathways that are activated in adipose tissues of obese individuals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmO9SQ6PLDDbVg90H21EOLACvtfcHk0lgmu_lJGkrwiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVSmtLvO&md5=5737fc015b73f7fc180664b93c63dc48</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1172%2FJCI200319246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI200319246%26sid%3Dliteratum%253Aachs%26aulast%3DWeisberg%26aufirst%3DS.%2BP.%26aulast%3DMcCann%26aufirst%3DD.%26aulast%3DDesai%26aufirst%3DM.%26aulast%3DRosenbaum%26aufirst%3DM.%26aulast%3DLeibel%26aufirst%3DR.%2BL.%26aulast%3DFerrante%26aufirst%3DA.%2BW.%26atitle%3DObesity%2520is%2520associated%2520with%2520macrophage%2520accumulation%2520in%2520adipose%2520tissue%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26spage%3D1796%26epage%3D1808%26doi%3D10.1172%2FJCI200319246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardet, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span> <span> </span><span class="NLM_article-title">Design and evaluation of a potential mutagen for Hepatitis C virus</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5261</span>– <span class="NLM_lpage">5264</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.bmcl.2007.03.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=17689246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1elsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5261-5264&author=Y.+H.+Kohauthor=J.+H.+Shimauthor=J.+L.+Girardetauthor=Z.+Hong&title=Design+and+evaluation+of+a+potential+mutagen+for+Hepatitis+C+virus&doi=10.1016%2Fj.bmcl.2007.03.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design and evaluation of a potential mutagen for Hepatitis C virus</span></div><div class="casAuthors">Koh, Yung-Hyo; Shim, Jae Hoon; Girardet, Jean-Luc; Hong, Zhi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5261-5264</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pyrrolopyrimidine nucleoside 1 was designed and synthesized as a potential mutagen for HCV.  An in vitro HCV NS5B enzymic assay indicated that pyrrolopyrimidine triphosphate acts as a CTP analog rather than a UTP analog.  The SATE-prodrug of pyrrolopyrimidine monophosphate showed a weak inhibitory activity in an HCV replicon system (EC50 = 60 μM) and did not exhibit cytotoxicity (CC50 > 100 μM).  Investigation of phosphorylation events using nucleoside kinases and LC-MS anal. revealed that the second phosphorylation step, from monophosphate ester to diphosphate ester, is unfavorable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUfn3C36AUELVg90H21EOLACvtfcHk0lgOIvJpvF67zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1elsrw%253D&md5=bc362262ac39a823c93cddbff57b2d19</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.091%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DY.%2BH.%26aulast%3DShim%26aufirst%3DJ.%2BH.%26aulast%3DGirardet%26aufirst%3DJ.%2BL.%26aulast%3DHong%26aufirst%3DZ.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520a%2520potential%2520mutagen%2520for%2520Hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5261%26epage%3D5264%26doi%3D10.1016%2Fj.bmcl.2007.03.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Mild Method for Ullmann Coupling Reaction of Amines and Aryl Halides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2453</span>– <span class="NLM_lpage">2455</span>, <span class="refDoi"> DOI: 10.1021/ol0346584</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0346584" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVGmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=2453-2455&author=D.+Maauthor=Q.+Caiauthor=H.+Zhang&title=Mild+Method+for+Ullmann+Coupling+Reaction+of+Amines+and+Aryl+Halides&doi=10.1021%2Fol0346584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mild Method for Ullmann Coupling Reaction of Amines and Aryl Halides</span></div><div class="casAuthors">Ma, Dawei; Cai, Qian; Zhang, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2453-2455</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Copper(I)-catalyzed Ullmann-type arom. amination of aryl iodides and aryl bromides in DMSO at 40-90° gave the corresponding N-aryl or N,N-diaryl amines in good to excellent yields by using either N-methylglycine or L-proline as a ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX5ndEYPU6SLVg90H21EOLACvtfcHk0lgOIvJpvF67zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVGmsL0%253D&md5=bc5b519b822d571da47dc09725177447</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fol0346584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0346584%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DMild%2520Method%2520for%2520Ullmann%2520Coupling%2520Reaction%2520of%2520Amines%2520and%2520Aryl%2520Halides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D2453%26epage%3D2455%26doi%3D10.1021%2Fol0346584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beveridge, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstenberger, B. S.</span></span> <span> </span><span class="NLM_article-title">A direct copper-catalyzed route to pyrrolo-fused heterocycles from boronic acids</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">569</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.11.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.tetlet.2011.11.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OlsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=564-569&author=R.+E.+Beveridgeauthor=B.+S.+Gerstenberger&title=A+direct+copper-catalyzed+route+to+pyrrolo-fused+heterocycles+from+boronic+acids&doi=10.1016%2Fj.tetlet.2011.11.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A direct copper-catalyzed route to pyrrolo-fused heterocycles from boronic acids</span></div><div class="casAuthors">Beveridge, Ramsay E.; Gerstenberger, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">564-569</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A convenient route to prep. azaindoles and related pyrrolo-fused heterocycles from boronic acids, DBAD (di-tert-Bu diazodicarboxylate), and enolizable aldehydes and ketones is presented.  E.g., reaction of 6-methoxy-3-pyridineboronic acid, DMAD, and PhCH2CHO, catalyzed by Cu(OAc)2, gave 70% azaindole deriv. I.  The reaction proceeds via a one-pot four-step cascade sequence with key steps involving a copper-catalyzed boronic acid coupling to DBAD and a Fischer indolization providing access to a variety of pharmaceutically interesting heterocycles including pyrrolopyridines, -pyrimidines, -quinolines, and -isoquinolines from readily available aza-aryl boronic acid precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHwILfeahtlLVg90H21EOLACvtfcHk0lgOIvJpvF67zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OlsL%252FO&md5=8228679938fb89609ae64cb65c65f8ed</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.11.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.11.091%26sid%3Dliteratum%253Aachs%26aulast%3DBeveridge%26aufirst%3DR.%2BE.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26atitle%3DA%2520direct%2520copper-catalyzed%2520route%2520to%2520pyrrolo-fused%2520heterocycles%2520from%2520boronic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2012%26volume%3D53%26spage%3D564%26epage%3D569%26doi%3D10.1016%2Fj.tetlet.2011.11.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Purbeta promotes hepatic glucose production by increasing Adcy6 transcription</span>. <i>Mol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.molmet.2019.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1016%2Fj.molmet.2019.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=31918924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOgsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=85-97&author=L.+Jiaauthor=Y.+Jiangauthor=X.+Liauthor=Z.+Chen&title=Purbeta+promotes+hepatic+glucose+production+by+increasing+Adcy6+transcription&doi=10.1016%2Fj.molmet.2019.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Purβ promotes hepatic glucose production by increasing Adcy6 transcription</span></div><div class="casAuthors">Jia, Linna; Jiang, Yunfeng; Li, Xinzhi; Chen, Zheng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-97</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Enhanced glucagon signaling and hepatic glucose prodn. (HGP) can account for hyperglycemia in patients with obesity and type 2 diabetes.  However, the detailed mol. mechanisms underlying the enhanced HGP in these patients are not fully understood.  Here, we identify Purβ as a pos. regulator of HGP and study its mol. mechanisms in the regulation of HGP both in vivo and in vitro. Adenovirus-mediated knockdown or overexpression of Purβ was performed in either primary hepatocytes or the livers of db/db mice.  Glucose metab., insulin sensitivity, and HGP were detd. by glucose, insulin, and lactate tolerance tests, resp.  Purβ/ADCY6 protein levels, glucagon signaling (p-CREB/CREB), and insulin signaling (p-Akt/Akt) were measured by immunoblotting.  Gene expression was measured by RNA-seq and real-time quant. polymerase chain reaction.  Luciferase reporter and chromatin immunopptn. assays were used to study the interaction between Purβ and the Adcy6 promoter. Purβ was abnormally elevated in obese mice and was also increased under fasting conditions or via the glucagon signaling pathway, which promoted HGP by increasing Adcy6 expression.  Liver-specific knockdown of Purβ in db/db mice significantly ameliorated hyperglycemia and glucose intolerance by suppressing the glucagon/ADCY6/cAMP/PKA/CREB signaling pathway.  Consistent with this observation, the knockdown of Purβ also inhibited glucose prodn. in isolated primary hepatocytes by inhibiting the glucagon/ADCY6/cAMP/PKA/CREB signaling pathway, whereas the overexpression of Purβ promoted glucose prodn. by activating this signaling pathway.  Mechanistically, Purβ directly binds to the promoter of the Adcy6 gene and thereby promotes its transcription. Taken together, these results illustrate a new model in which Purβ functions to regulate the glucagon/ADCY6/cAMP/PKA/CREB signaling pathway to help maintain glucose homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5WSFaj0Tc-LVg90H21EOLACvtfcHk0lhCGV4awXza_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOgsL3M&md5=709b7fbbea8bbe3cf39ea86280b25bbb</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2019.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2019.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DPurbeta%2520promotes%2520hepatic%2520glucose%2520production%2520by%2520increasing%2520Adcy6%2520transcription%26jtitle%3DMol.%2520Metab.%26date%3D2020%26volume%3D31%26spage%3D85%26epage%3D97%26doi%3D10.1016%2Fj.molmet.2019.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span> <span> </span><span class="NLM_article-title">NF-kappaB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">949</span>, <span class="refDoi"> DOI: 10.1038/nm.2756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.1038%2Fnm.2756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=22581287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFeqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=943-949&author=L.+Shengauthor=Y.+Zhouauthor=Z.+Chenauthor=D.+Renauthor=K.+W.+Choauthor=L.+Jiangauthor=H.+Shenauthor=Y.+Sasakiauthor=L.+Rui&title=NF-kappaB-inducing+kinase+%28NIK%29+promotes+hyperglycemia+and+glucose+intolerance+in+obesity+by+augmenting+glucagon+action&doi=10.1038%2Fnm.2756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action</span></div><div class="casAuthors">Sheng, Liang; Zhou, Yingjiang; Chen, Zheng; Ren, Decheng; Cho, Kae Won; Jiang, Lin; Shen, Hong; Sasaki, Yoshiteru; Rui, Liangyou</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">943-949</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The canonical inhibitor of nuclear factor κB kinase subunit β (IKK-β)-nuclear factor of κ light polypeptide gene enhancer in B cells 1 (NF-κB1) pathway has been well documented to promote insulin resistance; however, the noncanonical NF-κB-inducing kinase (NIK)-NF-κB2 pathway is not well understood in obesity.  Addnl., the contribution of counter-regulatory hormones, particularly glucagon, to hyperglycemia in obesity is unclear.  Here we show that NIK promotes glucagon responses in obesity.  Hepatic NIK was abnormally activated in mice with dietary or genetic obesity.  Systemic deletion of Map3k14, encoding NIK, resulted in reduced glucagon responses and hepatic glucose prodn. (HGP).  Obesity is assocd. with high glucagon responses, and liver-specific inhibition of NIK led to lower glucagon responses and HGP and protected against hyperglycemia and glucose intolerance in obese mice.  Conversely, hepatocyte-specific overexpression of NIK resulted in higher glucagon responses and HGP.  In isolated mouse livers and primary hepatocytes, NIK also promoted glucagon action and glucose prodn., at least in part by increasing cAMP response element-binding (CREB) stability.  Therefore, overactivation of liver NIK in obesity promotes hyperglycemia and glucose intolerance by increasing the hyperglycemic response to glucagon and other factors that activate CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcOdoju-8CbVg90H21EOLACvtfcHk0lhCGV4awXza_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFeqs7g%253D&md5=62840c2d7f7ddfac5d251f6ade9149f0</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnm.2756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2756%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DD.%26aulast%3DCho%26aufirst%3DK.%2BW.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DY.%26aulast%3DRui%26aufirst%3DL.%26atitle%3DNF-kappaB-inducing%2520kinase%2520%2528NIK%2529%2520promotes%2520hyperglycemia%2520and%2520glucose%2520intolerance%2520in%2520obesity%2520by%2520augmenting%2520glucagon%2520action%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D943%26epage%3D949%26doi%3D10.1038%2Fnm.2756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gittes, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span> <span> </span><span class="NLM_article-title">Islet alpha-cell inflammation induced by NF-kappaB inducing kinase (NIK) leads to hypoglycemia, pancreatitis, growth retardation, and postnatal death in mice</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5960</span>– <span class="NLM_lpage">5971</span>, <span class="refDoi"> DOI: 10.7150/thno.28960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=10.7150%2Fthno.28960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=30613274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;key=1%3ACAS%3A528%3ADC%252BC1MXps1Oqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=5960-5971&author=X.+Liauthor=L.+Jiaauthor=X.+Chenauthor=Y.+Dongauthor=X.+Renauthor=Y.+Dongauthor=Y.+Chenauthor=L.+Xieauthor=M.+Liuauthor=C.+Shiotaauthor=G.+K.+Gittesauthor=L.+Ruiauthor=Z.+Chen&title=Islet+alpha-cell+inflammation+induced+by+NF-kappaB+inducing+kinase+%28NIK%29+leads+to+hypoglycemia%2C+pancreatitis%2C+growth+retardation%2C+and+postnatal+death+in+mice&doi=10.7150%2Fthno.28960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Islet α-cell inflammation induced by NF-κB inducing kinase (NIK) leads to hypoglycemia, pancreatitis, growth retardation, and postnatal death in mice</span></div><div class="casAuthors">Li, Xinzhi; Jia, Linna; Chen, Xiaoyue; Dong, Ying; Ren, Xiaomeng; Dong, Yuefan; Chen, Ying; Xie, Liwei; Liu, Ming; Shiota, Chiyo; Gittes, George K.; Rui, Liangyou; Chen, Zheng</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5960-5971</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Islet α-cell dysfunction has been shown to contribute to type 2 diabetes; however, whether islet α-cell inflammation is involved in the occurrence of pancreatitis is largely unknown.  The aims of this study were to investigate how NF-κB inducing kinase (NIK) regulates pancreatic α-cell function, both in vitro and in vivo, and to assess how islet α-cell inflammation induced by NIK affects the development of pancreatitis.  Methods: We utilized adenovirus-mediated NIK overexpression, ELISA, qPCR, RNA-seq, and Western blot analyses to study the role of NIK in islet α cells in vitro.  Islet α-cell-specific NIK overexpressing (α-NIK-OE) mice were generated, and pancreatic α/β-cell function and the occurrence of pancreatitis in these mice were assessed via ELISA, qPCR, and immunohistochem. analyses.  Results: The LTβR/noncanonical NF-κB signaling pathway is present in islet α cells.  Overexpression of NIK in αTC1-6 cells induces inflammation and cell death, contributing to a decrease in the expression and secretion of glucagon.  Addnl., α-cell specific overexpression of NIK (α-NIK-OE) results in α-cell death, lower serum glucagon levels, and hypoglycemia in mice.  Strikingly, α-NIK-OE mice also display a reduced β-cell mass, growth retardation, pancreatitis, and postnatal death.  Conclusions: Islet α-cell specific overexpression of NIK results in islet α-cell dysfunction and causes islet β-cell death and pancreatitis, which are most likely due to paracrine secretion of cytokines and chemokines from islet α cells, thus leading to hypoglycemia, growth retardation, and postnatal death in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplJmXIblTd1rVg90H21EOLACvtfcHk0lhCGV4awXza_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXps1Oqsbk%253D&md5=9ca73a1cdaa350057bd5d1d9d033f8e6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.7150%2Fthno.28960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.28960%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DShiota%26aufirst%3DC.%26aulast%3DGittes%26aufirst%3DG.%2BK.%26aulast%3DRui%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DIslet%2520alpha-cell%2520inflammation%2520induced%2520by%2520NF-kappaB%2520inducing%2520kinase%2520%2528NIK%2529%2520leads%2520to%2520hypoglycemia%252C%2520pancreatitis%252C%2520growth%2520retardation%252C%2520and%2520postnatal%2520death%2520in%2520mice%26jtitle%3DTheranostics%26date%3D2018%26volume%3D8%26spage%3D5960%26epage%3D5971%26doi%3D10.7150%2Fthno.28960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G3E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G3E','PDB','4G3E'); return false;">PDB: 4G3E</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i121"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00396">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_75827"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00396?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00396</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Spectral data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_002.xlsx">XLSX</a>)</p></li><li><p class="inline">Spectra of <sup>1</sup>H and <sup>13</sup>C NMR, crystallography data of (<i>S</i>)-<b>S6</b>, a list of 98 kinases in a KINOMEscan assay (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_003.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_001.pdf">jm0c00396_si_001.pdf (7.84 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_002.xlsx">jm0c00396_si_002.xlsx (12.25 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00396/suppl_file/jm0c00396_si_003.pdf">jm0c00396_si_003.pdf (6.49 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00396&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-8%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00396%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00396" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b7e018292440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
